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To my dear family 
ABSTRACT 
Are you wanting a more popular scientific summary? Please turn to page 68.  
Vill du hellre läsa en populärvetenskaplig sammanfattning? Bläddra då till sid. 70. 
 
Many essential micronutrients found in fruits and vegetables exhibit antioxidant 
properties, protecting against oxidation and oxidative stress. Their ability to react with 
electrons also enables them to act as pro-oxidants, causing damage opposed to 
preventing it. While fruit and vegetables rich in micronutrients generally protect against 
oxidative damage and related diseases, supplementation studies with micronutrients 
have not been verified to have the same health beneficial effect. In fact, even harmful 
consequences have been seen. The reason for the ambiguous results is still not fully 
understood and this thesis investigates some of the factors believed to be involved. The 
focus is on the effect of micronutrients on DNA lesions, potential contributors to cancer 
development. The thesis takes you into chemical properties of micronutrients (papers I 
and II), it also explores their health effects in two human studies (papers III and IV).  
 
When investigating pro-oxidant properties of thirteen micronutrients in this thesis, two 
of them stood out oxidising the DNA nucleoside deoxyguanosine in a dose-dependent 
manner – namely vitamin A and vitamin C. Compounds permitted in supplements as 
either ‘vitamin A’ (four compounds) or ‘vitamin C’ (five compounds) also differed in 
their potencies to act as pro-oxidants. The combination of vitamin C and copper 
particularly stood out, inducing oxidation to pure deoxyguanosine, but also to the DNA 
of cells in culture, a potential concern since both are commonly found in multivitamin 
supplements. 
 
In an observational study, the impact of folate/folic acid status, intake or genes on DNA 
lesions (uracil misincorporation, oxidative DNA lesions, DNA breaks) in mononuclear 
cells of 36 infertile women was explored. Folate and related parameters were found not 
to correlate with DNA lesions in these women with adequate folate status. Our results 
add to the carefully accumulating evidence indicating that, even though folate status 
has been associated with DNA lesions, the effect seems to be more evident in subjects 
with folate deficiency. An increased interest has been drawn towards micronutrient 
supplements imitating the natural content of fruit, vegetables and berries, as for 
example with berry extracts. This thesis report on a crossover intervention study where 
chronic kidney disease patients were administered a supplement containing oil extracts 
from the sea buckthorn berry rich in micronutrients and fatty acids. An eight-week 
administration did not affect their levels of DNA lesions (oxidative DNA lesions, DNA 
breaks) in minor salivary glands, nor mouth dryness or disease specific parameters.   
 
Taken together, the results within this thesis add to the somewhat confusing evidence 
on micronutrient supplements and their properties and health effects. It emphasises that 
each micronutrient has unique properties, some with strong pro-oxidant activity 
dependent on factors in their immediate surrounding. The results also add to the 
growing evidence of a lack of effect on health from micronutrient supplements. It 
might be that supplementation with micronutrients provides best benefit in those with 
initially low nutrient levels.  
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Preface 
The field of micronutrient supplements is a somewhat controversial field, with pro-
supplement speakers on the one hand and con-supplement speakers on the other. Both 
sides are to some extent convinced that their view is correct. Since research has 
revealed both positive and negative health effects after micronutrient supplementation, 
it comes as no surprise that different views have arisen. And truthfully, who wouldn’t 
like the idea of one fast and simple way to get the nutrients we need? In this thesis, 
results from my and others studies concerning antioxidants and other micronutrients, 
their properties and health effects are presented.  
The world of research and science is a unique field; it is an exciting field where 
curiosity, learning and constant improvement is crucial parts in order to take the 
research in the direction of progression – and make a small contribution to something 
great. As for many before me, my time as a PhD student has been somewhat like a 
roller coaster ride, with both ups and downs with the project moving forward, standing 
still and even moving backwards (yes my friends, it is possible!), only to turn around 
and move forward again (luckily!). I’ve had the pleasure of having amazing colleagues 
who have inspired and guided me and with whom discussions have resolved many 
scientific issues.  
I have also had the pleasure to teach, lecture and organise courses and events alongside 
my research. On a personal level, the time as a PhD student has given me the 
opportunity to open my eyes for the exciting and highly important world of 
environmental medicine and all the areas that it includes. I am now looking forward to 
continue the exciting learning journey. 
The zigzag road of science will pervade as you read on in this thesis… 
 
Therese Woodhill, Stockholm October 2012 
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1 INTRODUCTION 
Have you ever taken a 
dietary supplement? Maybe 
with the intention to deceive 
that approaching cold? Or 
increase your general health? 
Or reduce the risk of cancer 
from suddenly developing? 
Multivitamin supplements 
containing a mix of vitamins 
and metals (‘minerals’) are 
widely consumed in the 
general population. Recent 
reports from the national 
health and nutrition examination survey (NHANES) in US indicate that 33% of the 
adults consume multivitamin supplements containing both vitamins and metals 
regularly, or ‘during the last month’ [1]. Dietary supplements on the whole are 
consumed on a regular basis by 49% of the US adults [1]. To my knowledge no such 
figures are available for Sweden alone, but the prevalence is assumed to be similar 
here. In 2010, vitamin and mineral supplements were sold for 490 million SEK in 
Sweden, a figure that has been steadily increasing [2]. 
 
The wide use of dietary supplements is anticipated to be due to its advertised and 
accredited health beneficial effects, but how much is supported by scientific evidence? 
When considering their effect on cancer, the wide use of micronutrient supplements can 
actually be viewed as a concern. The use of supplements is currently debated, with a 
number of recent articles addressing the issue [3,4]. The bulk evidence is pointing 
towards a lack of health beneficial effects, in relation to cancer, from supplements 
when consumed by the general, well-nourished population. Even harmful effects have 
been observed, which emphasises the concern of the wide use of supplements as well as 
the need for clarification of the mechanisms behind micronutrients. 
  
The thesis in your hand will bring you into the world of micronutrient supplements – 
discussing the (sometimes contradictory) properties of micronutrients, and their effects 
in humans, with a focus on their influence on the genetic make up, the DNA, and 
cancer.  
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2 FRUIT AND VEGETABLES VS. DIETARY 
SUPPLEMENTS 
Are micronutrient supplements and their properties favourable or harmful to us? This 
thesis explores this issue. What do studies say about them and their content? This 
chapter aims to give a background to the field of micronutrient supplements, giving an 
overview of the complexity that this field of research faces. Later chapters will go 
deeper into specific micronutrients within the scope of this thesis. For reasons that will 
be made clear later on, the main focus in this thesis is on the effect of micronutrients on 
DNA and cancer.  
 
 
2.1 FRUIT AND VEGETABLES 
Fruit and vegetables are rich in antioxidants and a number of other micronutrients. A 
varied diet with plenty of fruit and vegetables has not only been thought to be 
beneficial but scientific research has also verified that they are good for many aspects 
of human health. Fruit and vegetables in the diet lower the risk of for example stroke, 
coronary heart disease, hypertension and cancer as summarised in Table 1 [5,6]. 
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Since fruit and vegetables are rich in micronutrients (including both vitamins and 
antioxidants), antioxidants have to a large extent been accredited for the health 
beneficial effects of fruit and vegetables. What happens if we extract or synthesise 
(manufacture) individual or a few antioxidants/micronutrients and consume them on 
their own? Antioxidant supplements containing one or a few antioxidants have been 
synthesised with the aim to achieve the same health promoting effects as fruit and 
vegetables. But do they have the promised effects?  
 
 
2.2 DIETARY SUPPLEMENTS 
The micronutrients, vitamins and antioxidants that supplements contain have been 
added to the tablets or capsules in the hope to give the same health beneficial effects as 
those naturally found from fruit and vegetables. As will be discussed later the 
antioxidants and vitamins found in dietary supplements may be of synthetic origin, may 
be present in high doses, in unnatural forms and in combinations not naturally found in 
fruit and vegetables. This thesis is focused on the effects of micronutrient supplements 
  3 
on DNA and DNA damage/lesions. As will be further explained in chapter 5, some 
DNA lesions can potentially lead to mutation and cancer. As you read on, the focus lies 
on the effects of micronutrient supplements and their effect on cancer prevalence. This 
section will give a selected overview of the scientific literature on the topic, 
schematically summarised in Figure 2. Can micronutrient supplementation prevent 
cancer?  
 
The golden standard in micronutrient human studies is to conduct intervention studies 
which are randomised, large in size and placebo-controlled. These studies are also 
referred to as randomised controlled trials, RCTs. Other study designs are briefly 
described in chapter 6. Below, the attention is on well-established, large, randomised 
and placebo-controlled intervention studies conducted on micronutrient supplements in 
relation to cancer.  
 
2.2.1 The Linxian General Population Nutrition Intervention Trial 
Approximately 30 000 middle-aged men and women (n = 29 584, age 40-69 years) 
from the general population were given supplements containing different combinations 
of a number of micronutrients with the aim to monitor mortality and cancer frequency. 
The study was conducted between 1986 and 1991, and was carried out in the Linxian 
province in China, a region with a high incidence of oesophageal cancer and 
persistently low intake of several micronutrients. The participants were randomised into 
eight groups, receiving different combinations of vitamin A (retinol, 5000 IU), zinc 
(zinc oxide, 22.5 mg), vitamin B2 (riboflavin, 3.2 mg), vitamin B3 (niacin, 40 mg), 
vitamin C (ascorbic acid, 120 mg), molybdenum (molybdenum yeast complex, 30 μg), 
β-carotene (15 mg), selenium (selenium yeast, 50 μg) and vitamin E (α-tocopherol, 30 
mg). The figures within brackets denote the daily intake. When compared to current 
recommendations by the Swedish National Food Agency (year 2012), depicted in Table 
2, most of these vitamin doses are approximately twice the recommended daily intake 
(RDI). Supplements were taken daily during an average period of 5.25 years [7].  
 
At the end of the trial, a 9% reduction of the total mortality rate and a 21% reduction of 
gastric (stomach) cancer incidence were observed in the group receiving a combination 
of β-carotene, vitamin E and selenium [7]. In a follow-up study published in 2009, the 
beneficial effects remained [8]. In the same area, another study was conducted in which 
patients diagnosed with oesophageal dysplasia in the same area were administered 14 
vitamins and 12 minerals for six years. Again, positive results were obtained. The total 
mortality incidence was 7% lower in the supplemented group compared to controls, and 
the total cancer incidence was 4% lower [9]. 
 
2.2.2 The ATBC Lung Cancer Prevention Study 
The aim of the Alpha-Tocopherol, Beta-Carotene (ATBC) prevention study was to 
determine whether supplementation of vitamin E (α-tocopherol) or β-carotene, or both, 
reduce lung cancer incidence in male smokers [10-12]. Initiated in 1985 in Finland, this 
study included 29 133 male habitual smokers (20.4 cigarettes/day) aged 50-69 years. 
They received vitamin E (α-tocopherol, 50 mg), β-carotene (20 mg), a combination of 
both or placebo for 5-8 years [12]. The dose of vitamin E corresponds to five times the  
  4
1Recommendations by the Natural Food Agency in Sweden. 
21 retinol equivalent (RE) = 1 μg retinol = 12 μg β-carotene. 
31 niacine equivalent (NE) = 1 mg niacin = 60 mg tryptophan. 
4No Nordic recommendations. 5 mg is mentioned on the National Food Agency’s homepage (2012) as a norm in US. 
5No Swedish recommendations. A varied diet should give 40 mg per day on average. 
6300 μg: women above childbearing age, 400 μg: women who might become pregnant. 
710 μg for children under the age of two, and for elderly people with nonsufficient sun exposure. 
8α-tocopherol equivalents, 1 α-tocopherol equivalent (αTE) = 1 mg RRR-α-tocopherol. 
9Not part of the nutritional recommendations in the Nordic countries. The American Institute of Medicine considers 
120 μg for men and 90 μg for women as an adequate intake. 
 
recommended RDI in Sweden. The dose of β-carotene is of pharmacological (i.e. high) 
levels [11]. As a pro-vitamin A, β-carotene is included in the RDI for vitamin A, and 
20 mg β-carotene is equivalent to twice the RDI for vitamin A. 
 
The main finding of this intervention study came as a surprise to the authors. Amongst 
the subjects receiving β-carotene, the incidence of lung cancer was increased by 18% 
and mortality by 8%. Vitamin E supplementation significantly reduced prostate cancer 
[12]. The harm of β-carotene supplementation was diminished after the intervention 
was terminated, a follow-up after three years revealed a non-significant 17% increase 
of lung cancer incidence while the risk was absent six years after the intervention. The 
beneficial effect on prostate cancer was absent at the three-year follow-up [13].   
 
2.2.3 CARET 
The β-Carotene and Retinol Efficacy Trial, CARET, of US origin commenced in 1983 
[14-16]. The participants were 18 314 smokers, former smokers and/or workers 
exposed to asbestos aged 45-74 years. They were either given a combination of vitamin 
A (retinyl palmitate, 25 000 IU) and β-carotene (30 mg) or placebo. The intervention 
prolonged for 4.0 years on average, and was terminated 21 months earlier than planned 
due to the preliminary findings and the outcome of the ATBC study. As in the ATBC 
study, CARET caused an increase in lung cancer incidence following supplementation, 
with 28%. Among the supplemented participants, there was an increase in incidence of 
total mortality by 17%, in mortality from lung cancer by 46% and in mortality from 
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cardiovascular disease by 26% [16]. A 
six-year follow-up concluded that the 
adverse effects by β-carotene and 
vitamin A on lung cancer incidence 
and all-cause mortality remained, 
although they were no longer 
statistically significant [14]. The 
increased risk of mortality from 
cardiovascular disease was no longer 
present.  
 
2.2.4 Physicians’ Health Study I 
This intervention was designed to test 
the effect of low-dose aspirin and β-
carotene on cardiovascular and cancer 
disease in a healthy population [17,18]. It was initiated in 1982 when 22 071 US male 
physicians aged 40-84 years were given either aspirin (325 mg), β-carotene (50 mg), 
both or placebo to be consumed every second day. Due to clear beneficial effects of 
aspirin on myocardial infarction the aspirin intervention was terminated after five years 
while the β-carotene arm carried on [17]. After 12 years of β-carotene intake, no effect 
on cancer frequency or mortality was seen [18]. Neither among current nor former 
smokers, 11% and 39% of the study population, respectively, were there any effects in 
these outcomes [18].  
 
2.2.5 Physicians’ Health Study II 
Following the physician’s health study I (PHS I) a second study, PHS II, began in 1997 
[19,20]. 14 641 male physicians aged 50 years or older were enrolled with the intention 
to investigate the effect of micronutrients on cardiovascular disease, total cancer and 
prostate cancer. A 24 factorial design was used in which the participants were 
randomised into 16 groups and administered different combinations of vitamin C 
(ascorbic acid, 500 mg), vitamin E (α-tocopherol, 400 IU), β-carotene (50 mg), 
multivitamin or placebo during an average period of eight years, or until 2003 for β-
carotene. Vitamin E and β-carotene were taken on alternate days, while vitamin C and 
multivitamin were taken daily. The vitamin C and vitamin E daily doses are 
approximately six times and 20 times the Swedish RDI, respectively. β-carotene in 
PHS II has become subject to investigations beyond the scope of this thesis (i.e. on 
cognitive behaviour [21]). Neither vitamin C nor vitamin E either caused or prevented 
cardiovascular disease, prostate cancer or total cancer [19,20]. Results regarding the 
multivitamin supplementation were published while this thesis was at its final stage. 
These new results reveal a reduction in total cancer from multivitamin consumption in 
men with a baseline history of cancer [22].  
 
2.2.6 The Women’s Health Initiative 
The Women’s Health Initiative addresses the most common causes of death, disabilities 
and impaired quality of life in postmenopausal women, with focus on cardiovascular 
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disease, cancer and osteoporosis. The prevention study began in 1991, went on for 15 
years and included randomised controlled clinical trials as well as an observational 
study. One of the trials investigated the effect of vitamin D and calcium 
supplementation on colorectal cancer risk and bone fractures [23,24]. 36 282 
postmenopausal women from the US aged 50-79 years were administered a 
combination of calcium (calcium carbonate, 1 g) and vitamin D (vitamin D3, 400 IU) or 
placebo daily, during an average period of 7 years. Treatment with vitamin D and 
calcium did not have any effect on the incidence of colorectal cancer [24].  
 
2.2.7 The SU.VI.MAX study 
The Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) study 
initiated in 1994 involved 13 017 French adults, both men (aged 45-60 years) and 
women (aged 35-60 years). On a daily basis during a period of 7.5 years, the 
participants were given capsules of vitamin C (ascorbic acid, 120 mg), vitamin E (30 
mg), β-carotene (6 mg), selenium (selenium-enriched yeast, 100 μg) and zinc (20 mg), 
or placebo [25]. Overall, supplementation had no effect on total cancer incidence, 
cardiovascular disease or all-cause mortality. However, when analysing men and 
women separately, men in the supplementation group had lower cancer incidence (31% 
lower) as well as a lower mortality risk (37% lower) compared to the control group. 
The men also had lower levels of certain antioxidants at the start of the study (at 
‘baseline’). This reduced risk was no longer evident five years post-supplementation 
[26]. 
 
2.2.8 SELECT 
The Selenium and Vitamin E Cancer Prevention Trial (SELECT) commenced in 2001 
and included 35 533 men above 50 years of age from the US, Canada and Puerto Rico 
[27]. They were given vitamin E (α-tocopheryl acetate, 400 IU), selenium 
(selenomethionine, 200 μg), a combination of both, or placebo daily during an average 
period of 5.5 years. The main outcome investigated was prostate cancer, but also lung 
cancer, colorectal caner, other primary cancers and mortality. No significant reduction 
or increase in any of these cancer forms was observed. Initially a non-significant 
increase of 13% in prostate cancer was, however, seen amongst the participants 
receiving vitamin E [27]. In a follow-up this evolved to a significant increase of 17% 
[28]. The group receiving vitamin E had a statistically non-significant increase in 
prostate cancer of 13%.  The initial absence of significant data in SELECT opened a 
debate in which both the micronutrient form used [29] and the common use of one or a 
few antioxidants for therapeutic purposes were questioned and challenged [30]. 
 
2.2.9 Meta-analysis 
The attention of the current section is on large, randomised placebo-controlled 
intervention studies/trials. In order to obtain a comprehensive understanding of what 
the evidence from studies mean when they are put together, meta-analysis provides a 
helpful tool. In these studies, data from all available studies (within the set inclusion 
criteria) are considered in combination and conclusions drawn from all data.  
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A number of meta-analysis related to micronutrients and cancer or mortality have been 
conducted finding associations between for example β-carotene, vitamin A and vitamin 
E, singly [31,32] or in different combinations [31,33], and increased mortality risk. The 
same authors did, however, not find effects on mortality among the overall participants 
receiving vitamin C, selenium [31,32] or β-carotene [34]. Meta-analysis have 
concluded different micronutrients, alone or in combinations, to have either no effect 
on cancer [34-36], a protective effect [37] or a promoting effect [35]. 
 
2.2.10 Observational studies 
A PubMed search on observational studies (case-control studies or cohort studies) and 
antioxidants (conducted using Mesh-terms, on the 28th September 2012) reveals 2 846 
hits. In this section a selection of two large studies published during recent years are 
described within the scope of this thesis.  
 
VITAL 
In the VITamins And Lifestyle (VITAL) study 77 126 US men and women aged 50-76 
years were followed in respect to vitamin use and its effect on lung cancer. Slatore et 
al. [38] found no evidence that either multivitamin, vitamin C or folate had any effect 
on lung cancer. Vitamin E, however, was associated with a statistically non-significant 
5% increase in mortality risk, a risk that was more pronounced in smokers [38]. 
 
The Iowa Women’s Health Study  
This recent observational study from 2011, in which 38 772 women aged 55-60 years 
responded to food and supplement questionnaires concluded that a majority of the 
vitamin and mineral supplements consumed had no effect on mortality [39]. However, 
multivitamins, vitamin B6, folic acid, magnesium and copper individually increased 
mortality risk in some of the statistical models, while the association between iron and 
mortality was strongest showing a correlation to mortality risk in several statistical 
models. Calcium supplementation was associated with decreased mortality risk [39].   
 
2.2.11 What can explain the different effects from micronutrient supplements?  
Taken together, studies have not shown micronutrient supplementation to be disease 
preventive, instead they have raised questions of why they often do not protect, and 
have sometimes even shown harmful health effect. The discrepancy is illustrated in 
Figure 2. As depicted in Figure 3, several factors have been, or can be, pinpointed as 
contributors to the different outcomes:  
 
Nutritional status and health 
The Linxian trial that reported beneficial effects from supplementation, was carried out 
in a high risk population. The general population of this area have a high incidence of 
oesophageal cancer accompanied by persistently low intake of several micronutrients 
[7]. The reduced cancer and mortality risk seen in supplemented men in the 
SU.VI.MAX study was suggested to be attributed to low baseline statuses of certain 
antioxidants [25]. In the intervention studies mentioned above, the participants showing 
no or harmful health effects did not report low nutrient status. However, the ATBC trial 
identified an inverse association between intake of α-tocopherol and β-carotene from 
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food at baseline and the risk of lung cancer during the trial [12]. These above studies 
suggest that the nutritional status at baseline seems to be important for the outcome of 
supplementation. Evidence suggests that deficient subject might benefit from 
supplementation of micronutrients, while healthy individuals might not. In addition, in 
the trials where healthy participants were studied, to which PHS I and II, the Women’s 
Health Initiative, SU.VI.MAX and SELECT belong, no effect was observed on cancer 
incidence [18-20,24,25,27].  
 
Supplement composition 
Supplements often contain one or a few micronutrients present in combinations that 
differ from those naturally found in fruit and vegetables. Many antioxidants co-operate 
with one another and one antioxidant might therefore require the presence of another in 
order to function properly. For example, vitamin C and E cooperate in preventing 
oxidation of cell membranes. Vitamin E scavenges peroxyl radicals, protecting the 
membrane from lipid oxidation. Vitamin C recycles (reduces) vitamin E back to its 
original form, enabling further protection [40]. Without vitamin C, the protection from 
vitamin E would be less efficient. Similarly, expected properties of supplements can be 
speculated to be absent if the naturally cooperating ‘partner(s)’ are not present.  
 
Micronutrient dose  
Furthermore, it may not be enough that the correct micronutrients are present; they may 
need to be present at a specific dose. Micronutrient supplements often contain high 
doses of micronutrients, which might also hamper their function. Some properties of 
antioxidants are affected by the antioxidant’s own concentration. β-Carotene and 
vitamin C have both been observed to cause oxidation instead of protecting against it 
when present at high concentrations [41]. The ATBC trial, CARET as well as PHS I 
had pharmaceutical (i.e. high) levels of β-carotene, the two former causing harmful 
effects (in smokers) while the latter did not (in mostly non-smokers) [12,16,18].  
 
Micronutrient form 
Many micronutrients found in supplements are not of natural origin, instead many have 
been synthesised, i.e. chemically manufactured. Vitamin E constitutes a classic 
example of the important implications of this. Vitamin E is naturally found in eight 
isomeric forms, but is often only present in one form (α-tocopherol) in supplements. 
During recent years the importance of another vitamin E compound, γ-tocopherol, has 
been stressed, highlighting the importance of the choice of micronutrient forms [42]. As 
mentioned above, the SELECT opened a debate of the form of selenium used in 
supplement studies [29]. The European Parliament and Council regulate which specific 
compounds that are allowed in supplements (directive 2002/46/EC). For vitamin C this 
directive comprises five different compounds, and for vitamin A four different 
compounds. These are compared and discussed in paper II and chapters 7 and 8.  
 
Milieu 
Environmental factors also influence the action of many micronutrients. For example, 
under a high oxygen pressure or high temperature, β-carotene can act as a pro-oxidant 
instead of an antioxidant (pro-oxidants will be explained later in this and later 
chapters). In the ATBC trial as well as in CARET, smokers had an increased risk of 
developing lung cancer after β-carotene supplementation [12,16]. The lung of a smoker 
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is recognised for having a high oxygen pressure, a high level of free radicals and low 
antioxidant levels, especially of vitamin C and E [43]. These conditions can promote 
pro-oxidant behaviour of β-carotene but also oxidation of β-carotene. Resulting 
oxidation products have been proposed to be involved in the adverse health effects in 
smokers [43,44].  
 
Antioxidants – pro-oxidants 
Micronutrients with antioxidant properties generally help to protect biomolecules 
against oxidation and oxidative damage. Under certain conditions they can, however, 
start to act as oxidants instead of antioxidants, causing oxidative damage as opposed to 
preventing it. Antioxidants thus have the ability to also act as pro-oxidants. β-carotene, 
vitamin C and vitamin A have all been documented to be able to act as pro-oxidants 
[45-47]. In addition, the phenomenon of pro-oxidant properties is extensively studied in 
papers I and II and further described and discussed in chapters 5, 7 and 8. 
 
Oxidative stress 
When the antioxidants act as pro-oxidants, the balance between oxidising agents and 
the protective systems of the cell, can become disturbed and a condition referred to as 
oxidative stress occur. In all constituent articles, papers I-IV, oxidative stress plays an 
important role.  
 
 
This thesis investigates and discusses properties and health effects of micronutrients. 
Much focus lies on pro-oxidant properties of antioxidants, oxidative stress and DNA 
damage/lesions.  
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3  RESEARCH AIM 
The overall aim of this thesis is to investigate properties and health effects of 
micronutrients. Particular focus is put on properties related to oxidative stress since it is 
believed to be involved in the varied outcomes from micronutrient supplements, while 
their exact role is yet not fully understood. Emphasis is put on the effect of 
micronutrients on DNA, as well as on the ability of antioxidants or micronutrients to 
act as pro-oxidants.  
 
Specific aims have been to answer the following questions: 
 
1. Do micronutrients/antioxidants chemically act as pro-oxidants and if so, do they 
do so with different strengths? 
2. Do micronutrients with pro-oxidant potential act as pro-oxidants in cultured 
cells? 
3. Do different compounds in supplements classed as either vitamin A or C differ 
in their abilities to act as pro-oxidants? 
4. Do folate levels, intake or genes related to folate metabolism predict levels of 
DNA lesions?  
5. Does a supplement containing a berry extract rich in antioxidants reduce DNA 
lesion levels, improve health or improve the oral health of chronic kidney 
disease patients? 
 
 
 
  11
4 MICRONUTRIENTS 
So why do micronutrients receive so much attention? What is each of them good for? 
This section will briefly explain the role of individual micronutrients, giving an 
overview of their role in humans (also illustrated in Figure 4) as well as of potential 
supplementation recommendations. First, however, it is time to clarify what 
micronutrients, vitamins and antioxidants are and what their differences are. 
   
 
4.1 MICRONUTRIENTS, ANTIOXIDANTS AND VITAMINS – WHAT IS THE 
DIFFERENCE? 
Micronutrients, vitamins and antioxidants are often used without discrepancy in the 
literature. In fact, vitamins and antioxidants are often micronutrients, and many 
vitamins are also antioxidants, which justifies the confused use of the three terms.  
 
Micronutrients are elements needed in minute (small) quantities. They include 
vitamins, antioxidants, metals (minerals) and other compounds needed for the health of 
human cells. Vitamins are essential in minute quantities for a human body to function 
properly. Humans cannot synthesise these compounds and they are therefore required 
through the diet. 13 known vitamins exist.  Antioxidants are substances that, at low 
concentrations, delay or inhibit oxidative damage to molecules [48]. They may for 
example do so by reacting with and neutralising oxidants (free radicals or other reactive 
species), thereby preventing damage that the oxidants may otherwise have caused. 
Many, but not all, vitamins can act in this way and are therefore also classed as 
antioxidants.  
 
The term “micronutrients” is extensively used in this thesis and refers to vitamins, 
antioxidants as well as other micronutrients. 
 
 
4.2 VITAMIN A 
In its natural form vitamin A is found in animal products, and it serves as a helper in 
night vision. Particularly rich sources include liver, fish oil, dairy products and eggs. 
Consumption of vitamin A is required for a functioning vision, gene expression, cell 
growth and development, immune function and embryonic development [49]. Vitamin 
A is a generic term, a ‘family name’, that refers to a group of fat-soluble compounds 
with the biological activity of retinol. It constitutes both preformed vitamin A including 
retinyl esters and retinol, as well as provitamin A including β-carotene, α-carotene and 
β-cryptoxanthin. The latter class is cleaved (i.e. cut) to vitamin A in vivo and serves as 
an important source of vitamin A [40].  
 
When consumed as a supplement, vitamin A can be harmful at high doses. In its natural 
form, such high doses can only be achieved through excessive consumption of for 
example liver. High doses of vitamin A can affect vision, muscular coordination, liver, 
bones and joints and give rise to osteoporotic diseases. In Sweden, vitamin A was 
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withdrawn from AD-drops given to babies and infants in 2009, as much as 10 years 
after our neighbours in Denmark. Nevertheless, vitamin A has limited antioxidant 
capacity and has been shown to have preventive effects against certain cancer forms 
[50]. According to an extensive report conducted by the World Cancer Research Fund 
and American Institute for Cancer Research, there is ‘limited evidence’ that vitamin A 
protects against skin cancer [6]. Vitamin A is further described and discussed in chapter 
7, and constitutes, together with vitamin C, is the theme of papers I and II.  
 
 
4.3 B VITAMINS 
B vitamins comprise around 30 substances, whereof eight essential: 
 
B1 – thiamine 
B2 – riboflavin  
B3 – niacin  
B5 – pantothenic acid 
B6 – pyridoxine  
B7 – biotin  
B9 – folate (synthetic form: folic acid)  
B12 – cobalamins 
 
They are required as cofactors, for DNA-synthesis, replication, conformation (folate), 
neurotransmitter synthesis (B6), gene expression, development of red blood cells (B6), 
and for preventing neural tube defects (folate) [40]. It is also proposed that B vitamins 
also have preventive properties against DNA damage [51]. Even if many of the B-
vitamins do not have an antioxidant property per se, they cooperate in the protection 
against lipid peroxidation in the glutathione redox cycle (e.g. B2). Studies have also 
proposed B vitamins to affect cancer [40,52,53]. 
 
Folate. Folic acid (the synthetic, manufactured, form of folate, vitamin B9) is one of 
only two vitamins, the other being vitamin D, that the Swedish National Food Agency 
currently (2012) recommends Swedes to take supplements of. The recommendation is 
aimed at women who are planning to become, or are, pregnant (during the first 
trimester). The main reason for this recommendation is the preventive of folic acid on 
neural tube defects in new-borns, but evidence also suggests folates to be important in 
reproductive health as well as in preventing spontaneous abortions [54]. Several 
countries, including the US and Canada apply folic acid fortification of for example 
grains and cereals, while some countries, among which Sweden is one, have decided 
not to. Recent studies have also revealed a possible non-beneficial effect where high 
intake of folic acid supplements has been associated with increased cancer incidence 
[53,55,56]. Natural sources of folate include liver, green leafy vegetables (e.g. spinach, 
broccoli), citrus fruits and beans [40]. Paper III and chapter 9 are entirely devoted to 
folate and will discuss this in more detail. 
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4.4 VITAMIN C 
Vitamin C, also known as ascorbic acid and ascorbate is found in many fruits and 
vegetables. Citric fruits, berries and potatoes are particularly good sources. As vitamin 
C is a cofactor for a number of enzymes involved in the biosynthesis of collagen, 
carnitine and neurotransmitters, it is essential to obtain vitamin C through the diet [40]. 
However, the vitamin is prone to high temperature, oxidation as well as high amounts 
of water. Therefore, rough cooking procedures may reduce vitamin C levels in food. 
Deficiency of vitamin C leads to a weakening of collagenous structure, giving rise to 
tooth loss, joint pains, poor wound healing, bone and connective tissue disorders and 
eventually scurvy – a potentially fatal disease [40]. Vitamin C is a well-established 
antioxidant, with the ability to frequently react with free radicals and thus potentially 
prevent biomolecules from damage. It has been seen to lower the incidence of both 
cardiovascular disease and cancer [57]. Recently, vitamin C at high doses has also been 
suggested to have chemotherapeutic properties [58].  
 
Side-tracking beyond the scope of this thesis, vitamin C is commonly consumed in 
supplemental form with the aim to prevent, or improve symptoms of, the common cold. 
Scientific evidence does, however, not support a reduction of colds in the general 
population due to vitamin C supplementation. Nonetheless, a meta-analysis concluded 
that the incidence of colds in marathon runners undergoing acute physical stress could 
be reduced by supplementation [59]. Vitamin C is further studied and discussed in 
papers I and II, and in chapter 8.  
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4.5 VITAMIN D 
Vitamin D helps the body to utilise calcium and phosphorous, which are necessary to 
build up strong bones and teeth. Vitamin D is yet another generic term comprising a 
group of steroid compounds of which vitamin D2 and D3 are most prominent. Vitamin 
D3 is produced in the skin when the precursor 7-dehydrocholesterol is hit by sunlight. 
Together with other hormones it helps to maintain the calcium balance. Through this 
action, vitamin D is important for blood clotting, nerve pulse transmission, membrane 
structure and muscle contraction. A deficiency of vitamin D leads to low calcium and 
phosphorous levels which contribute to demineralisation of bone, which can lead to 
softening of bones in adults (osteomalacia) and rickets, causing the spine and legs to 
crook in children [40].  
 
Since the body can produce vitamin D3 itself, vitamin D is not “essential” to consume 
in the same sense as other vitamins, or as the term ‘vitamin’ implies (see section 4.1 for 
definition). When the amount of sunlight is insufficient, or large amounts of air 
pollution, clothing or sunscreens are hindering its entry; vitamin D3 is, however, 
required through the diet. Fatty fish is a good source of vitamin D, but to raise the 
consumption of this micronutrient, milk is fortified with vitamin D3. Vitamin D is the 
second, and last, vitamin that the Swedish National Food Agency recommends 
supplementation of (the other being folic acid). The recommendation is aimed at infants 
and toddlers between one month and two years of age, and elderly who are not 
sufficiently exposed to sunlight. In recent years, vitamin D and its link to cancer has 
become of interest to researchers and discussion have been raised about a link to cancer 
of for example the breast, colon and pancreas, as well as mortality due to cancer [60]. 
 
 
4.6 VITAMIN E 
E vitamins are different from other vitamins in that they are not functioning as co-
factors or hormones, nor do they have a role in the metabolism. Instead vitamin E’s 
important role is due to its antioxidant properties. They scavenge (“neutralise”) 
radicals, interrupt chain reactions and protect cells against lipid oxidation. They protect 
the membrane of cells against lipid oxidation [40].  
 
Vitamin E is found in for example vegetable oil, sunflower seeds and almonds. It is a 
generic name referring to eight fat-soluble, structurally similar compounds present in 
two groups named tocopherols and tocotrienols [40]. The structural difference between 
tocopherols and tocotrienols give rise to differences in the potency and efficacy of 
antioxidant capacity [42]. Although all E vitamins are naturally found in food items, 
vitamin E in supplements is commonly found only in the synthetic α-tocopherol form 
[40]. In addition, the synthetic form of α-tocopherol contains eight isomers whereas 
only one of them is believed to meet human requirements [40]. Vitamin E is present in 
the sea buckthorn berry that is discussed in paper IV and chapter 10. 
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4.7 VITAMIN K 
By serving as a cofactor vitamin K promotes the function of proteins involved in the 
clotting, or coagulation, of blood, and a deficiency in vitamin K leads to an acute life-
threatening condition as a result of excessive bleeding. This vitamin also plays a key 
role in maintaining bone strength, inhibiting arterial calcification and regulating cell 
growth [61]. Two natural forms of vitamin K exist, vitamin K1 and K2. Vitamin K1 is 
present in green leafy vegetables such as spinach and broccoli and is the primary 
vitamin K source for humans. Vitamin K2 comprises a group of compounds produced 
by bacteria [40].  
 
Vitamin K deficiency is rare in adults, consequently the Swedish National Food 
Agency does not give recommendations concerning vitamin K intake. Neonates, new-
born babies, are however more at risk of developing vitamin K deficiency [62]. 
Neonates have an insufficient intestinal colonisation (i.e. insufficient vitamin K2 
production) and, probably of greater importance, run the risk of not receiving sufficient 
amounts of vitamin K through breast milk, or through the placenta as foetuses [62]. As 
a consequence of this, many countries, including USA and Sweden, intravenously 
supplement neonates with vitamin K to prevent an increased risk of bleeding.  
 
 
4.8 PHYTOCHEMICALS 
Phytochemicals embrace a class of compounds to which thousands of compounds 
belong. The five main categories include phytoestrogens, carotenoids, phytosterols, 
isothiocyanates and chlorophyll. Phytochemicals are plant compounds that are non-
essential to humans, i.e. they are not classed as vitamins [63]. In recent years, 
phytochemicals have served much attention within research and interest has been 
drawn to their potential cancer-preventive effects. Most of the studies suggesting 
cancer-preventive effects are animal or cell culture studies and a recent review from 
2012 on the available epidemiological (human) studies have concluded that most 
phytochemicals do not affect cancer. Nonetheless, some studies have shown protective 
effects from for example β-carotene, β-cryptoxanthin, isothiocyanates, lignans and 
flavonoids on different cancer types [63].  
 
Carotenoids. Carotenoids constitute of a group of yellow to deep-red pigments found in 
many bright coloured fruits and vegetables. Over 600 known compounds belong to this 
group, whereof one is β-carotene. As a precursor to vitamin A, β-carotene is an 
important source of vitamin A. As opposed to vitamin A, high concentrations of β-
carotene consumed from natural sources has historically not been observed to have 
harmful effects [40]. This is because the absorption of β-carotene is regulated, and is 
irreversibly dependent on its in vivo concentration [40]. In reality, this means that β-
carotene will only be taken up by the cells if the body is in need of it. However, 
environmental factors might affect its destiny and as discussed in chapter 7, β-carotene 
supplementation caused increased lung cancer risk in smokers in the ATBC study and 
CARET [12,16].   
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4.9 METALS/MINERALS 
The human body also requires different elementary metals. Many enzymes require 
metal ions in order to function. In supplements, metals such as calcium, chromium, 
copper, iodine, iron, magnesium, manganese, molybdenum, selenium, zinc are also 
common. Many so called multivitamins which contain both antioxidants, vitamins and 
metals are available on the market. Metals are often referred to as minerals on dietary 
supplement containers. The effect of a combination of certain metals and vitamin A or 
C is brought up in paper I and in chapters 7 and 8. 
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5 OXIDATIVE STRESS, ANTIOXIDANTS AND DNA 
LESIONS 
This chapter brings up some of the most relevant conditions and elements for the 
research within this thesis. It will take you through the wonders of oxidative stress, its 
cause and prevention as well as damage that can occur to DNA.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.1 OXIDATIVE STRESS 
Oxidation is a constant threat to a cell, with the potential to cause damage to 
biomolecules, the compartments of the cell. Not only is it a threat though, oxidation is 
in fact foremost a normal and important step of many reactions taking place in cells, 
reactions in which electrons are transferred between molecules. Oxidising agents and 
other reactive species are continuously formed during normal processes such as during 
energy production in the mitochondrial electron transport chain and during the defence 
against foreign particles by phagocytes [48]. When the oxidising events overwhelm the 
antioxidant protective system of the cell, a condition referred to as oxidative stress 
evolves. Oxidative stress is an imbalance between the oxidising agents and the 
protective system, the term was first introduced in 1985 by Sies and defined in 1991 
[64] as:  
 
“a disturbance in the prooxidant-antioxidant balance in favour of the former, leading 
to potential damage” 
 
Since then, the expression has been broadened and oxidative stress was in 2007 
redefined by Halliwell and Gutteridge [48] as:  
 
“the biomolecular damage caused by attack of reactive species upon the constituents 
of living organisms”  
 
Oxidative stress can cause damage to biomolecules including proteins, lipids and 
DNA. Through this updated definition it becomes clear that oxidative stress can cause 
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not only oxidative damage to these biomolecules, but also that the condition oxidative 
stress itself can give rise to other events and other types of damages. Section 5.3 below 
describes different types of DNA lesions that may or may not arise as a consequence of 
oxidative stress. 
 
5.1.1 Causes of oxidative stress 
In principal, oxidative stress can arise from either of these two scenarios: 
 
• Elevated levels of reactive species. Reactive oxygen species (ROS), reactive 
nitrogen species (RNS), free radicals and other reactive compounds can give raise to 
oxidative stress. Collectively these are referred to as reactive species.  Examples of 
ROS include the superoxide anion (O2•-), hydrogen peroxide (H2O2) and the 
hydroxyl radical (•OH) while RNS include for example peroxynitrite (NO3). The 
concentration of reactive species might be increased above controllable levels by 1) 
an excessive production of naturally occurring reactive species in the cell, 2) 
exposure to particularly high O2 levels, or 3) the presence of toxins producing 
reactive species [48].  
 
• Reduced antioxidant protection. The other option for oxidative stress to occur is by 
an inadequate antioxidant defence, either by insufficient antioxidant enzymes or 
dietary antioxidant depletion. The level of antioxidant enzymes can be hampered by, 
for example, specific mutations, while a lack of exogenous antioxidants might arise 
from an insufficient dietary intake or an incorrect administration, distribution or 
metabolism.   
 
The production of many ROS in the body is strongly associated with redox cycling of 
transition metals. One well-established such reaction is the Fenton reaction, where the 
highly reactive hydroxyl radical is produced from the conjunction of a transition metal 
(M) ion (e.g. Fe2+, Cu+) and hydrogen peroxide.  
 
M 2+ +H2O2 →M 3+ +OH − +OH •  
 
The significance of the Fenton reaction in vivo is, however, unclear. While it is known 
to occur in vitro, the prevalence of for example free catalytic iron within the body is 
small under normal conditions due to the protection of many metal-binding proteins. 
There are, however, conditions under which metal ion levels are increased in vivo, and 
where Fenton reactions might possess a potential source of reactive species.  
 
5.1.2 Consequences of oxidative stress  
Oxidative stress can promote cell proliferation, an up-regulation of the antioxidant 
defence system, cell injury or even cell death [48]. This thesis focuses on effects on 
DNA, and oxidative stress can induce a number of different DNA lesions, oxidative 
DNA lesions. Lipids, proteins and other biomolecules are also prone to damage caused 
by oxidative stress, but these will not be further discussed in this thesis.  
 
(1) 
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Oxidative stress and an increased production of ROS has been connected to more than 
hundred diseases. Its impact seems to be particularly strong in cancer and 
neurodegenerative diseases, including Parkinson and Alzheimer diseases [65]. 
 
5.1.3 Protection against oxidative stress 
The defence system against oxidative stress consists of endogenous and exogenous, 
dietary, antioxidants.  
 
Endogenous antioxidants 
Cells have their own defence system to fight attack from reactive species, and by such 
defending themselves against oxidative stress. The defence comprises several 
antioxidant molecules and antioxidant enzymes as well as enzyme systems that either 
directly reduce reactive species or reduces other biomolecules, such as proteins. Much 
attention has been on the enzymes superoxide dismutases (SOD), catalase, glutathione 
peroxidases, and thioredoxin reductases as well as the antioxidant glutathione [48]. 
 
Exogenous – dietary – antioxidants 
Protection against oxidative stress is also achieved through the entry of antioxidants 
from the diet. These antioxidants can scavenge, i.e. react with – and thereby neutralise 
– reactive species including ROS and other free radicals. In this way, they are able to 
minimise the exposure to oxidising agents and the risk of oxidative stress to evolve. 
 
 
5.2 ANTIOXIDANTS – PRO-OXIDANTS? 
Antioxidants are substances that delay or inhibit oxidative damage to molecules [48]. 
They can scavenge free radicals or neutralise other reactive substances through electron 
transfers. In addition to their scavenging properties, some antioxidants can promote 
antioxidant enzymes or even repair existing DNA damage by e.g. reducing the guanyl 
radical, which is formed as an intermediate during oxidation of the DNA base guanine 
[66]. Alarmingly, their ability to react with electrons also enable antioxidants to act as 
pro-oxidants, causing oxidative stress as opposed to preventing it, as illustrated in 
Figure 5. 
 
Environmental factors influence the antioxidant or pro-oxidant activity and a high 
oxygen pressure (such as that of a smokers lung) and a high antioxidant dose has, for 
example, been seen to promote pro-oxidant behaviour [67,68]. 
 
 
5.3 DNA LESIONS  
The human genetic make-up our DNA is a necessity for life and is the key to the 
construction of all cellular components. It is also responsible for passing on properties 
from one generation to the next. The DNA, or deoxyribonucleic acid, is built up of four 
building blocks, so called nucleotides. The nucleotides consist of a pyrimidine 
(cytosine, C; thymine, T) or purine base (adenine, A; guanine, G), a five carbon sugar 
(2-deoxyribose) and one phosphate group, as seen in Figure 6. The carbon sugar 
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(deoxyribose) and the phosphate group build the backbone of a DNA strand while the 
nucleobase “sticks out” allowing bonds to be formed between bases on opposite DNA 
strands. G and C pair together through three hydrogen bonds and A and T bind through 
two bonds. This base binding holds two DNA strands together, forming the double-
stranded DNA helix for which DNA is recognised.    
 
Both the sugar-phosphate backbone and the bases are vulnerable to attack, which may 
cause different types of damage (lesions). Many important DNA lesions are, or can be, 
created as a consequence of oxidative stress, including the vastly studied 8-oxoguanine. 
Different DNA lesions are described below.   
 
5.3.1 Strand breaks 
Damage to the DNA backbone can lead to strand breaks, either single-strand breaks in 
which one of the strands are broken, or double strand breaks in which both strands are 
broken. If incorrectly repaired, these lesions can induce mutations [69]. Strand breaks 
can also be formed as an intermediate step of DNA repair. 
 
5.3.2 Oxidative DNA lesions 
The four DNA bases are receptive to oxidative damage by e.g. ROS. These damages 
are extensively referred to as oxidative DNA lesions/damages but because the resulting 
lesions are not necessarily oxidants themselves, but merely a result of oxidation 
reactions, some researchers encourage the use of phrases such as oxidatively damaged 
DNA and oxidative damage to DNA for a more accurate description.  
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8-oxoguanine 
The base guanine has the lowest redox potential out of all four DNA bases [70]. A low 
redox potential means that the agent more easily donates electrons, and thus becomes 
oxidised. Guanine is therefore the DNA base that is most susceptible to oxidative 
attack. A key site of radical attack is at the 8-position of guanine, where guanine is 
oxidised and 8-oxoguanine formed, see Figure 7. 8-Oxoguanine alone or its nucleoside 
equivalent (i.e. guanine + deoxyribose, the sugar) 8-oxoguanosine are common 
biomarkers for oxidative stress on DNA [71]. 8-oxoguanosine is commonly 
abbreviated to 8-oxoG or 8-oxoGua. Known by many names, 8-oxodeoxyguanosine is 
also referred to as 8-oxo-2’-deoxyguanosine and 8-oxo-7,8-dihydro-2’deoxyguanosine, 
and commonly abbreviated to 8-oxodG or 8-oxodGua. Undamaged G base pairs with 
C, both present in their anti-configuration. 8-oxoG can also base pair with C, but it can 
also adopt syn conformation and base pair with A instead. In this way a G:C to T:A 
transversion occurs during replication, resulting in a mutation [72]. 8-oxoG is thus a 
pro-mutagenic lesion. Whilst the clinical importance of oxidative DNA lesions remains 
unresolved to date, elevated levels of 8-oxoG have suggested associations with several 
diseases, including cancer and diabetes [73]. Due to it being relatively easily measured, 
in combination with its pro-mutagenic property, 8-oxoG (with or without the attached 
sugar unit) is the most studied lesion [74]. Under normal conditions a background level 
of 0.3-4.2 8-oxoguanine/106 guanine has been established by the European Standards 
Committee on Oxidative DNA Damages, ESCODD [71].  
 
Other oxidative DNA lesions 
Oxidation of guanine can also lead to other lesions including Fapy-guanine (FapyG; a 
ring opened form) and hyperoxidised guanine products, including for example 
oxazolone (Oz), spiroiminodihydantion (Sp), guanidinohydantoin (Gh) and 
imidazolone Iz [72]. Other DNA bases can also be oxidised at different positions, 
creating oxidative lesions including 8-oxoadenine, Fapy-adenine (FapyA), thymine 
glycols, 5-formyluracil, cytosine glycol, 5,6-dihydroxycytosine – to mention some [48]. 
  
5.3.3 DNA adducts 
Alkylation 
Alkylation of the DNA bases, in which carbon-hydrogen molecules bind to the oxygen 
atom, changes the size and shape of the DNA molecule and enables mismatched base 
pairing which may lead to mutations.  
 
Crosslinking 
DNA crosslinks are formed when nucleotides covalently bind to each other, either on 
the same strand or on opposite strands, forming intra- or inter-crosslinks, respectively. 
ROS can induce certain nucleotide modifications that can give raise to crosslinks. 
Crosslinks can block DNA replication and transcription and are believed to be 
mutagenic [75].  
 
  22
5.3.4 Misincorporation of incorrect bases into DNA 
Uracil misincorporation 
Another mutagenic DNA lesion is the presence of uracil (U) in DNA. Uracil is a 
nucleobase normally present in RNA, not in DNA. Deamination of cytosine results in 
the formation of uracil. Folate deficiency can also increase the presence of uracil, since 
a deficiency of folate prevents the conversion of dUMP to dTMP, deoxythymidine 
monophosphate, the thymine nucleotide required for DNA synthesis. Indeed, folate 
deficiency has been associated with uracil misincorporation [52], and this is further 
discussed in Paper III and chapter 9.   
 
5.3.5 Consequences of DNA lesions 
As is described in the following section, many DNA lesions are repaired and further 
damage to the cell is thus avoided. However, DNA lesions (e.g. FapyG and FapyA) 
might also block DNA replication and transcription, possibly resulting in mutation (i.e. 
an incorrectly incorporated base). Under circumstances when the repair is insufficient 
or even fail, mutations may also be created. Mutations occur in cells under normal 
conditions, without developing into cancer. It is primarily when the mutations occur in 
specific genes, for example in oncogenes, tumour-suppressor genes or stability genes, 
that cancer might follow. The process when normal cells are converted into 
proliferating cancer cells is referred to as carcinogenesis and is a complex multistep 
process [48].   
 
 
5.4 REPAIR OF DNA LESIONS 
Two principal repair paths take care of DNA lesions. Small alterations to bases, 
including oxidative DNA lesions, alkylations and single strand breaks, are mainly 
repaired by base excision repair (BER) whereas bulky adducts or bulky single strand 
breaks primarily are repaired by nuclear excision repair (NER). The cells also have 
repair systems for mismatches (misincorporations) as well as for double strand breaks 
[69].  
 
5.4.1 Base excision repair 
In principal, BER assures that the lesion is cut off, a break is formed and subsequently 
mended by the insertion of a correct nucleotide. BER steps in and a lesion specific 
glycosylase (enzyme) directly removes the lesion, i.e. the base. In the absence of a base 
the result is an apurinic/apyrimidinic (AP) site, which is converted to a break. During 
the repair process, a single strand break is thus formed. Some polymerases are 
bifunctional and can cut the DNA themselves while others need AP endonucleases to 
do so. The small gap is mended by DNA polymerase (usually polymerase β) and ligase, 
which removes the AP site, inserts a correct nucleotide and seal the DNA. BER steps in 
and removes lesions before DNA replication occurs, avoiding further consequences 
[48]. BER is the path most often used for the repair of oxidative lesions, but it can also 
repair for example alkylations and strand breaks [69]. For example, 8-oxodG is directly 
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repaired by BER, through the specific removal by the human 8-oxoguanine DNA 
glycosylase, OGG1 (hOGG1). In addition, this glycosylase also removes FapyG.  
 
5.4.2 Nuclear excision repair 
NER cuts the DNA some distance from the lesion and the oligonucleotide is removed. 
A DNA polymerase then fills the gap, and a ligase seals the DNA. The action of NER 
is down to several protein complexes. The lesion is recognised, unwound and cut (by 
excision) by several sets of proteins, where proteins referred to as XPC, XPB, XPD and 
XPF are involved. While BER gives rise to a gap the size of one nucleotide (short patch 
BER) or, by extension during the repair, up to eight nucleotides (long patch BER), 
NER contributes to a much larger gap. NER is particularly important in removing 
damage induced by UV exposure, but it can also help removing oxidative lesions [48].  
 
5.4.3 Mismatch repair 
Mismatch repair corrects incorrectly paired bases. While BER and NER acts before 
replication, mismatch repair acts on damages post replication. G:T, G:G, C:C or A:C 
mismatches are recognised by the Mut proteins and a nuclease removes the mispaired 
base. For example, incorrectly paired adenine can be removed by MUTYH. This 
glycosylase recognises adenine when it is incorrectly paired with C, G or 8-oxoG, and 
is thus also a repair mechanism for the 8-oxoG lesion. Misincorporated uracil is 
removed from DNA by uracil DNA glycosylase (UDG). 
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6 MONITORING THE PROPERTIES AND EFFECTS OF 
MICRONUTRIENTS - METHODS 
 
6.1 HUMAN STUDIES 
The ultimate goal is of course to elucidate the actual/real effects of micronutrients, 
vitamins, antioxidants and supplements in humans. Different approaches can be taken 
when conducting human studies. As can be seen in Table 3, the different study types 
are categorised depending on their design. In this thesis, one intervention study (paper 
IV) and one observational, yet experimental, study (paper III) have been conducted.     
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In the case of studies with micronutrient supplements, large randomised, placebo-
controlled intervention studies/trials are considered the ‘golden standard’. In these 
studies, one or more micronutrients are given as supplements over a given time period. 
The study population is randomly divided into two (or more) groups in which one 
group receives the supplement whereas the other group (the control group) receives 
placebo, a tablet with the same appearance but without the micronutrients of interest. In 
this type of study, it is possible to compare the effect with and without the supplement, 
avoiding some of the confounders that hamper the interpretation of many observational 
studies. Nonetheless, observational studies, particularly case-control and cohort studies, 
also constitute a helpful tool in researching the effects of micronutrient supplements. 
Case-control studies enable us to investigate the impact on previous supplement usage 
and its association to a particular disease. This study type can be time and cost efficient 
and enable the study of rare diseases. One of its drawbacks is, however, the risk of 
recall bias. In cohort studies, this risk is avoided. Here, the effect of supplement use on 
disease can be studied by following people who take a certain supplement, and 
compare the prevalence of disease amongst them with those of a control group. 
However, selection bias, failure to follow-up the participants, possesses a challenge in 
this type of study.  
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In experimental human studies, the output analysed may be a disease itself, or one or 
more biomarkers associated with e.g. a disease. DNA lesions are one example of 
biomarkers used in human studies. In papers III and IV the amount of different types of 
DNA lesions were analysed using the comet assay, a method described in section 6.6.2. 
Different inflammation markers were also analysed as biomarkers of immune response.  
 
 
6.2 IN VIVO STUDIES 
In many research areas animal studies, i.e. in vivo studies, are utilised in order to come 
closer to a human situation, but without risking the health of human participants. When 
investigating micronutrients, cellular studies and human studies are more common and 
no attention is given to in vivo studies in this thesis. In addition, laboratory rats and 
mice seem to be responding differently to antioxidant supplements than humans do 
[65]. 
 
 
6.3 IN VITRO STUDIES 
In vitro studies is a broad term that includes many different types of studies, often 
designed with the aim to investigate a particular issue. The common denominator is 
that they are not conducted in humans or animals, instead components of an organism, 
or cell lines are used. In studies investigating mechanisms and properties of 
micronutrients, the use of cell lines enables fast and simple experiments, in comparison 
to human studies. In papers I and II, in vitro methods are utilised.  
 
 
6.4 CHEMICAL STUDIES 
Another approach to investigating micronutrients’ chemical properties is through 
strictly chemical studies in which no human material or cells are used. In the absence of 
human material as well as cell lines, it is for example possible to investigate antioxidant 
and pro-oxidant properties of antioxidants without the interference of other 
components. Through such experiments, the chemical ability of micronutrients to act as 
either antioxidants or pro-oxidants can be investigated. Papers I and II uses this 
approach.  
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6.5 STUDY DESIGNS USED IN PAPERS I-IV 
6.5.1 In vitro and chemical studies – Papers I and II 
The main aim of papers I and II was to investigate and compare whether a range of 
different micronutrients – of which a majority are antioxidants – have pro-oxidant 
properties. These antioxidants and micronutrients are by EU regulations permitted in 
dietary supplements. The approach used in papers I and II were of in vitro and chemical 
character, and the study designs are seen in Figure 8.  
 
In vitro studies. In papers I and II, pro-oxidant properties of micronutrients, through 
their ability to cause oxidative damage to DNA, were studied using cell lines. Cells 
were grown in culture and exposed to micronutrient for one (paper I) or 24 (paper II) 
hours after which the cells were analysed for DNA lesions using the comet assay, as 
well as for cell death (cytotoxicity) using trypan blue staining. The analytical methods 
are described in section 6.6. The levels of damage were compared to those in cells that 
were not exposed to micronutrient (i.e. controls). Since antioxidants commonly are 
distributed through the blood stream, the cells used were of blood origin, the 
promyelocytic leukaemia cell line HL-60. In paper I, it was also investigated whether 
the pro-oxidant property of chosen antioxidants was affected in the presence of a metal 
(also found in supplements) and/or the ROS hydrogen peroxide, H2O2. The cells were 
then exposed to metal and/or H2O2 at the same time as micronutrient. 
 
Chemical studies. When investigating the micronutrients’ ability to chemically act as 
pro-oxidants, the DNA nucleoside deoxyguanosine (dG) was used as a model in order 
to see the chemical effects on a biologically relevant molecule. Since dG is a 
constituent of the DNA, potential oxidation of it by a micronutrient is directly relevant 
to the human situation. dG was exposed to a micronutrient for one hour and the 
oxidation product 8-oxodG was analysed using the HPLC-EC/UV system described 
below.  
 
Concentrations. Physiological concentrations of micronutrients were used throughout 
these studies, based on normal plasma levels. We also included concentrations up to ten 
times normal plasma levels, since both plasma and specific tissues/cells can have much 
higher concentrations. Intravenous administration of vitamin C, for therapeutic 
purposes, can, for example, produce plasma levels as high as 20 mM (400 times normal 
levels) [58]. The studies in papers I and II are further discussed in Chapters 7 and 8. 
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6.5.2 An observational, experimental human study – Paper III 
Paper III investigates the impact of folate status and metabolism on different types of 
DNA lesions. The study group consisted of 36 women with unexplained infertility, who 
were attending the Department of Obstetrics and Gynecology at the Karolinska 
University Hospital in Huddinge, Sweden. A dietary survey and an interview were 
conducted wherefrom intake of dietary folate and supplement use was gained. Blood 
samples were also collected, and used for the analysis of e.g. folate, vitamin B12 and 
polymorphism in genes involved in folate-metabolising pathways. Using the comet 
assay, DNA lesions, including uracil misincorporation into DNA, strand breaks and 
oxidative DNA lesions (FPG-sensitive sites), were also analysed from drawn venous 
blood samples. Associations between folate status, intake and metabolism were then 
explored. This study is further discussed in Chapter 9. 
 
6.5.3 An intervention study – Paper IV 
Paper IV is an intervention study in which patients suffering from chronic kidney 
disease are given a supplement containing an extract from the berry sea buckthorn. This 
berry is rich in many antioxidants as well as fatty acids. As can be seen in Figure 8, the 
intervention was a crossover study in which the patients were randomly assigned into 
two groups. One group were given the sea buckthorn extract while the others received 
placebo, then they changed. The supplementation period went on for eight weeks and 
before given the other type of tablet, there was a four weeks wash-out period in order to 
limit the risk for carry-over effects, i.e. effects from period one to carry over to period 
two. Before and after each treatment period (i.e. four times in total), salivary glands 
biopsies, saliva and blood samples were collected. The main outcomes were different 
DNA lesions in minor accessory salivary glands, salivary flow rates and inflammation 
markers in blood. Paper IV is further discussed in Chapter 10. 
 
 
6.6 METHODS TO DETECT THE BIOMARKERS IN PAPERS I-IV 
Oxidative stress is a condition that cannot be measured per se. Instead the presence of 
damaging agents (reactive species or ROS) need to be measured, alternatively the 
levels of damage. ROS are short-lived, and thus challenging to measure. Another 
approach is therefore to measure the amount of damage that they cause. These so called 
biomarkers are often more feasible and robust to measure. A commonly measured 
biomarker for oxidative stress is the oxidative DNA lesion 8-oxodG. The methods used 
in papers I-IV to detect biomarkers and other types of damage are described below.   
 
6.6.1 HPLC-EC/UV system 
The oxidative DNA lesion 8-oxodG can be quantified using high performance liquid 
chromatography (HPLC) coupled to electrochemical (EC) and ultraviolet (UV) 
detection, as seen in Figure 9 [78]. The oxidation product 8-oxodG and the undamaged 
nucleoside dG are separately detected. 8-oxodG is measured using the EC detector at 
350 mV and quantified via the peak area. The amount of dG is, on the other hand, 
measured via the UV detector using a wavelength of 290 nm. From the results, it is 
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possible to calculate the amount of dG that is oxidised (i.e. the amount of 8-oxodG 
formed) in relation to the undamaged dG that is retained. The result is often reported as 
8-oxodG/106 dG.   
 
This method can be used both for chemical studies as well as for cell and human 
studies. The analysis of 8-oxodG levels in blood requires sample preparation that takes 
several hours, before analysis of 8-oxodG and dG is feasible. The long work-up 
procedure adds a challenge – the creation of artificial oxidation, which encumbers the 
interpretation of the results. In material where dG is already isolated, this problem is 
avoided. The HPLC-EC/UV system for quantification of 8-oxodG is specific and has 
previously been evaluated and validated by ESCODD [79]. In the chemical studies of 
papers I and II, the HPLC-EC/UV system was used for analysis of oxidative damage.   
 
6.6.2 The comet assay 
The comet assay, or single-cell gel electrophoresis, is a sensitive and established 
method in which different types of DNA lesions can be measured. The alkaline comet 
assay is the most extensively used version. In its simplest form, it detects strand breaks 
and alkali labile sites, which together are referred to as DNA breaks in this thesis. 
Alkali labile sites are apyrinic sites formed during alkaline conditions. The comet assay 
can also be modified by the addition of lesion-specific repair enzymes enabling other 
DNA lesions to be analysed [80]. Enzymes utilised include formamido pyrimidine 
DNA glycosylase (FPG), human 8-oxoguanine DNA glycosylase (hOGG1), 
endonuclease III (EndoIII), 3-methyladenine glycosylase II (AlkA), T4 endonuclease V 
and uracil-DNA glycosylase (UDG), detecting oxidatively damaged bases (FPG, 
hOOG1, EndoIII), alkylated bases (AlkA), cyclobutane pyrimidine dimers (UV-
induced bulky DNA adducts; T4 endonuclease V) and misincorporated DNA (UDG) 
[80,81]. FPG is the bacterial equivalent to the human hOGG1 and recognises oxidised 
purines, primarily 8-oxoG but also e.g. fapy-guanine and fapy-adenine.  
 
As depicted in Figure 10, the comet assay consists of a number of steps. In principal, 
cells to be analysed are embedded in agarose on a microscope slide where after they are 
lysed (i.e. broken down). To allow the DNA to unwind, treatment with an alkaline 
solution is performed, which is followed by electrophoresis under alkaline conditions. 
During this step, the presence of DNA breaks contribute to the extension of DNA 
	67(.()#5'%#)")4%'$".( (%'%#)%'#(2)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loops. Structures resembling comets are formed, for which the size and intensity of the 
“tail” indicate the amount of DNA breaks. The “head” contains the supercoiled DNA 
attached to a matrix or scaffold [82]. After electrophoresis, the cells are washed and 
fixated. Following staining, the comets can be analysed using a microscope and 
computerised image analysis. Different units can be used when reporting the level of 
DNA, where the percentage of DNA in tail (‘% DNA in tail’) is widely recommended 
as the most accurate to use [83]. The software calculates the percentage of intensity in 
tail (i.e. damage) compared to intensity of head (i.e. intact DNA).   
 
When other DNA lesions are analysed with the addition of an enzyme, additional steps 
are added between the lysis and alkaline treatment. Directly after lysis, the cells are 
then equilibrated in enzyme buffer and subsequently incubated with enzyme. The 
enzyme locates and cuts the lesion, and an apurinic/apyrimidinic site is formed. In the 
subsequent alkaline treatment, a break is formed. These samples include both ‘general’ 
DNA breaks and enzyme specific lesions. Therefore, samples that are not treated with 
enzyme need to be included. The amount of enzyme specific DNA lesions is then 
calculated by 
 
% DNA in tail (enzyme treated) - % DNA in tail (without enzyme)        (2) 
 
The comet assay has been extensively validated, both in ESCODD and the European 
Comet Assay Validation Group, ECVAG (within the European Network of Excellence 
ECNIS) [71,84]. The method requires only a small number of cells, is sensitive in 
detecting low levels of DNA damage and can be applied on most eukaryotic cell types 
[83]. The comet assay is used in all constituent papers of this thesis, both without 
enzymes (papers I-IV), with FPG (papers I-IV) and with UDG (paper III). As far as I 
am aware, only a handful studies have previously used the UDG in the comet assay in 
human biomonitoring samples [85-87]. 
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6.6.3 Trypan blue staining 
Different viability assays can be used to monitor the viability of cells. Also referred to 
as cytotoxicity tests, these assays are readily used in toxicity testing, in order to detect 
whether an agent is cytotoxic, i.e. causes the death of cells. Some assays require cells 
to be viable in which case the utilization of viability assays are crucial prior to 
analysis. In this thesis, the viability of cells has been analysed both as a toxicity test 
of the micronutrients (in the in vitro cell studies) as well as in order to assure a high 
percentage of viable cells prior to running the comet assay.  
 
Trypan blue staining, or trypan blue exclusion test, is a ‘simple’ method for the 
analysis of cell viability. The trypan blue stain penetrated damaged cell membranes 
allowing discrimination between damaged (unviable) cells and intact (viable) cells. 
Cells are incubated with the stain and the cells are then observed in a microscope and 
the number of stained (unviable) and unstained cells (viable) counted, from which a 
percentage of unviable cells can be computed. Strictly speaking, the trypan blue 
exclusion test detects cells with disrupted cell membranes; these cells are not 
necessarily dead per se [83]. Nonetheless, the output from trypan blue staining is 
often loosely referred to as cytotoxicity or unviable cells.  
 
6.6.4 Other methods 
Micronutrient intake. Surveys or interviews can be used to obtain information on the 
intake of dietary and supplemental micronutrients. In paper III, 24-hour recalls was 
used, an interview method where the subjects report all food and beverage consumed 
during the last 24 hours. In addition, questionnaires were used from which supplement 
intake was obtained. The supplement content was approximated using the labels on 
supplement containers.  
 
Micronutrient status. The plasma or blood level of a micronutrient can be measured 
using for example immunoassays, fluorometric or HPLC methods. In paper III folate, 
homocysteine and vitamin B12 levels were measured using a solid-phase time resolved 
fluoroimmunoassay, a flourescence polarization immunoassay and a fluorometric 
method, respectively.  
 
 
6.7 OTHER METHODS OF INTEREST 
6.7.1 Detection of DNA lesions 
Oxidative DNA lesions. While the comet assay has been recommended by ESCODD 
for detecting oxidative DNA lesions due to minimal risk of ‘artificial’ oxidation, 
chromatographic methods might be necessary when the detection of the damage needs 
to be more precise than what the enzymes used in the comet assay can offer. The 
HPLC-EC/UV system for the detection of 8-oxodG is one such chromatographic 
method. Others include gas chromatography-mass spectroscopy (GC-MS) and HPLC-
MS/MS. Capillary electrophoresis (CE)-EC or enzyme-linked immunosorbent assay 
(ELISA) can also be utilised to measure oxidation products of DNA [71]. ELISA is, 
however, not explicit for 8-oxodG since antibodies are not specific to a particular 
oxidised base [88]. 
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Bulky DNA adducts. Bulky DNA adducts can be analysed using for example 32P-
postlabelling and HPLC, immunoassays and GC-MS.  
 
6.7.2 Antioxidant assays 
This thesis does not focus on the antioxidant capacity of micronutrients/antioxidants. 
However, there are of course a number of assays in which the strength of the 
antioxidant property can be measured/analysed. Even though all antioxidants protect 
against oxidation, they have different preferences regarding what reactive species they 
quench, for example singlet oxygen (1O2, an electronically excited state of O2; e.g. 
carotenoids), other ROS (e.g. vitamin C) or peroxyl radicals (e.g. phenolics). Since 
antioxidant capacity assays measure the quenching of specific reactive species, the 
choice of assay might reflect the results. Common total antioxidant capacity (TAC) 
assays include FRAP, ORAC, TRAP and TEAC [89]. 
 
When we are interested in the antioxidant effect on DNA, detection of DNA lesions 
through the methods mentioned above is another appropriate approach. The major 
difference compared to the pro-oxidant assay in papers I and II, described in section 
6.5.1, is that damaged cells are used. Cells are first exposed to a damaging agent and 
then incubated with an antioxidant. Using the comet assay, the level of DNA lesions 
can subsequently be analysed. Lower levels of DNA lesions compared to control (i.e. 
cells not incubated with antioxidant) indicate a direct antioxidant effect. Lower levels 
can, however, also indicate an upregulation of repair enzymes instead, an indirect 
antioxidant effect by the antioxidant. 
 
 
6.8 METHODOLOGICAL ISSUES  
The ultimate goal with any in vitro assay would be to imitate an in vivo situation so 
well that the effects would be identical to a human situation in vivo. Unfortunately, no 
assay is able to imitate the human situation with such preciseness, although immense 
effort is dedicated to getting as close as possible. Nevertheless, every assay has its 
drawbacks and issues that need to be taken into consideration when interpreting the 
results. Even human studies have challenges that need to be overcome.  
 
6.8.1 Chemical studies 
Chemical studies enable us to dig deep and investigate properties of micronutrients in 
more detail. It provides us with the opportunity to study individual properties with no 
or few interfering factors. The benefits from this type of study can, however, also pose 
challenges. Extrapolation to a human situation should be done with great care, if at all, 
particularly in studies with antioxidants. Antioxidants are highly dependent on the 
surrounding and factors such as temperature, buffer content, oxygen pressure and 
antioxidant concentration can affect how an antioxidant acts. Pro-oxidant properties of 
β-carotene have, for example, been seen to be promoted by high oxygen pressure and 
high β-carotene dose [41,90]. As seen in Figure 11, the choice of buffer highly affected 
the pro-oxidant property of different vitamin C compounds in paper II. Chemical 
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studies provide us with insight of the chemical properties of antioxidants, of how they 
are capable of acting, but only under the specific experimental conditions used.  
 
dG. The use of dG in the chemical studies of papers I and II enables a direct connection 
to the in vivo situation, since dG is a biological component of DNA. However, dG was 
dissolved and present in solution when exposed to antioxidant in these studies. In vivo 
dG is present in the nucleotide pool and incorporated in DNA, clearly less accessible to 
attack. Nonetheless, (d)G is susceptible to oxidative attack even when present in DNA. 
Hence, exposure of pure dG in chemical experiments provide us with insight of an 
antioxidant’s ability to oxidise the base, but it is important to keep in mind the different 
circumstances that characterise an in vivo situation.  
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6.8.2 Cellular in vitro studies 
In vitro studies using cell lines takes us one step closer towards an in vivo situation. 
Again, great care needs, however, to be given when attempting to extrapolate to an in 
vivo situation.  
 
Cells 
What is the ultimate cell model for micronutrient studies? A straight answer is far from 
easy to give. The kinetics of micronutrients in vivo enables them to be in contact with a 
huge variety of cell types. The ADME (administration, distribution, metabolism and 
excretion) route also differs between micronutrients – contributing further to the 
difficulty of using one universal cell type. Thereby, cell lines used in micronutrient 
studies in the literature vary and range from blood cells, cervical cells and colon cells to 
lung cells and include cell lines such as HL-60 [47], HeLa [91], Caco-2 [91] and A549 
[92], respectively. Cell lines have been adapted to a cell culture environment and are 
able to grow for more passages (i.e. a longer tine) than primary cells. In an article from 
2003 [93], Halliwell proposes that cells in culture may be exposed to a much higher 
oxidative stress level. During the adaptation, the cells have attained certain properties 
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that will differ from the original cells. It has even been argued that a considerable 
number of cell lines have changed to such an extent that they no longer are the cells 
they are supposed to be [94]. The interpretation of studies using cell lines should 
therefore bear in mind that this, too, is a model system.  
 
In papers I and II, the promyelocytic leukeaemia cell line HL-60 was used. After 
ingestion, many micronutrients are absorbed in the gastrointestinal tract in humans and 
distributed via the blood stream. Blood cells are therefore exposed to many 
micronutrients, and are because of that one type of cells used in micronutrient studies. 
HL-60 cells are grown in suspension in cell medium, i.e. the cells’ ‘food’.  
 
Cell Medium 
In cell studies, the choice of cell medium and medium components has been widely 
suggested to affect the outcome of studies involving antioxidants [65]. The presence or 
absence of serum [95], antioxidants and metals may affect the behaviour of 
micronutrients. Cell media are frequently deficient in antioxidants. In addition, 
commonly used cell media also contain iron. For example, the DMEM (Dulbecco’s 
Modified Eagle Medium) is used for many cell types and contains iron(III) nitrate 
(Fe(NO3)3). Calf (foetal bovine) serum, which contains some transferrin with bound 
iron in, is also often added to media. Since some antioxidants can take part in Fenton 
reactions, the presence of transition metals is important to consider when interpreting 
the results [93]. The medium RPMI (Roswell Park Memorial Institute) used in papers I 
and II does not contain added iron salts, nor copper [96]. Halliwell [65] even argues 
that effects of antioxidants on cultured cells may be artefacts, created by reactions with 
medium components or by antioxidant metabolites.   
 
In order to investigate the impact of medium on the outcome of our results, we 
conducted a small pilot study comparing the effects of RPMI (with serum) and PBS. 
PBS, or phosphate buffered saline, is a common buffer solution used in biological 
research. We investigated the vitamin compounds that had revealed to be most 
influenced by buffer type in the chemical dG experiments of paper II. We exposed HL-
60 cells to these vitamins present either in medium or PBS. No great influence of the 
medium (medium or PBS) beyond normal variations was observed in this pilot study 
(n=1), where we analysed for DNA breaks and FGP-sensitive sites. 
 
Comet assay and cell viability 
Although subjected to debate, the use of a high proportion of viable cells when running 
the comet assay simplifies the interpretation of the results. If unviable cells are analysed 
and high DNA lesion levels detected, we are faced with the chicken and egg causality 
dilemma of what caused what? Did the cell death cause the DNA lesions or were the 
DNA lesions present in the cell anyway, possibly causing the cell death? If we analyse 
cells that are viable instead, this confusion is avoided. Within this thesis, a cell viability 
of above 90% (paper I) or 94% (paper II) was accepted for the comet assay runs. 
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6.8.3 Human studies 
Even human studies face challenges and possess many requirements in order to be 
considered reliable.  
 
Intervention studies 
Randomised placebo-controlled studies (randomised control trials, RCT) are considered 
the most rigorous method in evaluating the effect of a substance. Nonetheless, certain 
factors need to be considered. A high compliance and a low dropout is, for example, 
desirable. Dropouts refer to participants who, for whatever reason, drop out of the 
study, while compliance refers to how well the subjects comply to the supplementation. 
It is important to collect data on both compliance and the number of dropouts. There 
are different approaches for how to deal with dropouts during the interpretation of 
results. The exclusion of participants who have not complied to the intervention (drop-
outs or poor compliance) from the analysis enables analysis of the efficiency of the 
actual treatment, and is referred to as a per-protocol analysis. Another approach is to 
include all subjects who were included in the study, regardless of how well they 
complied to the intervention. This is called an intention-to-treat analysis and shows the 
practical value of the supplementation. Furthermore, blinding of the supplements (i.e. 
not revealing if it is a supplement or placebo) further enhances the quality of an RCT. 
Blinding can be done for the study participant only or for the participant and study 
conductor, the latter being double-blinding. Ethical considerations, the sample-size, the 
often high costs and long time that RCTs take also need to be considered when 
designing an RCT [97]. In crossover study designs, as used in paper IV, a wash-out 
period between treatments is essential in most cases, in order to avoid the effect from 
treatment one to influence treatment period two. Statistical analysis for carry-over 
effects can be conducted in order to verify that the washout period was sufficient.      
 
Observational studies  
In all observational studies, there is a risk of misinterpreting results since an effect 
might be caused by an unknown factor, a confounder. Statistical methods are used in 
order to account for known confounders, but the risk of unknown confounders remains. 
Since observational studies by nature cannot use randomisation, there is also a risk of 
selection bias where the exposed and control groups differ in factors of importance. If 
surveys or interviews are utilised, recall bias can also influence the data, meaning that 
the memory or “exaggeration of the truth” interfere with reality.  
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7 DIGGING DEEPER – VITAMIN A 
In papers I and II, a large focus is on vitamin A and its pro-oxidant and DNA-damaging 
properties. This chapter will discuss vitamin A in more detail, unravelling its action in 
humans. It will also discuss its properties, in context of papers I and II and the current 
scientific literature. The focus is on basic research, understanding the basic properties 
of vitamin A compounds. 
 
 
7.1 WHAT IS VITAMIN A? 
Vitamin A is required for a functioning vision, reproduction, membrane integrity, cell 
growth and cell development [49]. Vitamin A is a generic term referring to compounds 
with the same biological effect as retinol. Vitamin A needs to be attained from the diet, 
either as preformed vitamin A or as provitamin A. Preformed vitamin A include retinol 
and retinyl esters (including e.g. retinyl acetate and retinyl palmitate) while common 
provitamin A’s include β-carotene, α-carotene and β-cryptoxanthin which are cleaved 
to vitamin A in vivo. β-Carotene exhibits the greatest retinol activity of the provitamin 
A’s. The chemical structure of vitamin A compounds, or retinoids, some of which can 
be seen in Figure 12, consist of three parts: a cyclohexane ring with three methyl 
groups, a conjugated tetraene side chain and a structural sidegroup. Retinoids can 
display many isomeric forms due to the presence of double bonds that can attain both 
trans- and cis- form, but the all-trans configuration tends to be the most stable [40].  
 
Vitamin A deficiency affects the eye, and can lead to dryness of the conjunctiva of the 
eye, decreased night vision or in severe cases to blindness. A deficiency can also result 
in growth retardation and decreased resistance to infections. The three latter conditions 
still occur in large numbers of children in less developed countries [98]. 
 
7.2 THE FATE OF VITAMIN A IN HUMANS 
Most human tissue require vitamin A in the form of retinoic acid, while the eye needs 
retinal to retain vision. The vitamin A metabolism has two main functions: 1) to assure 
that tissues receive the correct retinoid in order for them to locally produce retinoic 
acid, and 2) to assure that retinol reaches the retina of the eye, in order for it to produce 
11-cis-retinal [40]. 
 
Vitamin A compounds do not freely wonder around the blood system, instead different 
proteins lead their way. Lipoproteins transport retinyl esters and carotenoids 
(provitamin A) while retinoid binding proteins transport retinol, retinal and retinoic 
acid. The proteins assure that the retinoids do not damage membranes to any significant 
degree. In plasma, retinol is transported by retinol-binding protein (RBP). RBP is 
synthesised in the liver. Still present in the liver, one RBP (‘apo-RBP’) binds to one 
retinol, forming retinol-RBP (‘holo-RBP’) which is let out to the plasma. Transthyretin 
(TTR) non-covalently binds to retinol-RBP, stabilising the interaction between retinol 
and RBP. Moreover, RBP protects retinol from oxidation. Retinoic acids circulating in 
plasma are bound to albumin [40].  
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Intracellularly, retinoid binding proteins including CRBP-1, CRBP-II, CRBP-III, 
CRBP-IV, CRABP-I and CRABP-II protect the retinoids from degradation, protect 
membranes from vitamin A accumulation, facilitate the “solubility” in water, and 
transports the retinoids to enzymes involved in the metabolism. Some retinoids (e.g. 9-
cis-retinoic acid) can also bind to, and thereby activate, nuclear retinoid receptors, 
which then act as transcription factors [40].  
 
Regardless of the retinoid consumed, retinol is often formed during the process of 
absorption and thus the common form transported to tissues. The common route goes 
from the gastrointestinal tract, to the intestines where absorption occurs, via the 
blood/plasma and into the liver for storage or to extrahepatic tissues. 80% of vitamin A 
is stored in the liver (as retinyl esters), in stellate cells, also referred to as Ito cells, 
vitamin A storing cells or fat-storing cells [99]. Most tissues also store retinyl esters, 
but in lower concentrations. When there is a need for retinol in tissues, retinyl esters in 
stellate cells are hydrolysed to retinol in the liver, and then transported (with RBP) to 
plasma and distributed to where required. At low vitamin A concentrations, RBP is 
accumulated in the liver, ready to transport retinol and increase its plasma 
concentration. Vitamin A consumed as retinyl esters are hydrolysed to retinol in the 
intestines, absorbed and re-esterified in enterocytes (cells in the intestines). Retinyl 
esters are then transported via the plasma to the liver where the retinyl esters are 
hydrolysed back to retinol. The retinol enters stellate cells where it is stored as retinyl 
esters.  In humans, the absorption of β-carotene differs from the preformed A vitamins 
in that it is absorbed through the intestines as intact β-carotene. β-Carotene then either 
passes unmetabolised across the intestine, or is cleaved to two molecules of all-trans-
retinal. The conversion is regulated: the more there is the less is taken up. Excess intake 
of β-carotene from natural sources is therefore not linked to toxicity [40,49]. 
 
In tissues, the major vitamin A form is esterified retinol (retinyl esters), where the fatty 
acid group can be palmitate (most common), stearate or oleate [40]. The ester form 
protects the hydroxyl group from oxidation. Retinyl esters can be hydrolysed to retinol 
in tissue cells and retinol oxidised to all-trans-retinoic acid, via the intermediate all-
trans-retinal. All-trans-retinoic acid is the most bioactive form of vitamin A. It has 
been seen to be capable of promoting almost all functions caused by vitamin A in 
humans, with the exception of vision. Retinol-RBP can also be transported to the retina 
in the eye, where formed retinyl ester is hydrolysed and isomerised to 11-cis-retinol, 
which in turn is oxidised to 11-cis-retinal. This retinal isomer is a constituent of dark 
adaptation (visual cycle or retinoid cycle) and is required for a properly functioning 
night vision [40]. Retinoic acid cannot be reduced to retinal in vivo, which might 
explain why retinoic acid does not affect vision.  
 
Physiological plasma levels of vitamin A are normally stable, with low inter- and intra 
variation. Normal retinol concentrations (majority bound to RBP) are reported to be 2-
2.2 μM [40] or 1-3 μM [99]. Other retinoids detected in plasma, at much lower levels, 
include all-trans-retinoic acid, 9-cis-retinoic acid, 13-cis-retinoic acid and di-cis-
retinoic acid [40]. Retinyl esters in serum are usually below 0.2 μM [99].  
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7.3 VITAMIN A SUPPLEMENTS – COMPOSITION 
Supplements often contain synthesised vitamin A, 
where the retinol is stabilised by forming acetate, 
propionate or palmitate esters [40]. A supplement 
of vitamin A can contain any of four different 
vitamin A compounds, without the specification of 
which is present. According to the European 
Parliament and Council’s directive (2002/46/EC), 
any of the compounds listed in Table 4 are 
permitted. Consequently, the exact form of vitamin 
A consumed from a dietary supplement is not known to the consumer. The chemical 
structures of the compounds are seen in Figure 12, with the addition of retinal found in 
vivo. 
 
 
7.4 TOXICITY OF VITAMIN A 
At high concentration of vitamin A, when the RBP transport proteins capacity is 
exceeded and non-bound vitamin A is presented to membranes, toxicity may result. 
Also referred to as hypervitaminosis A, vitamin A toxicity can be acute or chronic. In 
acute hypervitaminosis A, excess vitamin A binds to lipoproteins, producing for 
example changes in biological membranes, headaches, nausea and fever. Chronic 
vitamin A toxicity is more common than acute and can arise after months or years of 
high intakes of preformed vitamin A from e.g. liver or supplements [49,99]. Chronic 
toxicity manifests as dry skin, hair loss, intracranial pressure or anorexia, for example. 
For acute toxicity the RDI needs to be exceeded by hundredfold (adults) over a few 
days, while chronic toxicity in adults occurs after a consumption of 25 000 IU/day 
(approximately eight times the RDI in Sweden) for more than six years, or over 100 
000 IU (approximately 110 times the RDI) for over six months [99]. 
 
 
7.5 VITAMIN A – THE THEME OF PAPERS I AND II 
Papers I and II aimed to investigate vitamin A properties, properties related to pro-
oxidation and DNA lesions. The papers describe basic research, with the objective to 
understand fundamental principles, yet not assured, of vitamin A. An outline of the 
study designs of papers I and II can be seen in chapter 6, Figure 8. Cultured leukaemia 
cells (HL-60) were exposed to vitamin A for one (paper I) or 24 (paper II) hours and its 
potential to affect DNA and cell viability was studied. The influence of metals and/or 
H2O2 was also investigated (paper I), and in addition the different vitamin A 
compounds permitted in supplements were also researched and compared (paper II). 
Below follows a discussion on the findings from these and other related studies. 
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7.6 VITAMIN A AND ITS EFFECT ON DNA LESIONS 
In cell studies, vitamin A has shown various effects on DNA. It has been seen to 
enhance the production of oxidised purines by PMA (a tumour promoter)-activated 
neutrophils [100], enhance strand breaks induced by the cancer drug CPT-11 [101], and 
contradictory, to decrease DNA adducts (induced by benzo(a)pyrene) [102]. The DNA 
damage promoting effects in these studies were enhancements of already occurring 
damage. In our cell studies, we did not induce damage using other agents, on the 
contrary the aim was to investigate if vitamin A has properties that enable it to cause 
damage to DNA alone (but in the presence of cell medium etc.), without promoting 
damage by other agents. In our studies, retinol did not show any capability to cause 
DNA strand breaks or oxidative DNA lesions (FPG-sensitive sites) to HL-60 cells, nor 
did any of the other preformed vitamin A compounds analysed. Contradictory to our 
results, a study from 2000 revealed retinol to induce strand breaks, 8-oxodG and DNA 
fragments at concentrations of 1-5 μM, also in HL-60 cells [47]. The oxidation in that 
study was increased with concentration. We used concentrations four times higher than 
in the 2000 study and yet did not observe DNA lesions by retinol. While copper and 
iron have been suggested to promote pro-oxidant behaviour of retinol [47,103], the 
addition of copper or iron ions did not affect the results on DNA damage in our study. 
In HP-100 cells, derived from HL-60 cells but more resistant to H2O2, retinol did not 
cause oxidative damage in the study by Murata and colleagues [47].  
 
It is notable that HL-60 cells can be induced to differentiate into melocytes, 
metamyelocytes and neutrophils by different agents, including DMSO, retinoids and 
ascorbic acid (vitamin C) [104]. When dissolving the retinoids in papers I and II, 
DMSO was initially used. During cell exposure with A vitamins, ≤ 0.5% DMSO was 
present. This is 1.5-3 times lower than what was used when differentiation of HL-60 
cells was previously achieved [104]. Retinoic acid at 1 M, has been shown to 
differentiate over 90% of HL-60 cells in six days and close to 20% in one day [105]), 
consequently some of the cells exposed to retinoids in paper II (although not retinoic 
acid per se) are likely to have differentiated after the 24 hour exposure. Differentiation 
by retinol in paper I is assumed to be much less pronounced (if even present), due to the 
shorter exposure time of one hour. Differentiation can also lead to a difference in the 
oxidative defence, primarily in regard to the oxidative burst, the release of ROS when 
for example fighting bacteria [106]. It is unknown whether the cells in our studies and 
the study by Murata et al. were in the same stage or not when it comes to differentiation 
and related properties. In addition, the presence or absence of serum can affect the 
action by certain antioxidants [95], a possible contributing factor to differences in 
results. In papers I and II, 10% FBS (foetal bovine serum) was used when culturing the 
cells, while 6% was used by Murata et al. [47].  
 
Retinal, the vitamin A metabolite formed from retinol, β-carotene and retinyl esters, 
has previously been seen to have pro-oxidant properties [47]. In paper II, retinal – as 
the only vitamin A compound – caused cytotoxicity to cultured cells. The cell death 
was almost complete, leaving next to no cells alive, or with intact cell membranes (as 
detected with trypan blue staining). Due to the high cytotoxicity by retinal, DNA 
damage had to be analysed using a lower concentration compared to the other vitamin 
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A compounds. 2 μM did not induce any DNA breaks or oxidative DNA lesions in our 
study. Retinal has, however, previously been reported to cause strand breaks, 8-oxodG 
and DNA fragments [47]. In that study, a stronger DNA damaging effect was seen from 
retinal than from retinol. As will be revealed further in the coming section, retinal 
clearly has the ability to induce oxidation to biomolecules, such as oxidising dG to 8-
oxodG, something which together with results from the other authors, suggests an 
underlying oxidative mechanism not detectable in the cell-based experiments in paper 
II to be behind the cytotoxicity by retinal.  
 
When comparing the effects on DNA damage by the different vitamin A compounds 
permitted in supplements, the differences were minimal. None of the preformed A 
vitamins induced either DNA breaks or oxidative DNA lesions. The provitamin A β-
carotene stood out, inducing a small but statistically significant increase in oxidative 
DNA lesions, as will be discussed below. None of the preformed A vitamins caused 
cytotoxicity to the cells. In this aspect the compounds found in supplements seem to act 
similarly to each other. Their chemical properties, discussed in the next chapter, reveal 
another story. 
 
Human and animal studies. A report by the European Network of Excellence ECNIS 
(Environmental Cancer risk, Nutrition and Individual Susceptibility) concluded in 2007 
that vitamin A has a limited capacity to act as an antioxidant in vivo, and that there is a 
lack of intervention studies using increased doses of vitamin A [98]. Since then, some 
evidence further suggesting antioxidant behaviour, but also pro-oxidant behaviour has 
emerged. In a study from 2012, supplementation of a multivitamin containing vitamin 
A (as retinol and β-carotene) along with other antioxidants (selenium, vitamin C and 
vitamin E) to young, healthy, non-smoking adults reduced the levels of DNA strand 
breaks in those with the highest damage levels before supplementation, as analysed 
with the comet assay [107]. This indicates a potential to reduce high levels of DNA 
damage. Other studies have shown both positive [108] and negative [109,110] 
associations between vitamin A and 8-oxodG levels. In animal studies, protection 
against induced DNA damage detected as 8-oxodG in leukocytes [111] or strand breaks 
[112] has been reported in rats by retinyl acetate and retinoic acid, respectively. On the 
other hand, oxidation of lipids and proteins in rats have also been reported [113], 
emphasising that vitamin A has potential to protect as well as promote damage to 
biomolecules in vivo. 
 
 
7.7 VITAMIN A AND PRO-OXIDANT PROPERTIES? 
Out of thirteen micronutrients, vitamin A stood out in paper I as one of three showing 
chemical pro-oxidant properties. It also showed to be one of only two that acted as a 
pro-oxidant at singular doses as well as caused a dose-response, increasing oxidation 
with an increased concentration of vitamin A – in the form of retinol. Vitamin A even 
showed a stronger pro-oxidant effect than the well-known antioxidant/pro-oxidant 
vitamin C. Under the conditions of the study in paper I, retinol caused oxidation to the 
DNA nucleoside dG. Normal plasma levels were not sufficient to induce oxidation. 
When present at three or ten times plasma levels, however, retinol acted as a pro-
oxidant, causing oxidation to dG. From this, it is clear that vitamin A is yet another 
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micronutrient whose chemical pro-oxidant action is dependent on its concentration, a 
phenomenon that has been proposed for other antioxidants [45-47,90]. Suggestions 
have been made that retinol-induced oxidative damage to DNA is mediated by 
transition metals, Murata et al. [47] identified copper (Cu(II)) and Dal-Pizzol et al. 
[103] identified iron to be required for the DNA to be oxidatively damaged by retinol. 
In addition, superoxide and the generation of H2O2 was discussed to be behind 
copper(II)-mediated damage to DNA by retinol [47]. In our cellular experiments, the 
presence of copper or iron did not affect the outcome on DNA damage suggesting the 
involvement of these metals to be lower than anticipated. The chemical pro-oxidant 
effect by retinol was, however, significantly enhanced by both copper and iron, iron by 
far showing the strongest effect. Contrary to the results from the cellular exposure, this 
is in line with a role of copper and iron in retinol’s pro-oxidative potential, as suggested 
by authors of the studies mentioned above. Moreover, the complete mechanisms of 
how retinol causes its pro-oxidant properties is to my knowledge not clear. Vitamin C 
can form complexes with iron and copper, while vitamin A is, to my knowledge not 
known to do so. In paper I, we speculate whether vitamin A can form weak complexes 
or not. Retinol might also induce the production of ROS in cells [114]. 
 
From paper II and Figure 13, it is very clear that the vitamin A compounds permitted in 
supplements differ in their chemical properties with rather great variety, specifically in 
their potential to act as pro-oxidants. Two out of the four vitamin A compounds 
permitted in supplements showed chemical oxidation potency (retinol and retinyl 
acetate), while two (retinyl palmitate and β-carotene) did not. Retinal also revealed pro-
oxidant properties. These results support the studies mention in the previous section 
discussing DNA lesions, where vitamin A has been seen to induce oxidation to DNA in 
cells and rodents [47,109,113].  
 
Vitamin A is a fat-soluble vitamin. With the intention to produce a supplement with 
less risk of toxic effects, a water-soluble vitamin A has been manufactured. Ironically, 
the water-soluble vitamin A was in 2003 shown to be more toxic than the fat-soluble 
[115], certainly emphasising the difference between different vitamin A compounds 
and more importantly the significance of knowing their properties when choosing 
compound for supplement use.  
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7.8 VITAMIN A AND CANCER 
Vitamin A has limited antioxidant capacity and has been shown to have preventive 
effects against certain cancer forms [50]. The World Cancer Research Fund and 
American Institute for Cancer Research concluded in 2007 that there is limited 
evidence that vitamin A protects against skin cancer [6]. In addition, as reviewed in 
[116] preventive effects on breast and cancer have also been observed. Studies are, 
however, not completely unified and disappointing results from vitamin A 
supplementation on cancer are also evident. For example, no effect on head, neck or 
lung cancer was observed after two years of supplementation [117]. During therapeutic 
use it is also important to avoid hypervitaminosis A and one approach taken to improve 
the effectiveness of vitamin A in preventing and treatment of cancer is to synthesise 
new retinoids with more specific actions and less toxic effects [116].  
 
7.9 PROVITAMIN A – β-CAROTENE 
Following the ATBC trial and CARET in the 1990s, β-carotene has received much 
attention. Partly in line with our results, β-carotene has previously been concluded to 
exhibit pro-oxidant properties. The effect is promoted by high concentrations and an 
oxidised environment (such as that of a smokers lung) [41,90]. We observed β-carotene 
to cause an increase in FPG-sensitive sites in HL-60 cells, but not strand breaks or 
cytotoxicity at a concentration 40 times that of normal plasma levels, and ten times that 
of normal vitamin A levels. Neither did β-carotene cause oxidation to dG in our 
chemical set-up. The increase in FPG-sites was statistically significant, nonetheless the 
increase was small. The specific environment of a smoker’s lung, characterised by 1) a 
high oxygen pressure, 2) low antioxidant levels (especially vitamin C and E, normally 
stabilising β-carotene) and 3) elevated levels of free radicals, can promote oxidation of 
β-carotene. In the literature, the metabolites formed have been suggested to play an 
important role in the lung cancer promoting effect in smokers [43,44]. Considering that 
we only observed a damaging effect on one out of four parameters and that the 
observed effect was small, our results are in line with that hypothesis.  
 
7.10 CONCLUSION 
A PubMed search on the Mesh term ‘vitamin A’ reveals 35 745 publications on the 
topic. Although vitamin A is well studied, many question marks concerning its 
properties, mechanisms and effects on cancer or other human health aspects remain.  
 
While vitamin A is essential for humans, it has chemical pro-oxidant properties in 
addition to its antioxidant properties. Thus it has the potential to cause oxidative 
damage to biomolecules. Studies have shown damaging effects by retinoids to for 
example DNA, as well as no effect. The exact mechanisms to how and when vitamin A 
causes oxidation is still not completely clear, but might be linked to the presence of 
transition metals, the formation of ROS and resulting pro-oxidant action, as well as the 
vitamin A concentration. In addition it became clear from our studies that the different 
vitamin A compounds permitted in supplements greatly vary in their chemical potential 
to act as pro-oxidants, a potential concern during manufacturing of supplements. 
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8 DIGGING DEEPER – VITAMIN C 
This chapter will guide you through basic research on vitamin C, unravelling its 
properties on its potential to act as a pro-oxidant. 
 
8.1 VITAMIN C – A HISTORICAL ANTIOXIDANT 
Vitamin C is a well-documented antioxidant. It has an active hydroxyl group and is 
therefore a very efficient free radical scavenger. Under this process, a radical form of 
vitamin C is formed, as seen in Figure 14. This vitamin C radical is significantly more 
stable than other radicals due to resonance stabilisation, and therefore the ascorbyl 
radical does not possess a threat to the cell. Vitamin C is probably the most known 
vitamin of them all. It was on voyages with Vasco da Gama and other explorers in the 
15th and 16th centuries that the symptoms of scurvy were observed and the 
consequences of feeding the crew a diet without e.g. fruit, vegetables or herbs were 
learnt the harsh way [118]. Subsequent research led to the identification of vitamin C in 
the 1920s [119]. Humans lack a key enzyme (L-gulonolactone) needed for the synthesis 
of ascorbic acid and vitamin C intake is therefore required through our diet. During 
evolution the enzyme has been retained in the kidney of many fish, reptiles and birds, 
and in the liver of many mammals [40]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8.2 THE FATE OF VITAMIN C IN HUMANS 
Vitamin C is water-soluble and is therefore able to circulate fluids without transport 
proteins. Vitamin C ingested through food or supplements is absorbed in the small 
intestine, transported in to the blood stream and distributed to key tissues where it is 
absorbed and utilised as co-factor for enzymes or as an antioxidant [120]. Moreover, 
the kidneys play an important role in reabsorbing ascorbic acid from the renal filtration. 
Vitamin C can adopt two main forms, the reduced form ascorbic acid (AA), and the 
oxidised form dehydroascorbic acid (DHAA). See Figure 14 or 15 for their structural 
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differences. At physiological pH, ascorbic acid is negatively charged and present as 
ascorbate (an anion), while DHAA remains uncharged.  
 
Ascorbate and DHAA require special transport systems aiding them across cell 
membranes. Absorption in the intestine occurs via sodium dependent transporters or via 
glucose transporters. Ascorbate is transported across membranes via the sodium 
dependent transporters SVCT1 or SVCT2, one or both which are found in most tissues 
[121], while the glucose transporters GLUT1, GLUT3 and GLUT4 (the latter in insulin 
sensitive cells) transports DHAA. Once absorbed, DHAA is quickly reduced to 
ascorbate. After absorption, vitamin C is transported in portal blood and distributed to 
tissues. When normal physiological concentrations, 20-150 μM of ascorbic acid is 
present, high-affinity transporters help to transport ascorbic acid into tissues. At 
unphysiological vitamin C concentrations, transportation into tissue occurs via low-
affinity transporters. Certain tissues have particularly high concentration of vitamin C. 
These tissues exhibit special transporters that facilitate the intake of vitamin C despite 
an already high intracellular concentration [122]. 
 
In recent years, it has become evident that vitamin C efflux also occurs, i.e. vitamin C 
is transported out of cells through activated transport systems. DHAA can thereby be 
absorbed, reduced to ascorbate and ascorbate then transported to the extracellular fluid. 
Under physiological pH DHAA is unstable and it is rather rapidly, and irreversibly, 
hydrolysed to 2,3-diketo-L-gulonate. The purpose with vitamin C efflux could therefore 
be to convert unstable vitamin C to a more stable form, maintaining vitamin C 
concentrations, or simply to transfer electrons across membranes [123].  
 
Vitamin C plasma concentrations from food sources are strictly controlled around 70-
85 μM, where excess amounts are excreted with urine. Oral supplementation has, 
however, been predicted to achieve levels of up to 220 μM and intravenous 
administration can lead to a vitamin C plasma concentration of 1500 μM [124].  
 
 
8.3 VITAMIN C SUPPLEMENTS – COMPOSITION 
A vitamin C supplement can contain any of the 
five compounds presented in Table 5, in 
accordance with the directive by the European 
Parliament and Council (2002/46/EC). Their 
chemical structures are seen in Figure 15, with the 
addition of DHAA, the oxidised form. As with 
vitamin A and other micronutrients, the exact form 
of vitamin C present in a supplement is not known 
to the consumer. In addition, the matrix and 
formula of the supplement might influence to what 
extent oxidation occurs in and from supplements. For example, it has been reported that 
metal-catalysed oxidation of vitamin C can be slowed down by altering the matrix 
[125].  
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8.4 VITAMIN C – THE THEME OF PAPERS I AND II 
Similarly as for vitamin A, papers I and II also aimed to investigate vitamin C 
properties, properties related to pro-oxidation and DNA lesions. The papers describe 
basic research, with the objective to understand fundamental principles of vitamin C. 
The study design is outlined in Figure 8, chapter 6. In the chemical set up, the DNA 
nucleoside dG was exposed to vitamin C for one hour and the amount of oxidised dG 
was analysed. Cultured leukaemia cells (HL-60) were exposed to vitamin C for one 
(paper I) or 24 (paper II) hours and its potential to affect DNA and cell viability was 
studied. The influence of metals and/or H2O2 was also investigated (paper I). 
Furthermore, the different vitamin C compounds permitted in supplements were 
investigated and compared (paper II). It is noteworthy that the vitamin C concentrations 
used for exposure were of physiological concentrations, equivalent to plasma 
concentrations and up to ten times plasma levels, representing intracellular levels [126]. 
Below follows a discussion on the findings from these and other related studies. 
 
 
8.5 VITAMIN C AND ITS EFFECT ON DNA LESIONS 
Vitamin C is an ambiguous compound, which has the ability to act in a range of 
different ways. It is, as mentioned, known to act as a pro-oxidant when involved in 
Fenton reactions. Reports on the effect of vitamin C on DNA have been varied and cell 
culture studies (of cell lines or ex vivo cells) have concluded vitamin C to protect 
against DNA lesions [127-129], induce DNA lesions [130-132], or leave the DNA 
unaffected [130,131,133]. The dose has been pinpointed to affect the outcome, where a 
low dose has a greater tendency to give protection [127,129] and higher doses to induce 
DNA damage [131]. This does, however, not always hold true. For example, exposure 
to HepG2 cells (a hepatocellular carcinoma cell line) with 70 μM AA (a low dose) for 
24 and 48 hours induced DNA damage in a study from 2011 [132]. 
 
In papers I and II, we exposed cultured cells to concentrations up to ten times the 
normal plasma level, i.e. 500 μM, and saw no effect on the DNA lesions measured 
using the comet assay. In experimental studies, concentrations are often much above 
physiological levels, and the dose used in papers I and II is by such standards 
considered low, adding to the evidence of non-pro-oxidant behaviour of vitamin C in 
cells at low concentrations. We also investigated the effect of ascorbic acid together 
with metals that are also found in supplements, commonly together with vitamin C in 
multivitamins. A different scenario was seen in the presence of copper. Ascorbic acid 
and copper stood out as the only combination that caused DNA damage in the cellular 
studies – both DNA breaks and oxidative DNA lesions (FPG-sensitive sites). Co-
supplementation of ferrous (Fe2+) salts and vitamin C has been reported to increase 
oxidative stress in the gastrointestinal tract [134], suggesting that the effects observed 
in the present study might also affect an in vivo situation. The effect of vitamin C and 
metals will be further discussed in section 8.7.  
 
The different vitamin C compounds permitted in supplements did not differ in their 
potencies to induce DNA lesions to cells under this study design, none of them caused 
damage to DNA. Contrary, ascorbic acid, sodium ascorbate and calcium ascorbate,  
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Vitamin C compounds 
Ascorbic acid 
Dehydroascorbic acid 
Sodium L-ascorbate 
Calcium L-ascorbate 
L-Ascorbic acid 6-palmitate Figure 6. Bergström et a
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three out of the four compounds, caused cytotoxicity to cells to different extents, 
confirming what others have previously reported concerning ascorbic acid and sodium 
ascorbate [135-137]. DNA lesions were not affected by these compounds indicating 
that the cytotoxicity was initiated by other factor(s)/mechanisms. However, because of 
the cytotoxicity caused at 500 μM, the concentrations used for analysis of DNA 
damage had to be lower for ascorbic acid, sodium ascorbate (250 μM) and calcium 
ascorbate (150 μM). At 500 mM, ascorbic acid did in fact induce FPG-sensitive sites, 
but since the cytotoxicity limit set was exceeded it cannot be concluded if these 
oxidative lesions underlie the cytotoxicity or not, or if the cytotoxicity caused the DNA 
lesions. Moreover, ascorbic acid has been reported to protect against apoptosis (cell 
death) induced by depriving the cells of serum [138,139]. DHAA is not permitted in 
supplements, but is the oxidised form of ascorbic acid, also present in vivo. While 
ascorbic acid promoted cytotoxicity of cells, DHAA did not. This was somewhat 
surprising since HL-60 cells express GLUT transporters that normally transport DHAA 
into the cells [140]. However, DHAA forms a bicyclic structure in aqueous solution 
and predominantly exists as the bicyclic hemiketal hydrate, while AA remains in the 
monocyclic form, contributing to physiochemical differences [125]. Moreover, HL-60 
cells have the ability to stabilise extracellular ascorbate, increasing its presence [141].   
 
Human studies. A combination of vitamin C and E supplementation lowered DNA 
damage levels in breast cancer patients simultaneously undergoing chemotherapy 
[142]. A two to four hour supplementation of vitamin C has provided protection to 
oxidative damage induced ex vivo [143]. Oxidative DNA damage was reduced in male 
smokers following four weeks of vitamin C and E supplements [144]. These studies 
indicate that vitamin C supplementation might, despite the somewhat unclear pro-
oxidant property, yield beneficial effects on DNA lesions in humans.  
 
 
8.6 VITAMIN C AND PRO-OXIDANT PROPERTIES 
In paper I, ascorbic acid stood out as the only micronutrient out of thirteen to induce 
oxidation to the nucleoside dG at normal plasma concentrations. The chemical pro-
oxidant property was dose-dependent and oxidation increased with dose. Vitamin C has 
documented pro-oxidant properties [46], and the results from the chemical study in 
paper I adds to that evidence. More importantly, it points out ascorbic acid to 
chemically act as a pro-oxidant already at physiological concentrations. When, in paper 
II, comparing the chemical pro-oxidant properties of the different vitamin C 
compounds permitted in supplements, all (the same that caused cytotoxicity to cells) 
but one induced oxidation to dG. The exception, ascorbic acid 6-palmitate was 
subjected to solubility difficulties under the experimental conditions and was therefore 
only analysed in the lowest concentration. Therefore it cannot be excluded that it might 
have pro-oxidant potential at higher doses. Nonetheless, ascorbic acid 6-palmitate is 
more stable than Ascorbic acid and the lack of reactivity by it in the assays was 
therefore not unexpected [145]. Just as with DNA lesions, cell studies have shown both 
antioxidant [146] and pro-oxidant [147] behaviour from vitamin C, reducing or 
increasing ROS production.  
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The action by all vitamin C compounds found in supplements were highly dependent 
on the buffer type used in the experiments. It is clear, as observed by others [130], that 
the surrounding environment influences the pro-oxidant property of vitamin C. When 
present in phosphate buffer, ascorbic acid, sodium ascorbate and calcium ascorbate 
produced a several-fold higher increase in the oxidation of dG when compared to 
acetate buffer, as can be seen in Figure 11, chapter 6. The spread of oxidation level 
caused by calcium ascorbate contributed to a non-significant difference in phosphate 
buffer versus acetate buffer, although the visual increase was big. The presence of zinc 
in the acetate buffer reduced the oxidation by the same compounds, emphasising that 
both buffer type and metal content (other than the transition metals iron and copper) 
influence the pro-oxidation by ascorbic acid.  
 
 
8.7 VITAMIN C AND METALS 
Together with ascorbic acid, both iron and copper are well documented to catalyse 
oxidation reactions [134,148]. In Fenton reactions a transition metal is oxidised by 
H2O2 producing a reduced transition metal, a hydroxide ion and the reactive hydroxyl 
radical [48]. Ascorbic acid can interact with metals through redox reactions and reduce 
Fe3+ (ferric iron) to Fe2+ (ferrous iron) and Cu2+ (cupric ion) to Cu+ (cuprous ion), 
thereby facilitating Fenton type reactions. Moreover, the combination of vitamin C and 
iron is referred to as the Udenfriend’s system and is frequently used to promote 
oxidation. In this system, vitamin C acts as a two-electron donor complexed to a 
transition metal, inducing oxidation of aromatic moieties [148]. The results from paper 
I imply, however, that it might be even more efficient to use copper for such purposes. 
Copper really stood out when in combination with vitamin C, causing both strictly 
chemical oxidation to dG (synergistically) and – as the only combination – DNA breaks 
as well as oxidative DNA lesions to cultured cells. Vitamin C is currently being 
investigated as a potential future chemotherapheutic agent due to its pro-oxidant 
properties, and copper ions, to a greater extent than iron ions, have been suggested to be 
involved in the process, causing oxidative DNA lesions [134,149].  
 
The combination of vitamin C, transition metal ions and H2O2 in vitro is well-known to 
cause pro-oxidation [48,148], an effect that was confirmed in the present study. The 
pro-oxidant effect by vitamin C has repeatedly been attributed to the presence of 
transition metals, in large or small quantities [150,151]. Although some evidence has 
pointed towards a damaging effect by vitamin C independent of metals [137], or a 
protective effect even in the presence of iron-overload [152]. A recent study suggests 
that ascorbic acid exposure in air, or ascorbic acid and H2O2, can produce the hydroxyl 
radical (and DHAA), which then promotes damage to DNA [153]. From the results of 
paper I, two main mechanisms were proposed to underlie the chemical pro-oxidation: 
1) Fenton reactions in the presence of H2O2 (where such was present) and transition 
metal ions (e.g. Fe2+, Cu2+); (2) vitamin C-metal complexes are formed, promoting 
oxygen transfer and thereby oxidation of dG and DNA. Such chemical structures of 
vitamin C-metal complexes have previously been proposed [154-156]. The suggested 
mechanisms are schematically outlined in Figure 16. According to Halliwell et al., all 
laboratory solutions and cell media are contaminated with transition metals unless 
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specifically purified [93]. It is therefore likely that the mechanisms mentioned above 
can hold even for studies where metals have not been added.  
 
 
8.8 CELL EXPOSURE WITH VITAMIN C – CHALLENGES 
The nature of cell cultures give rise to some factors to consider when investigating 
vitamin C. First, cell medium may contain metals and as discussed above, their 
presence might affect the action of vitamin C. For example, the very common DMEM 
(not used in this thesis) contains iron(III) nitrate. Serum from calves (used in this thesis) 
also contains transferrin, proteins with bound iron. Iron in transferrin will, however, 
normally not catalyse free radical reactions. In addition, laboratory equipment contain 
trace amounts of metals, unless specifically purified [93]. RPMI medium used within 
this thesis does, however, not contain added iron salts, nor copper [96].  
 
In addition, different cell types express certain transporters to different extents. Hence, 
the choice of cells might affect the uptake of the vitamin. HL-60 cells has, for example, 
the ability to stabilise extracellular ascorbate [141], while they also express GLUT 
transporters [140]. Moreover, exposure using DHAA has been argued to demonstrate 
an artificial uptake, via GLUT [157]. It was, to me, surprising that DHAA did not affect 
the HL-60 in paper I, considering that ascorbic acid did (inducing cytotoxicity) and that 
DHAA was expected to be taken up via GLUT, and then reduced to ascorbic acid. This 
emphasises the challenge in foreseeing the most appropriate circumstances in in vitro 
studies. Furthermore, due to its instability, most cell media do not contain added 
vitamin C, nor vitamin E [93,158]. Exposure of these antioxidants have been speculated 
to be artefacts due to the cells lack of these antioxidants or due to oxidation in the 
medium [93].  
 
 

	 


	 


	




"'!#
	
	
%(
	 &(
&(
&(
%%

(!(
(
%(
%(
%%

(!(
 %%



(#) 8$%$6()%  %#)' 9(*##'.%)#$ (#( $) " ).%+ )# $
$#)"($7%'	==)%%-  (5'+ )) %$4*2%&&'32%-.*$%( $32 '%$32
("$ *#5 
  51
8.9 VITAMIN C AND CANCER 
Cancer cells display special properties, some which might intervene with the action of 
vitamin C. As a consequence, vitamin C has become a hot topic within cancer research 
and is discussed and speculated as a potential future chemopreventive agent.  
 
Cancer cells often have an overexpression of GLUT transporters, enabling a high 
uptake of DHAA and accumulation of ascorbate [116]. Cancer cells also have low 
levels of antioxidant enzymes and high levels of ROS, and it has been speculated 
whether vitamin C is able to enhance this effect in such a way that it can promote death 
of these cells [116]. Moreover, progress has been made in achieving pharmacological 
concentrations of vitamin C by intravenous administration, enabling higher in vivo 
concentrations than was previously achieved by oral administration [159]. As reviewed 
by Verrax and Calderon, and Mamede et al. [58,116], vitamin C has been reported to 
increase the efficiency of cancer drugs in vitro and in vivo, but the opposite effect has 
also been observed in vitro, with a resulting decreased effect of cancer drugs. 
Importantly, cancer treatment in the form of radiotherapy generates ROS in irradiated 
tissues, and chemotherapies might also affect oxidative stress through its different 
modes of action [58]. The use of antioxidants/pro-oxidants might therefore interfere 
with cancer chemo- and radiotherapy. Consequently, the potential use of vitamin C as a 
chemopreventive agent is at an early stage and needs immense considerations and 
further research. 
 
 
8.10 VITAMIN C VERSUS VITAMIN A 
Out of the thirteen micronutrients investigated in paper I, vitamin A and C stood out in 
particular. Vitamin C has well-documented pro-oxidant properties while the pro-
oxidant potential of vitamin A has been reported to a lesser degree. Somewhat 
surprising, we observed that vitamin A caused oxidation to dG with an even stronger 
pro-oxidant potential than vitamin C. Retinol concentrations in plasma are stable and 
do not fluctuate much. Three times normal plasma levels of retinol is therefore not 
normally achievable in human plasma, but more likely to occur in tissues utilising or 
storing vitamin A. Plasma levels of vitamin C are also kept stable but are able to 
fluctuate more than for vitamin A, for example after vitamin C supplementation [124]. 
Moreover, since even normal plasma levels were sufficient to cause oxidation, the 
relevance in vivo might be suspected to be higher for vitamin C. On the other hand, the 
properties of vitamin C is, as discussed in previous sections, highly dependent on 
environmental factors, and extrapolation to an in vivo situation is for that reason 
premature. The results from paper I do, nonetheless, give important insight into pro-
oxidant properties of both vitamin A and C, enabling a direct comparison between the 
two as well as eleven other micronutrients.  
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8.11 CONCLUSION 
The pro-oxidant potential previously documented from vitamin C is confirmed in this 
thesis. Vitamin C stood out among the thirteen micronutrients as the only one capable 
of pro-oxidant activity at normal plasma concentrations. The presence of iron or copper 
further enhanced the effects, and the combination of vitamin C and copper stood out the 
most, causing oxidation both in the chemical and cellular analyses. This is a potential 
concern since vitamin C and copper are both commonly found in supplements. The 
forms of vitamin C present in supplements also differ in their chemical properties, 
emphasising the importance of making an aware decision during the synthesis of 
antioxidant supplements. To compound the situation, supplements are also easily 
accessible to the public, enabling individuals to be exposed to very high doses. On the 
other hand, the pro-oxidant potential of vitamin C along with characteristic properties 
of cancer cells opens up for a potential use for vitamin C for cancer prevention and 
treatment. 
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9 DIGGING DEEPER – FOLATE  
In this chapter, you will be guided through the effects of folate in humans, with an 
emphasis on the effect of folate status, folic acid status and the link to DNA lesions. 
The chapter revolves around the observational study conducted in paper III.  
 
 
9.1 FOLATE OR FOLIC ACID? 
Folate, vitamin B9, is a water soluble vitamin involved in amino acid metabolism, 
correct DNA synthesis and in a range of transfers of methyl-groups [54]. While 
naturally occurring folate is found in food sources, folic acid is the synthetic form 
present in supplements. Folate is a generic term referring to compounds with similar 
chemical structures, containing three moieties, 1) a pterin ring, 2) para-aminobenzoic 
acid (joint by a methylene bridge) and 3) a glutamic residue (joint by a peptide bond) 
[160]. Figure 17 shows the chemical structure. The different folate compounds arise 
since the pterin ring can be reduced or oxidised to different extents and the glutamic 
acid can be extended to include a glutamate chain. A majority of the naturally occurring 
folates include five to eight glutamate units in its side chain [40]. The fully reduced 
form of folate is referred to as tetrahydrofolate and frequently abbreviated to THF. In 
supplements, a synthetic form of folate is commonly present – folic acid. This form is 
specific, containing one glutamate unit only, and a fully oxidised pterin ring [40].  
 
 
9.2 THE FATE OF FOLATE IN HUMANS 
In vivo, folates from oral consumption are absorbed in the intestine, transported out to 
the blood system and guided to tissues where it is absorbed and stored and/or 
metabolised. The kidney also serves as a key site for the re-absorption of folate [40]. 
Before absorption can occur in the intestine, folates in polyglutamate form (folate PG) 
are enzymatically hydrolysed to monoglutamate form (folate MG). Subsequently, 
several transport systems facilitate the uptake of the folate MG. The intestinal transport 
is believed to be mediated mainly by proton-coupled folate transporter (PCFT), reduced 
folate carrier (RFC) is also present as well as a mechanism by which the folates are 
taken up through endocytosis, folate receptor (FR)-mediated endocytosis. PCFT also 
takes part in the latter [54]. Once absorbed, both folate and folic acid are metabolised to 
5-methyl THF, which is taken up by the peripheral blood stream via RFC and folate 
receptors [40]. In plasma the form most predominantly present is 5-methyl THF, found 
bound to albumin or to a high-affinity folate binder [40]. 
 
To be retained and stored in cells, folate MG is converted to folate PG, intracellularly 
folate PG is stored bound to enzymes. To be released to the extracellular milieu, the 
folate PG is hydrolysed back to folate MG. The uptake of folate is concentration 
dependent and the expression of folate transporters adapts to the extracellular 
concentration [40].  In addition, in most tissues, although not liver tissue, the RFC has a 
higher affinity for folate compared to folic acid. The presence of high levels of folic 
acid also affects the ADME in that absorption of folic acid also occurs through a 
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diffusion-like process in the intestines at high folic acid concentrations. As opposed to 
folate, unmetabolised folic acid can be found both in plasma and excreted in urine [40].  
 
In mammals, folate is required for the activation and transfer of one-carbon units, 
known as folate-mediated one-carbon metabolism. As portrayed in Figure 17, it can be 
seen to include two intervening pathways: 1) a DNA cycle, and 2) a methylation cycle. 
In the DNA cycle, adenine, guanine and thymidine (dTMP) precursors are produced, as 
well as the amino acids serine, glycine and methionine. In the methylation cycle, the 
primary methylation agent s-adenosylmethionine, SAM, is formed, as well as the 
amino acids homocysteine, cysteine and methionine. The two cycles compete for the 
use of 5,10-methylene THF, especially at low folate levels [54]. The folate-mediated 
one-carbon metabolism also requires other micronutrients, such as vitamin B2, B6 and 
B12 and low levels of these might also affect the metabolism – something which is 
referred to as ‘functional’ folate deficiency.  
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9.3 FOLATE – THE THEME OF PAPER III 
The main aim of paper III was to investigate associations between intake or status of 
folate, folic acid or folate metabolising enzymes with DNA lesions. A particular 
interest was dedicated to the lesion of uracil misincorporated into DNA since folate 
depletion will prevent the conversion of dUMP to dTMP in the DNA cycle, see Figure 
17. Consequently, the synthesis of thymine is inhibited and instead uracil becomes 
available for incorrect incorporation [54]. We aimed to investigate if folate parameters 
could predict levels of uracil misincorporation, oxidative DNA lesions or DNA strand 
breaks. Folate is extensively studied in relation to fertility and folate parameters are 
therefore comprehensively analysed in infertile women. For that reason, infertile but 
otherwise healthy women were chosen as the study population in paper III. The study 
design is shown in Figure 8, chapter 6, and described in detail in paper III. In short, 36 
infertile women were studied. The women answered food questionnaires and 
interviews, from which folate/folic acid intake could be estimated. Blood samples were 
also drawn from the participants, from which DNA lesions (DNA breaks, oxidative 
DNA lesions and uracil misincorporation into DNA), levels of folate, vitamin B12 and 
homocysteine, and polymorphisms for genes involved in folate metabolism were 
analysed.  
 
 
9.4 FOLATE, FERTILITY AND FOETUS HEALTH – IS THERE A LINK? 
Folate status has, to different extents, been connected to neural tube defects, 
spontaneous abortions and infertility. Within 28 days of conception, the nervous system 
is being developed through the closure of the neural tube, which subsequently develops 
into the spinal cord and surroundings of the brain. In between 0.4 to 2‰ (i.e. per 
thousand) of all pregnancies, the neural tube is not closed properly, leading to neural 
tube defects [53]. Survivors of neural tube defects suffer from neurological motor 
deficits. They vary in severity depending on the site and size of the defect but can, for 
example, include water in the brain, cognitive dysfunction, learning disabilities or 
walking difficulties [53]. Folate is a crucial component of many one-carbon reactions, 
and a sufficient folate status is required for a functioning DNA synthesis, cell division, 
correct SAH/SAM ratio and homocysteine levels, all needed for a functioning 
development of the nervous system [40]. Folic acid supplementation has proven highly 
successful in preventing neural tube defects [161].  
 
While the influence of folate in neural tube defects is clear, its role in fertility is more 
uncertain and is currently being subject to research. In fact, studies have observed that 
folate insufficiency, high homocysteine levels (hyperhomocysteinemia) and certain 
polymorphisms of genes involved in folate metabolism negatively affect oocyte and 
embryo quality, oocyte production, ovulation, implantation and pregnancy viability. 
Whether folic acid supplementation can improve female fertility and foetus viability 
remains to be seen [54].  
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9.5 FOLATE AND DNA LESIONS 
9.5.1 Uracil misincorporations 
As can be seen from Figure 17, a low folate level will produce low 5,10-methylene 
THF levels, which in turn will hamper the conversion of dUMP to dTMP. The result is 
elevated uracil concentrations accompanied by reduced thymidine levels. Uracil and 
thymidine differ only by one methyl group, and their resemblance makes it possible for 
uracil to be misincorporated into DNA, in place of thymine. Uracil is normally present 
in RNA only and therefore becomes subjected to DNA repair mechanisms. During 
repair, uracil is removed, producing a single strand break. Unless thymidine synthesis is 
resumed (i.e. by raised folate status), the correct base might not be inserted and DNA 
double strand breaks, chromosomal aberrations and malignant transformation (i.e. 
initiation of cancer) may follow [52]. In human studies, the evidence is inconsistent but 
DNA damages including uracil misincorporation and chromosomal breakage have been 
observed [51,85,162-164]. In subjects with a sufficient folate status, the amount of 
uracil misincorporated into DNA has been seen to be either unaffected by the folate 
level in red blood cells, or to be negatively correlated [85]. Folic acid supplementation 
for twelve weeks reduced the level of uracil misincorporation among the healthy 
participants in the latter study [85]. In another study conducted on healthy women with 
sufficient folate status, the level of uracil misincorporation was not altered when folic 
acid supplementation was given for four weeks. In splenectomised individuals (i.e. with 
the spleen partially or completely removed), sufficient folate levels have been 
associated with normal levels of uracil misincorporated into DNA, while folate 
deficiency has been correlated to higher levels of uracil misincorporation [162].  
 
In paper III, we studied infertile, but otherwise healthy, women. Since these women 
were aiming to become pregnant they fall under the recommended population groups 
who, by the Swedish National Food Agency, are advised to consume folic acid 
supplement. Approximately 67% in our study reported taking supplements. However, 
41% consumed less than recommended despite supplement use. On average, 
approximately 520 μg folate and folic acid were consumed from food and supplements, 
and a serum level of 20 nM was achieved, which is well within normal and 
recommended levels. In these subjects with adequate folate levels, we did not find any 
association between folate status and uracil misincorporation into DNA, nor between 
folate status and vitamin B12 or homocysteine levels. These results, in combination with 
the results from the studies described above, indicate that even though folate status has 
been associated with uracil misincorporation, the effect seems to be more pronounced 
in subjects with a poor folate status.  
 
9.5.2 Other DNA lesions 
Folate status and its association to other DNA lesions have been reported in studies. 
Kapisewska et al. reported no correlation between folate status and DNA strand breaks 
in healthy women with sufficient folate status, after a four week folic acid 
supplementation period [86]. In another study, young healthy individuals with adequate 
folate levels were studied and no correlation between red cell folate and micronuclei 
formation in lymphocytes were observed [51]. Micronuclei formation is characteristic 
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of cells with DNA lesions. Despite the lack of association, the authors experienced a 
reduction of micronuclei formation following 24 weeks of folic acid supplementation, a 
reduction associated with vitamin B12 and homocysteine levels, but not with red cell 
folate [51]. In splenectomised individuals, adequate folate levels have been associated 
with normal micronucleated reticulocytes (immature red blood cells), while folate 
deficiency was associated with higher levels of micronucleated reticulocytes [162]. In 
another study in splenectomised subjects, those with the highest micronucleated 
reticulocytes were folate or vitamin B12 deficient [163].  
 
As with uracil misincorporated into DNA, the women studied in paper III, who had 
adequate folate levels revealed no correlation between folate status and DNA breaks or 
oxidative DNA lesions. As with the uracil lesions, these results together with results 
from the other studies discussed, imply that, even though folate status has been 
associated with different DNA lesions, the effect seems to be more prominent in 
participants with a poor folate status.  
 
Enzyme polymorphisms. The impact of different polymorphisms in key enzymes in the 
folate-dependent one-carbon metabolism on fertility as well as DNA lesions have been 
implicated in previous studies [54,86]. In paper III, we observed a small, yet 
statistically significant, effect by the MTHFR 677 polymorphism on the level of DNA 
strand breaks. The MTHFR 677 enzyme is involved in the conversion of 5,10-methyl 
THF to 5-methyl THF as seen in Figure 17. In paper III, the MTHFR 677 CT genotype 
was associated with lower levels of DNA strand breaks, as compared to the CC wild-
type genotype. The actual difference was, however, only 0.5%, and would not have 
been significant if Bonferroni correction for multiple tests had been conducted. In our 
study, the clinical relevance of this decrease can be questioned. In addition, the power 
to detect effects of DNA damage by different polymorphisms was low, due to the 
relatively few participants. The extent of uracil misincorporation into DNA has 
previously been linked to different genotypes of the MTHFR 677 enzyme. Contrary to 
what was indicated in our results, CT and TT polymorphisms have instead been 
associated with lower levels of uracil misincorporation into DNA, as well as with lower 
plasma levels of folate, as compared with the CC wild-type [86]. The effect of 
polymorphisms of different enzymes involved in folate metabolism on DNA lesions 
and fertility remains to be further researched.  
 
It cannot be excluded that a larger study population and participants with lower folate 
levels might have revealed a different association between DNA lesions, folate status 
and gene polymorphisms.  
 
 
9.6 FOLATE AND CANCER 
Evidence has indicated that folate deficiency might contribute to an increased risk of 
cancer of the colorectum, breast, ovary, pancreas, brain, lung and cervix [52]. However, 
recent studies and meta-analysis raise concern that high doses of folic acid 
supplementation might also contribute to an increased cancer risk [53,55,56].  
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9.7 CONCLUSION 
Folate is essential for one-carbon reactions involved in amino acid metabolism, correct 
DNA synthesis and a range of transfers of methyl-groups. Maternal folate deficiency is 
associated with neural tube defects in foetuses, and has been implicated in oocyte 
viability, pregnancy outcome and in infertility. Folate deficiency has also been 
correlated with different types of DNA lesions, where the misincorporation of uracil 
into DNA is particularly dependent on folate status. In paper III, we investigated the 
association between folate and folic acid intake with uracil misincorporation into DNA, 
DNA strand breaks or oxidative DNA lesions. Our results add to the carefully 
accumulating evidence indicating that, even though folate status has been associated 
with DNA damage, the effect seems to be more evident in subjects with folate 
deficiency.  
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10 DIGGING DEEPER – SEA BUCKTHORN 
Since many large intervention studies administering micronutrients in rather large doses 
have failed to show health beneficial effects, interest has been drawn to micronutrient 
supplements that are imitating the content of fruits and vegetables. One such approach 
is using extracts from fruit and berries. This chapter revolves around the effects of 
extracts from the sea buckthorn berry, a berry rich in antioxidants and fatty acids. The 
sea buckthorn will be discussed in the light of the intervention study conducted among 
chronic kidney disease patients in paper IV.  
 
 
10.1 THE SEA BUCKTHORN BERRY 
The sea buckthorn berry, as seen in Figure 18, has historically been used as a medicinal 
plant in China, Turkey and Russia for hundreds of years. Its Latin name is Hippophae 
rhamnoides and it is one of six species and twelve subspecies belonging to the genus 
Hippophae L. Sea buckthorn is the only one of these species that grows outside of 
Central Asia and can also be found in, for example, Europe, Russia, China and India. 
More than 80% of the land used to grow sea buckthorn, for either wild or cultivated 
plants, is found in China. Although to a much lesser extent, sea buckthorn is also found 
in the Nordic countries. It is well adapted to extreme conditions and can grow in 
nutritionally deficit soils, drought, salinity (an environment rich in salt), wind and at 
temperatures ranging from -43°C to +40°C [165]. 
 
Sea buckthorn is rich in nutrients, such as unsaturated fatty acids, B, C and E vitamins, 
carotenoids and polyphenols [165,166]. Oil from this berry is particularly rich in the 
fatty acids linoic (18:2 n-6), α-linoic (18:3 n-3), oleic (18:1 n-9), palmitoleic (16:1 n-7) 
and palmitic (16:0) acids, as well as vitamin E, tocopherols and tocotrienols, flavonoids 
and carotenoids [167]. The precise content of a sea buckthorn berry is dependent on 
several factors. The subspecies, the growth place and the maturity level all contribute to 
the levels of fatty acids and micronutrients present [167-170]. The content of sea 
buckthorn oil is also dependent on whether the oil has been extracted from seed or pulp, 
resulting in different fatty acid components and ratios. Juice and oil from sea buckthorn 
berries also differ in their contents [171].  
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While the sea buckthorn plant has been used as a medicinal plant in certain parts of 
Asia for many centuries, it is only during recent years that an increasing interest in the 
plant has arisen in the Western world. Today, sea buckthorn is found on the food 
market, present in a wide range of products including jam, curd, juice, wine, liquors, 
tea, pie, cake, honey, sweets and ice cream. Sea buckthorn can also be purchased as 
berry oil and as a dietary supplements, and is also used in cosmetics [165].  
 
 
10.2 A SEA BUCKTHORN EXTRACT – THE THEME OF PAPER IV 
The aim of paper IV was to research the effect of a supplement containing sea 
buckthorn oil extract on oral health, inflammation markers and DNA lesions in patients 
suffering from chronic kidney disease (CKD). 45 patients were studied, all undergoing 
haemodialysis treatment. DNA lesions including DNA breaks and oxidative DNA 
damage (FPG-sensitive sites) were measured using the comet assay. Analyses of blood 
markers from routine samples of haemodialysis patients were also included. This 
intervention study had a randomised, double blind crossover design. Patients were 
given supplement or placebo to start with, following which, after a washout period, 
they consumed the other type of capsule. The supplementation periods lasted for eight 
weeks and the washout period stretched over a four-week period. The study design can 
be seen in Figure 6, chapter 8. A more detailed description of the study is found in 
paper IV. 
 
Supplement content. One capsule contained 500 mg of sea buckthorn extract, and the 
participants consumed four capsules daily. The content of the sea buckthorn capsules 
are listed in Table 6. The placebo capsules contained coconut oil and were similar in 
physical appearance.  
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10.3 CHRONIC KIDNEY DISEASE AND DIALYSIS PATIENTS 
CKD is a progressive loss of renal function accompanied with uremic symptoms. 
Patients with CKD suffer from numerous discomforts. Damage to the kidneys induces 
uremia, a state of intoxification that leads to alterations of many biomolecular 
processes. CKD can affect all tissues and organs in the human body, including the 
heart, blood vessels, nerves and muscles [172]. Therapy to avoid these complications 
consists of medication at a first stage, and ultimately of dialysis treatment or a 
transplant. During dialysis the blood is cleaned through a membrane enabling toxins to 
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be eliminated or decreased. Two forms of dialysis exists, peritoneal and haemodialysis, 
the latter being the most commonly used, with an estimated one million users 
worldwide [173]. The experience of a haemodialysis session can be seen in Figure 19.  
 
In recent years an increasing attention has been brought to the oral health problems that 
CKD patients also suffer from as a consequence of both the disease and therapy. 
Problems with the bone as well as soft tissue structure have been reported. Many 
patients experience, for example, xerostomia (mouth dryness), eating-, swallowing- and 
speaking difficulties, tooth and gingival sensitivity, bad appetite, painful mouths, 
gingival bleedings and an increased risk of infections [172-175]. CKD is also 
associated with malnutrition, high levels of oxidative stress and inflammation, thus 
contributing to a higher risk of developing cardiovascular diseases. Patients undergoing 
haemodialysis have been revealed to have an increased production of free radicals, 
impaired antioxidant mechanisms and an oxidant/antioxidant imbalance, all 
contributing to oxidative stress [176]. 
 
Patients undergoing haemodialysis often have low nutrient levels due to the loss of 
water soluble vitamins during the dialysis treatment, but also due to their restricted diet 
as well as lost ability to, for example, activate vitamin D [177]. Because of a loss in 
kidney activity, certain micronutrients are prevented from being excreted and are on the 
contrary to others found in high levels, for example vitamin A [177]. The level of 
micronutrients can also fluctuate depending on the time left until dialysis treatment 
[178]. Treatment normally occurs at a medical centre three times per week, and 
requires several hours per session. Vitamin E-coated dialysis membranes have been 
introduced with encouraging results, reducing lipid peroxidation [179]. 
Supplementation with a few micronutrients has also indicated promising results. Folic 
acid contribute to a reduction in cardiovascular disease [180], omega-3 fatty acid to a 
pronounced antioxidant defence [181], a fish oil supplement to a reduction in the 
inflammation marker C-reactive protein (CRP) [182] and vitamin E to a reduction of 
DNA breaks [176], for example. 
 
 
10.4 SEA BUCKTHORN AND HEALTH EFFECTS 
As will be unravelled in this and the following section, the sea buckthorn berry has 
been attributed antioxidant properties as well as immune response regulatory effects, 
anti-inflammatory effects and anticancer effects in a mix of in vitro, animal and human 
intervention studies.  
 
Inflammation is induced by the body during the course of many different diseases, and 
is well-known to be elevated in CKD disease patients. In paper IV, inflammation 
markers measured in the CKD patients undergoing dialysis treatment were not affected 
by sea buckthorn oil consumption. This was despite elevated inflammation in the 
patients group, as seen in a previous study among the same patients [183]. The 
inflammation markers measured were hsCRP (high sensitive C-reactive protein), 
antitrypsin, orosomucoid and leukocytes – some of which sea buckthorn has previously 
been reported to affect. For example, Larmo et al. [184] observed that consumption of 
sea buckthorn puree reduced the CRP level, an effect that was not correlated with the 
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flavonol content as hypothesised [185]. Anti-inflammatory activity has also been 
documented in rats [186]. Two obvious differences between our study and the one by 
Larmo and colleagues [184] are the participants and the sample size. While Larmo et 
al. included 254 healthy participants, we studied 45 chronically ill patients. In addition, 
the form of sea buckthorn consumed differed between the two studies. Larmo et al. 
administered sea buckthorn puree while the CKD patients in paper IV received 
capsules containing oil extracts. Considering that the antioxidant and fatty acid content 
of sea buckthorn differ between different parts of the plant and is dependent on 
maturity as discussed above, the content of the sea buckthorn is excepted to differ in the 
two studies, and it is possible that the oil extract used in paper IV has a lower ratio of 
less lipophilic compounds.  
 
Certain parameters related to the development of cardiovascular disease, in addition to 
inflammatory markers, have also been affected by sea buckthorn. In an in vivo study in 
rabbits, sea buckthorn oil displayed anti-artherogenic and cardioprotective activity, as 
determined by a reduction in, for example, plasma cholesterol [187]. In a human 
intervention in which 229 healthy adults consumed puree from sea buckthorn the 
results differed, and neither LDL or HDL cholesterol, or triacylglycerol, were affected 
by a three months intervention [185]. Platelet aggregation has, however, been inhibited 
in adult men after four weeks of sea buckthorn oil consumption [188]. In paper IV, the 
focus was on the specific health effects related to CKD, and cholesterol values were not 
measured. Another health aspect for which sea buckthorn has been observed to be 
positively related to and which paper IV did not investigate, is the linkage to metabolic 
disease. Lehtonen et al. [189] reported improvements of different parameters related to 
metabolic disease in overweight and obese women after a 33-35 day intervention with 
sea buckthorn extract. 
 
In paper IV, we did not expect disease parameters to significantly change during the 
intervention, CKD is an irreversible process and it would be premature to expect a 
dietary intervention to interfere with the disease progression. The hypothesis was rather 
to improve other health aspects such as DNA lesions or mouth dryness. As expected, 
creatinine and urea were not affected by sea buckthorn supplementation. A few 
parameters were, however, significantly affected, but their changes were small and their 
clinical relevance therefore questioned. 
 
The dryness of eyes has been improved by consumption of oil from sea buckthorn 
[166]. Adults using contact lenses reported fewer days experiencing dry eye symptoms 
in comparison to placebo consumers. Analytical values that improved, not only in 
contact lens users, include tear film osmolarity, redness and burning. The improvement 
of dry eye symptoms were not caused by a change in fatty acid content of the tear film 
as speculated [190]. CKD disease patients commonly experience mouth dryness. Based 
on the improvement in dry eye symptoms, we investigated if a sea buckthorn oil extract 
could improve mouth dryness symptoms in CKD patients. In paper IV, the mouth 
dryness was analysed using salivary flow (excretion) rates, which often, but not always, 
correlate with mouth dryness. The CKD patients did, however, not display any 
improvement in oral health after supplementation.  
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Since the sea buckthorn berry is rich in vitamin C and other micronutrients, it comes as 
no surprise that its potential effect on the common cold has been investigated. Larmo et 
al. did, however, not observe any change in frequency or duration of the common cold 
or urinary tract infection after 90 days of consumption of sea buckthorn puree [184].  
 
 
10.5 SEA BUCKTHORN AND DNA LESIONS 
The sea buckthorn berry has attributed antioxidants properties as described by several 
in vitro studies, while the number of published articles with reference to sea buckthorn 
and human studies measuring DNA damage is low. A high antioxidant activity has 
been seen from extracts, using different antioxidant assays (e.g. FRAP) [191]. A 
reduced free radical production [192,193], apoptosis and DNA fragmentation have also 
been observed from sea buckthorn [192], along with an increased antioxidant status 
[192]. Mice have been protected against induced oxidative damage by sea buckthorn 
[194,195]. In a cell-free system, an oil extract has revealed potential to be metal 
chelating, metal (iron) reducing, and radical scavenging [196]. A study conducted in 
2010 revealed antioxidant properties from a sea buckthorn extract – when at a low 
dose, but not at a high dose [197]. Higher doses provided a pro-oxidant effect – as with 
many other antioxidants in this thesis. The berry has in fact also been observed to 
induce DNA-protein cross-links [198]. Moreover, a protective effect on DNA breaks in 
lymphocytes measured using the comet assay has also been detected [199]. 
 
In paper IV we investigated the effect of supplementation with a sea buckthorn oil 
extract on DNA lesions in CKD patients. Considering the discomforts that CKD 
patients experience in the oral cavity (e.g. mouth dryness), we focused on effects in 
local tissue with the aim to investigate if local damage could be improved by the 
intervention. Our results, however, did not reveal any beneficial effect on DNA lesions, 
neither DNA breaks or oxidative DNA lesions, in minor salivary glands among the 
participants. CKD patients have elevated inflammatory levels as well as oxidative stress 
levels [176]. In addition, the two are intervened since ROS are produced during 
inflammatory response. Despite this, and along with antioxidant potential of sea 
buckthorn documented in in vitro studies, we did not observe an antioxidant effect. 
However – and importantly – CKD has repeatedly been reported to be associated with 
elevated levels of oxidative stress and DNA damage in leukocytes [200,201]. Whether 
oxidative stress levels in blood cells reflect the level in tissues is, however, unclear and 
it was recently shown that the CKD patients in our study had lower oxidative stress 
levels (as determined by oxidative DNA lesions using the comet assay) in salivary 
glands compared to healthy controls [183]. A lack of protective effect against DNA 
damage could be due to the already relatively low levels of DNA lesions present in the 
salivary glands, and it cannot be excluded that a different result may be achievable in 
tissues with initial elevated levels of DNA lesions. 
 
Thus, in paper IV we did not reveal any protective effect from sea buckthorn on DNA 
lesions. Whether sea buckthorn supplementation can protect against or improve DNA 
damage in tissues containing higher levels of initial damage, alternatively in blood 
cells, needs to be further investigated.  
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10.6 SEA BUCKTHORN AND CANCER 
In addition to its antioxidant activity, and other health promoting properties discussed, 
the sea buckthorn has also been suggested to have antimutagenic potential. A study 
published in 2009 showed ‘remarkable antitumor activity’ by a sea buckthorn extract 
towards a two-stage carcinogenesis induced by a tumour promoter (TPA) in mice 
[202]. In mice, a decrease in carcinogen-induced forestomach and skin tumourigenesis 
have also been seen from sea buckthorn, with an indication of an up-regulation of 
antioxidant and phase II enzymes, and DNA-binding activity of the transcription factor 
interferon regulatory-1 [203]. Olsson et al. observed that sea buckthorn inhibit 
proliferation of cancer cells in a cell study, an effect that was correlated with carotenoid 
and vitamin C content of the berry [204]. The absence of effect on DNA lesions in 
CKD patients in paper IV does not add evidence to a cancer protective effect by the 
berry. Nevertheless, studies published on sea buckthorn and cancer effect provides 
promising evidence to elaborate on in future research.  
 
 
10.7 CONCLUSION  
In paper IV, the CKD patients undergoing dialysis treatment were not affected by sea 
buckthorn supplement consumption. Published clinical trials are not consistent in 
showing effects on inflammatory markers form sea buckthorn berry and our study adds 
to the evidence of no effect on inflammation.  While some intervention studies have 
shown health beneficial effects on DNA lesions in CKD patients, sea buckthorn did not 
affect DNA breaks or oxidative DNA lesions in our study. We did, however, measure 
the damage in local tissue – minor salivary glands – while it is more common to 
analyse DNA lesions in blood cells since blood is simple to collect from participants. It 
cannot be excluded that sea buckthorn supplementation could affect the DNA of blood 
cells more, or that the effect of sea buckthorn could be different in another patient 
group. The results from paper IV add to the ambiguous evidence in the literature 
concerning supplementation of micronutrients or berry extracts.  
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11 CONCLUDING REMARKS AND FUTURE 
PERSPECTIVES 
11.1 CONCLUDING REMARKS 
What are the contributions of this thesis to the fields of nutrition, micronutrients and 
toxicology? The thesis adds to the evidence that micronutrients can act differently 
depending on external factors – that many of them can behave both as antioxidants and 
pro-oxidants. It also adds to the confusion of micronutrient supplements, implying that 
supplements do not always have significant contributions to our DNA, specifically on 
the levels of DNA breaks and FPG-sensitive sites (oxidative DNA lesions). The results 
within the thesis also reveal that berry extracts are not automatically health beneficial 
even if the berries have been described as having health-promoting effects. Synthetic 
forms of a micronutrient, as often found in supplements, may have different qualities 
and take different actions compared to its natural form. An interest has therefore been 
drawn to the use of natural ingredients in supplements, such as extract from berries. 
However, the results herein show that health beneficial effects do not automatically 
follow simply because the micronutrients are of natural origin. The health effects from 
micronutrient supplements may vary – independent of if the supplement contains 
micronutrients of synthetic origin or extracts from natural sources. The thesis has 
answered the following questions, as outlined in chapter 3: 
 
1. Do micronutrients/antioxidants chemically act as pro-oxidants and if so, do they do 
so with different strengths? 
Some do. Out of thirteen micronutrients vitamin A and vitamin C were found to 
particularly stand out with strong pro-oxidant activity in a strictly chemical set-up. The 
pro-oxidant activity was further enhanced, synergistically, in the presence of iron or 
copper, also found in supplements. Environmental factors (i.e. buffer type, dose) also 
significantly affected the pro-oxidant capacity of the vitamins.  
 
2. Do micronutrients with pro-oxidant potential act as pro-oxidants in cultured cells? 
Mostly not, but in some combinations they can. In this thesis, vitamin A or C alone did 
not cause oxidative damage to the DNA of cells in culture in this thesis. Nor did they 
cause DNA strand breaks. Noteworthy, however, the combination of vitamin C and 
copper did cause oxidative DNA damage as well as DNA breaks – a combination 
standing out with particular pro-oxidant activity in this thesis.  
 
3. Do different compounds in supplements classed as either vitamin A or C differ in 
their abilities to act as pro-oxidants? 
Yes. It is clear that the different vitamin A compounds permitted in supplements have 
different chemical properties and different abilities to act as pro-oxidants. The same 
was concluded about vitamin C compounds present in supplements. This poses a 
potential concern during for example manufacturing of supplements. When it came to 
the effect on the DNA of cultured cells the compounds did, however, not differ 
between each other to the same extent and most compounds did not cause DNA 
lesions.  
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4. Do folate levels, intake or genes related to folate metabolism predict the level of 
DNA lesions?  
The results herein imply that such predictions should not be made at this point. In our 
observational study, folate/folic acid intake or folate status was not associated with the 
level of DNA lesions in 36 infertile women. Most polymorphisms of genes involved in 
folate-mediated one-carbon metabolism were not associated with DNA breaks, 
oxidative DNA lesions or uracil misincorporation into DNA either. The folate status 
and intake in these participants were within a desired range, and it could be that an 
association between folate and DNA lesions is stronger in participants with a poor 
folate status – a hypothesis that needs further investigation.  
 
5. Does a supplement containing a berry extract rich in antioxidants reduce DNA 
lesion levels, improve health or improve the oral health of chronic kidney disease 
patients? 
Unfortunately not in our study. An eight week long intervention with a sea buckthorn 
extract did not change the level of DNA lesions in chronic kidney disease patients 
undergoing haemodialysis treatment. Neither did it affect mouth dryness as determined 
by salivary secretion, nor did it affect inflammation or disease specific parameters to 
any level that would be anticipated to be of clinical relevance. The initial level of DNA 
lesions in minor salivary glands among the patients were, however, not elevated and a 
different effect on DNA lesions might be achievable in patients with higher initial 
damage, or in a different cell type.  
 
This thesis emphasises that the properties of micronutrients and antioxidants are in fact 
not straightforward, further adding to their mystery. An antioxidant is not always an 
antioxidant – with its ability to take part in electron transfers it can also act as a pro-
oxidant. The ambiguousness is further enhanced due to that many external factors can 
have an effect on the micronutrients’ actions. The chemical effects of micronutrients 
can thus vary. Neither is it clear and obvious how they act when ingested as a 
supplement. Will the micronutrient supplement help us in our strive to live a long and 
healthy life, or will they be nothing but a burden added to our economical concern? Or, 
if worse comes to worse, will they even cause harm? Previous studies in smokers and 
workers exposed to asbestos have shown just that: that antioxidants in fact are capable 
of causing harm. However, in many studies antioxidant supplements have simply not 
had any effect at all on studied parameters, and the study on patients with kidney failure 
presented within this thesis adds to this non-effective result by micronutrients. It is 
important to mention that this thesis focuses on the effects of micronutrients in 
supplements on DNA and cancer, and the micronutrients discussed may very well have 
other health effects, beneficial or not, which have not been covered in this thesis. There 
are also certain groups of the population that might benefit from consumption of 
specific dietary supplements in a different way compared to the general population. 
Clinically defined nutrient deficient individuals might be one such group.  
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11.2 FUTURE PERSPECTIVES 
Most studies investigating health effects related to DNA and cancer in the general 
healthy population have failed to reveal beneficial effects from micronutrient 
supplements. Thus, future research that instead concentrates on specific high-risk 
groups might be more relevant at this point. Another challenge lies in identifying health 
effects from individual micronutrients, and a greater focus on the cocktail effect of 
several micronutrients might be desirable, whether as a multivitamin or a berry or fruit 
extract. 
 
While the use of micronutrient supplements by the general population is being 
questioned, more and more interest is shifted towards the micronutrients’ potential 
benefit within epigenetic and cancer preventing research. Epigenetics is a blooming 
field and refers to modifications in gene expression caused by changes in DNA 
methylation and chromatin structure. Epigenetic changes do not alter the DNA 
sequence but are – importantly – inheritable. Folate, retinoic acid and selenium have all 
been implied in epigenetic processes and comprise potential benefits to be investigated 
in future cancer preventive research [52,205].  
 
In an article published in 2011, Halliwell [65] proposes an interesting view that might 
come to challenge the field of antioxidants. He argues that reactive species might play a 
more important role in the antioxidant defence in humans than dietary antioxidants, by 
triggering increased levels of endogenous antioxidants. From this follows that pro-
oxidant action by antioxidants may play an role in enhancing the body’s own 
antioxidant defence, while the scavenging potential by antioxidants might be of less 
importance – a hypothesis opening up for interesting research in the future.  
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12 POPULAR SCIENTIFIC SUMMARY 
A strive to find a simple cure against diseases such as cancer has long been evident. 
The hope that it could be true arouse when it was observed that fruit and vegetables 
could prevent and reduce the appearance of several diseases, including cancer. Was it 
possible to extract the active substances and consume these in tablet form and achieve 
the same protective effect against cancer and other diseases? Fruit and vegetables 
contain small essential compounds called micronutrients. Many of these micronutrients 
are also so called vitamins and/or antioxidants. These small nutrients have been 
attributed responsible for the disease protection seen from fruit and vegetables. Keeping 
that in mind, vitamin supplements were manufactured with the hope that they would be 
just as health promoting.  
 
Over a third of the population consume vitamin supplements on a regular basis. While 
many people take supplements with the belief that their health will benefit from it, 
scientific studies have not been able to verify that effect. Contrary, many large studies 
have shown that vitamin supplements often have no effect at all. In fact, micronutrient 
supplements have also been seen to have harmful health effects, increasing cancer and 
death incidence among smokers. However, studies also exist where vitamin 
supplements have indeed protected against cancer, primarily in deficient participants. 
Much research has been conducted on micronutrients, yet a lot of question marks 
remain concerning their properties and health effects. Several factors are believed to 
affect their disputed health effects, including: 
 
- Initial health and nutrition status of the person. 
- Supplement composition – are micronutrients that normally cooperate present? 
- Dose – the dose is often higher in supplements than in fruit and vegetables. 
- Micronutrient form – naturally occurring or manufactured?  
- The surrounding environment – can influence the action of micronutrients. 
- Antioxidant or pro-oxidant? 
- Oxidative stress 
 
In this thesis, my colleagues and myself have investigated some of the factors that are 
believed to underlie the different results obtained form vitamin supplements. I have 
focused on how micronutrients interfere with our genetic make-up, the DNA. Damage 
to the genetic make-up can sometimes give rise to cancer. The thesis describes both 
experimental studies on a chemical and cellular level as well as studies on humans.  
 
Our genetic make-up contains instructions for how the components of the cell, our 
building blocks, are built. Imagine that the genetic make-up contains words (DNA 
bases) that together create instructions of how the different components should be built. 
If the instruction is damaged – for example if the instruction paper is ripped, letters 
removed or entire words removed or replaced – it severely complicates the building 
process. Depending on what letters that have been changed or gone missing, one 
scenario that may evolve is that the components or cells are built over and over again, 
in a quantity and speed that was not intended – this is how tumours and cancer can 
arise. One type of damage that can occur on our genetic make-up is through oxidation – 
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just as iron rusts. The body has a well functioning antioxidant system that protects 
against oxidation and damage that it causes (oxidative damage/lesion), but sometimes 
the protective system is overwhelmed, resulting in oxidative stress. Many micro-
nutrients are also so called antioxidants, with the ability to protect against oxidation. 
There is, however, a paradox in that the property that makes them able to protect 
against oxidative damage (as antioxidants), also enables them to change behaviour and 
start to act as pro-oxidants, causing damage opposed to protecting against it.  
 
In this thesis, we have used different model systems to compare the ability of thirteen 
micronutrients (whereof many antioxidants) to act as pro-oxidants, and cause oxidation 
to one of the ‘words’ in our genetic make-up (the DNA base guanine). Two 
micronutrients stood out – vitamin A and C. These oxidised, i.e. damaged, the DNA 
base and the effect increased with an increased dose. Directives at EU level regulate 
which compounds that are permitted in supplements. We saw that several of the 
compounds that are classed as either ‘vitamin A’ or ‘vitamin C’ differed in their ability 
to act as pro-oxidants. The pro-oxidant potential was, in line with what others have 
observed, affected by the immediate surrounding. The environment (probably also in 
the body) is thus essential for how an antioxidant/pro-oxidant behaves. We also 
observed that adding metals, such as copper or iron, enhanced the pro-oxidative 
activity. The combination of vitamin C and copper particularly stood out, causing 
oxidation not only to the DNA base, but also to the genetic make-up of cells in a system 
one step closer to a human situation (although still very far from it). Vitamin C and 
copper are both found together in multivitamin supplements. The different abilities by 
micronutrients to act as antioxidants or pro-oxidants should be taken into account 
when, for example, manufacturing supplements.  
 
This thesis also includes two human studies, where the effect of supplements was 
investigated. In one of these studies, we investigated if folate, or folic acid, affects the 
level of damages on the genetic make-up. Supplementation with folic acid is 
recommended by the Swedish National Food Agency to women who are planning to 
become pregnant or who are in the beginning of a pregnancy for a normal development 
of the foetus. In our study of 36 infertile women, we found no associations between 
folate/folic acid and the level of damage on the genetic make-up. The women had 
adequate levels of folate and it could be that the damage levels had been affected by 
folate status if the participants had had low folate levels. The lack of positive health 
effects in many studies with vitamin supplements has led to an increasing interest for 
supplements that imitate the content of fruit and vegetables to a greater extent – can 
they give more promising results? We conducted a so called intervention study where 
45 patients suffering from chronic kidney disease consumed a supplement containing 
oil from sea buckthorn, a berry rich in antioxidants and fatty acids. Unfortunately, the 
sea buckthorn supplement did not have any effect on the damage levels in the genetic 
make-up, neither did it improve mouth dryness or other disease related parameters.  
  
The results in this thesis add to the growing evidence that vitamin supplementation do 
not always have a health protective effect. The thesis emphasises that each 
micronutrient has unique properties, dependent on factors in their immediate 
surrounding. It might be that supplementation with micronutrients provides best benefit 
in those with initially low nutrient levels.  
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13 POPULÄRVETENSKAPLIG SAMMANFATTNING 
Länge har väl önskan om att finna ett enkelt botemedel mot sjukdomar så som cancer 
funnits. Hoppet om att detta kunde bli verkligen väcktes när man såg att frukt och 
grönsaker kunde motverka och minska uppkomsten av en mängd olika sjukdomar, 
däribland cancer. Kanske kunde man utvinna de aktiva ämnena och konsumera de i 
tablettform och få samma skydd mot cancer och andra sjukdomar? Frukt och grönsaker 
innehåller små livsviktiga ämnen som kallas för mikronutrienter. Många av dessa 
mikronutrienter är också så kallade vitaminer och/eller antioxidanter. Skyddet mot 
sjukdomar från frukt och grönt har trotts komma från dessa små näringsämnen. Med 
det i bakhuvudet har vitamintabletter (vitamintillskott) tillverkats med förhoppningen 
om att de skulle vara lika fördelaktiga för vår hälsa.  
 
Över en tredjedel av befolkningen äter vitamintillskott regelbundet. Medan många i 
allmänheten äter tillskotten i tron om att hälsan ska förbättras så har studier gällande 
vitamintillskott inte kunnat bevisa att det faktiskt är så. Istället har många stora studier 
visat att vitamintillskott ofta varken gör till eller från hos ”vanliga” friska personer. 
Dessutom har vitamintillskott till och med visat sig kunna ha hälsofarliga effekter, 
genom att öka risken för cancer och dödlighet hos rökare. Dock finns även studier, 
främst hos folk med näringsbrist, där vitamintillskott faktiskt har visat en skyddande 
effekt mot cancer. Det har forskats mycket på mikronutrienter men trots det kvarstår 
många frågetecken vad gäller deras egenskaper och hälsoeffekter. Flera faktorer tros 
påverka deras omstridda hälsoeffekter, så som: 
 
- Personens hälsa och näringsstatus från början. 
- Tillskottets sammansättning – finns de mikronutrienter som brukar samarbeta?  
- Dosen – ofta är mängden större i tillskott än i frukt och grönt.  
- Mikronutrientens form – naturlig eller kemiskt framställd? 
- Miljön omkring – vissa miljöfaktorer kan ändra hur mikronutrienter beter sig. 
- Antioxidanter eller pro-oxidanter?  
- Oxidativ stress. 
 
I denna avhandling har jag och mina kollegor undersökt några av de faktorer som tros 
ligga bakom att vitamintillskott kan ge så skilda resultat hos olika individer. Jag har 
fokuserat på hur mikronutrienter påverkar vår arvsmassa, vårt DNA. Skador på vår 
arvsmassa kan i vissa fall ge upphov till cancer. Avhandlingen beskriver både 
experimentella studier på en kemisk och cellulär nivå och studier på människan.  
 
Vår arvsmassa innehåller instruktioner för hur cellernas komponenter ska byggas. Man 
kan se det som att arvsmassan är uppbyggs av ord (DNA-baser) som tillsammans bildar 
instruktioner för hur olika komponenter ska byggas upp. Skadas instruktionen – till 
exempel genom att instruktionslappen rivs itu, bokstäver i orden försvinner eller att 
hela ord försvinner eller byts ut – så försvåras uppbyggnaden av komponenterna 
avsevärt. Beroende på vilka ord som försvunnit eller ändrats så kan ett scenario bli att 
byggstenarna eller cellerna byggs om och om igen i en mängd och fart som inte var 
tänkt – det är på så vis tumörer och cancer kan uppstå. En typ av skador som kan ske på 
vår arvsmassa är genom oxidation – precis som när järn rostar. Kroppen har ett väl 
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uppbyggt antioxidantsystem som skyddar mot oxidation och skador som de orsakar 
(oxidativa skador), men ibland överbelastas skyddssystemen, då oxidativ stress 
uppkommer. Många mikronutrienter är även så kallade antioxidanter och dessa kan 
också skydda mot att oxidation uppstår. Det paradoxala är att samma egenskap som gör 
att de skyddar mot oxidativa skador (som antioxidanter) också gör att de har förmågan 
att ändra deras sätt att verka och agera som pro-oxidanter och orsaka oxidation istället 
för att skydda mot det.  
 
I denna avhandling har vi använt olika modellsystem för att jämföra förmågan av 
tretton olika mikronutrienter (varav många antioxidanter) att agera som pro-oxidanter 
och orsaka oxidation till ett av ”orden” i vår arvsmassa (DNA-basen guanin). Två 
mikronutrienter stack ut – vitamin A och C. Dessa oxiderade, alltså skadade, DNA-
basen och effekten ökade när dosen ökades. Direktiv på EU-nivå reglerar vilka 
föreningar som får finnas i tillskott och vi såg att flera av de föreningar som räknas som 
”vitamin A” eller ”vitamin C” skilde sig åt i sin förmåga att agera som pro-oxidanter. I 
linje med vad andra har sett så påverkade omgivningsmiljön deras förmåga att agera 
som pro-oxidanter. Omgivningsmiljön (förmodligen även kroppens) är således 
väsentlig för hur en antioxidant/pro-oxidant agerar. Vi såg också att tillsatsen av 
metallerna koppar eller järn förstärkte pro-oxidativa aktiviteten från både vitamin A 
och C. Kombinationen av vitamin C och koppar utmärkte sig genom att inte bara 
oxidera DNA-basen utan även arvsmassan i celler i ett system som efterliknar 
människosituationen lite mer (men som ändå är långt ifrån). Vitamin C och koppar 
förekommer dessutom tillsammans i multivitamintillskott. Vitaminernas olika förmågor 
att agera som antioxidanter eller pro-oxidanter bör tas i bejakande vid exempelvis 
framställningen av tillskott.  
 
Denna avhandling innehåller också två stycken humanstudier, alltså studier på 
människor där effekten av tillskott i människor undersökts. I den ena studien 
undersökte vi om nivån eller intag av folat, eller folsyra, påverkade nivån av skador på 
arvsmassan. Tillskott med folsyra rekommenderas av Livsmedelsverket till kvinnor 
som planerar att bli gravida eller som är i början av en graviditet, för en normal 
utveckling av fostret. I vår studie bland 36 infertila kvinnor fann vi inga samband 
mellan folat/folsyra-status eller intag och skadenivåer på arvsmassan. Kvinnorna hade 
tillfredsställande nivåer av folat i kroppen och det kan vara så att skadenivån på 
arvsmassan hade påverkats mer av folsyranivån om de hade haft låga folatnivåer. 
Avsaknaden av positiva hälsoeffekter i många studier med vitamintillskott har bidragit 
till ett ökat intresse för tillskott som efterliknar innehållet i frukt och grönt i större 
utsträckning – kan de ge mer utlovande resultat? Vi utförde en så kallad 
interventionsstudie där 45 njursjuka patienter åt ett tillskott innehållande olja från 
havtorn, ett bär innehållande bl.a. antioxidanter och fettsyror. Dessvärre hade 
havtornstillskottet ingen effekt på skadenivån på arvsmassan i salivkörtlar, inte heller 
hade den någon effekt på muntorrhet eller andra sjukdomsrelaterade mätningar. 
 
Resultaten i denna avhandling bidrar till den växande bevisbördan för att 
vitamintillskott inte har en skyddande hälsoeffekt i alla lägen. Avhandlingen betonar att 
varje mikronutrient har unika egenskaper, vilka också kan påverkas av dess omgivning. 
Det kan vara så att vitamintillskott har bäst verkan hos de med näringsbrist.  
 
  72
14 ACKNOWLEDGEMENTS 
From the bottom of my heart I would like to express my gratitude to everyone who has 
supported and helped me throughout the process leading up to this thesis, and to 
everyone who has brought joy to my life through this process! Especial thanks to: 
 
Prof. Lennart Möller, my main supervisor, for letting me become a part of AnTox, for 
giving me the opportunity to do research and for supporting me through the process. I 
also want to thank you immensely for the opportunity to teach and administer courses – 
something that I (once I got over the initial shock) have truly enjoyed!  
  
Prof. Em. Jan Bergman, my co-supervisor, for always being accessible and available 
for help and for your invaluable help whenever I was encountered by the world of 
organic chemistry. 
 
Johan Ancher, my mentor, thank you for your sincere interest in what I do, for finding 
the time to meet me despite your tight schedule and for your valuable tips!  
 
All collaborators: Clara Ersson, Ylva Rodhe, Britta Hylander-Rössner, Royne 
Thorman, Agneta Yngve, Anneli Stavreus-Evers, Signe Altmäe, Tiina Murto, 
Cecilia Wanhainen, Eric Poortvliet and Anna Böttiger, thank you for good 
collaborations and for sharing your experiences and expertise. Also thanks to Klara 
Midander, for help with the metal analysis.  
 
My current colleagues and friends at AnTox: Clara Ersson, Ylva Rodhe, Johanna 
Kain, Pontus Cronholm, Hanna Karlsson, Staffan Larsson, Karine Elihn and Siiri 
Latvala. Clara, thank you for all the invaluable support during this rollercoaster ride. It 
is thanks to you that I am ready to defend! Ylva, thank you for good cooperation in the 
sea buckthorn study, good discussions and great company in the office, as well as for 
the invaluable feedback on my thesis. Johanna, thank you for cooperation in the lab, 
help, and talks about big and small as well as for the fun times we’ve had outside the 
work sphere! Pontus, thank you for your kindness and big heart, and for the many talks 
about everything from research, PhD and life itself. I have really enjoying sharing 
office with you! Hanna K, thank you for the inspiration that you have given me. Siiri, 
the group’s newest addition, I hope you will enjoy being part of AnTox. 
 
The former AnTox colleagues, Jingwen Shi, Hanna Zandrén, Michael Cornelius, 
Eszter Nagy, Rikard Åsgård, Mary-Ann Zetterqvist and Magnus Zeisig. Jingwen, 
thank you for coming to our group with such an openness, optimism and enthusiasm. 
Eszter, Micheal, Rikard, Mary-Anna and Magnus, thank you for introducing me 
into this wonderful working group and to the world of science, Macintosh and ‘fika’-
routines! Hanna Z, thank you for all the talks during your time here. I also want to 
thank my former master thesis student Jolanta Nowodzinska, with your warm heart 
and fast legs you made the days as a sturdy rock with a big belly and walking 
disabilities so much easier. I wish you the very best! A huge immense collective thank 
you to all current and past members of the AnTox group (including all master thesis 
students) – it has been a true pleasure to get to know you all and have you all as 
  73
colleagues, it has made the days so much fun! I hope we manage to stay in touch 
whatever the future holds for each of us! 
 
Other people who have contributed to this thesis: Cassandra Reynolds, thank you for 
the illustrations that you’ve made, your work impresses me. Carolin Ekman, thank 
you for taking the time to proof read my thesis, despite your already tight schedule.  
 
My other dear friends who I treasure so much, I’m so glad to have you, your 
husbands/boyfriends and families in my life! Jenny, Lotta, Carolin, Emma, Anna, 
Linda and Daniel. Thank you all for contributing to relaxing and fun times! Thank you 
also for showing interest and supporting me, and – not least – for still being my friends 
despite my absence at times! My study mates from KTH, Johanna, Lotta, Ida, Sara 
and Jeanette, I’m so glad we’re still in touch and it’s always great to see you! The 
‘mums’ Linda, Susanna, Jessica, Karolina, Madeleine and Helena, thank you for 
fun and relaxing times, I’m so glad we’ve managed to keep up our ‘mummy dinners’!  
 
My in-laws, Anne and Michael, Andrew and Cass, thank you for so warmheartedly 
taking me in to your family.  
 
My brothers and their families: Mikael, Magnus, Pia, Victor, Mathias, Carl, 
Lennart, Lotta, Andreas, Maria and Rikard. I am happy and blessed to have you all 
in my life. With this thesis you will finally get a glimpse of what it is that I do. Especial 
thanks to Micke for all the help you have given me throughout the years and thank you 
Magnus and Pia for all the recent help in the preparation for our wedding as well as 
my dissertation party!  
 
My grandparents: ‘Morfar’ Mats, thank you for everything throughout the years, it is 
wonderful to have you so close and to share so many enjoyable moments with you! 
‘Farmor’ Alva and ‘farfar’ Ragnar, thank you for showing such interest in what I do, a 
special thank you to ‘farfar’ for making a genuine attempt to read every report and 
article that I write!  
 
My parents, Agneta and Göran, thank you for your unconditional love and immense 
support throughout the years, and in particular during the hectic study, research and 
thesis writing times. Without your help, this would have been so much harder for me. 
Thank you for always being there and always being on stand by! 
 
My husband, Ian, thank you for being you! Thank you also for putting up with me 
during the ups and downs leading up to this thesis. Now you’re wife is back! And last, 
but not least – our daughter Emilia, you are the best that ever happened to me! You 
have given me strength and energy during this hectic time – älskade hjärtat, nu har 
mamma skrivit klart!   
 
The PhD studies were financially supported by KID, an individual PhD grant from the 
Board of Postgraduate Studies at Karolinska Institutet. The author of this thesis is a 
member of ECNIS (Environmental Cancer Risk, Nutrition and Individual 
Susceptibility), a network of excellence within the European Union 6th Framework 
Program, Priority 5: ‘Food Quality and Safety’ (Contract No 513 943). 
  74
15 REFERENCES 
[1]  Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, et al. 
Dietary supplement use in the United States, 2003-2006. J Nutr 2011;141:261-6. 
[2]  B.S. Egenvård, URL: http://www.svenskegenvard.se/index.php/statistik-om-
branschen. Access: April 7, 2011. 
[3]  Rutkowski M, Grzegorczyk K. Adverse effects of antioxidative vitamins. 
International journal of occupational medicine and environmental health 
2012;25:105-21. 
[4]  Soni MG, Thurmond TS, Miller ER, 3rd, Spriggs T, Bendich A, Omaye ST. 
Safety of vitamins and minerals: controversies and perspective. Toxicol Sci 
2010;118:348-55. 
[5]  Boeing H, Bechthold A, Bub A, Ellinger S, Haller D, Kroke A, et al. Critical 
review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr 
2012;51:637-63. 
[6]  World Cancer Research Fund/American Institute for Cancer Research. Food, 
nutrition, physical activity, and the prevention of cancer: a global perspective. 
Washington, USA: American Institute for Cancer Research; 2007. 
[7]  Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. Nutrition 
intervention trials in Linxian, China: supplementation with specific 
vitamin/mineral combinations, cancer incidence, and disease-specific mortality 
in the general population. J Natl Cancer Inst 1993;85:1483-92. 
[8]  Qiao YL, Dawsey SM, Kamangar F, Fan JH, Abnet CC, Sun XD, et al. Total 
and cancer mortality after supplementation with vitamins and minerals: follow-
up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer 
Inst 2009;101:507-18. 
[9]  Li JY, Taylor PR, Li B, Dawsey S, Wang GQ, Ershow AG, et al. Nutrition 
intervention trials in Linxian, China: multiple vitamin/mineral supplementation, 
cancer incidence, and disease-specific mortality among adults with esophageal 
dysplasia. J Natl Cancer Inst 1993;85:1492-8. 
[10]  The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The 
alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, 
participant characteristics, and compliance. Ann Epidemiol 1994;4:1-10. 
[11]  Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, et 
al. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence 
in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-
line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70. 
[12]  The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The 
effect of vitamin E and beta carotene on the incidence of lung cancer and other 
cancers in male smokers.. N Engl J Med 1994;330:1029-35. 
[13]  Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, et al. 
Incidence of cancer and mortality following alpha-tocopherol and beta-carotene 
supplementation: a postintervention follow-up. JAMA 2003;290:476-85. 
[14]  Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FLJ, Omenn 
GS, et al. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung 
cancer and cardiovascular disease mortality during 6-year follow-up after 
stopping beta-carotene and retinol supplements. J Natl Cancer Inst 
2004;96:1743-50. 
[15]  Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et 
al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-
Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996;88:1550-9. 
  75
[16]  Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et 
al. Effects of a combination of beta carotene and vitamin A on lung cancer and 
cardiovascular disease. N Engl J Med 1996;334:1150-5. 
[17]  Steering Committee of the Physicians' Health Study Research Group. Final 
report on the aspirin component of the ongoing Physicians' Health Study. N 
Engl J Med 1989;321:129-35. 
[18]  Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. 
Lack of effect of long-term supplementation with beta carotene on the incidence 
of malignant neoplasms and cardiovascular disease. N Engl J Med 
1996;334:1145-9. 
[19]  Gaziano JM, Glynn RJ, Christen WG, Kurth T, Belanger C, MacFadyen J, et al. 
Vitamins E and C in the prevention of prostate and total cancer in men: the 
Physicians' Health Study II randomized controlled trial. JAMA 2009;301:52-62. 
[20]  Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, et al. 
Vitamins E and C in the prevention of cardiovascular disease in men: the 
Physicians' Health Study II randomized controlled trial. JAMA 2008;300:2123-
33.  
[21]  Grodstein F, Kang JH, Glynn RJ, Cook NR, Gaziano JM. A randomized trial of 
beta carotene supplementation and cognitive function in men: the Physicians' 
Health Study II. Arch Intern Med 2007;167:2184-90. 
[22]  Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, et al. 
Multivitamins in the prevention of cancer in men. The Physician's Health Study 
II Randomizes Controlled Trial. JAMA 2012; in press, doi: 10.1001/ 
jama.2012.14641. 
[23]  Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, et al. 
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 
2006;354:669-83. 
[24]  Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, 
O'Sullivan MJ, et al. Calcium plus vitamin D supplementation and the risk of 
colorectal cancer. N Engl J Med 2006;354:684-96. 
[25]  Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. The 
SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects 
of antioxidant vitamins and minerals. Arch Intern Med 2004;164:2335-42. 
[26]  Hercberg S, Kesse-Guyot E, Druesne-Pecollo N, Touvier M, Favier A, Latino-
Martel P, et al. Incidence of cancers, ischemic cardiovascular diseases and 
mortality during 5-year follow-up after stopping antioxidant vitamins and 
minerals supplements: a postintervention follow-up in the SU.VI.MAX Study. 
Int J Cancer 2010;127:1875-81. 
[27]  Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et 
al. Effect of selenium and vitamin E on risk of prostate cancer and other 
cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). 
JAMA 2009;301:39-51. 
[28]  Klein EA, Thompson IM, Jr., Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, 
et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E 
Cancer Prevention Trial (SELECT). JAMA 2011;306:1549-56. 
[29]  Schrauzer GN. RE: Lessons from the selenium and vitamin E cancer prevention 
trial (SELECT). Crit Rev Biotechnol 2009;29:81. 
[30]  Block KI. Antioxidants: SELECTed out? Integr Cancer Ther 2009;8:5-8. 
[31]  Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in 
randomized trials of antioxidant supplements for primary and secondary 
prevention: systematic review and meta-analysis. JAMA 2007;297:842-57. 
  76
[32]  Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant 
supplements for prevention of mortality in healthy participants and patients with 
various diseases. Cochrane Database Syst Rev 2012;3, doi: 
10.1002/14651858.CD007176.pub2. 
[33]  Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements 
for prevention of gastrointestinal cancers: a systematic review and meta-
analysis. Lancet 2004;364:1219-28. 
[34]  Jeon YJ, Myung SK, Lee EH, Kim Y, Chang YJ, Ju W, et al. Effects of beta-
carotene supplements on cancer prevention: meta-analysis of randomized 
controlled trials. Nutr Cancer 2011;63:1196-207. 
[35]  Myung SK, Kim Y, Ju W, Choi HJ, Bae WK. Effects of antioxidant 
supplements on cancer prevention: meta-analysis of randomized controlled 
trials. Ann Oncol 2010;21:166-79. 
[36]  Papaioannou D, Cooper KL, Carroll C, Hind D, Squires H, Tappenden P, et al. 
Antioxidants in the chemoprevention of colorectal cancer and colorectal 
adenomas in the general population: a systematic review and meta-analysis. 
Colorectal Dis 2011;13:1085-99. 
[37]  Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H. Meta-analysis of vitamin D, 
calcium and the prevention of breast cancer. Breast Cancer Res Treat 
2010;121:469-77. 
[38]  Slatore CG, Littman AJ, Au DH, Satia JA, White E. Long-term use of 
supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce 
the risk of lung cancer. Am J Respir Crit Care Med 2008;177:524-30. 
[39]  Mursu J, Robien K, Harnack LJ, Park K, Jacobs DR, Jr. Dietary supplements 
and mortality rate in older women: the Iowa Women's Health Study. Arch Intern 
Med 2011;171:1625-33. 
[40]  Zempleni J, Rucker RB, McCormick DB, Suttie JW. Handbook of vitamins. 4th 
ed: CRC Press, Taylor & Francis Group 2007. 
[41]  Palozza P, Simone R, Mele MC. Interplay of carotenoids with cigarette 
smoking: implications in lung cancer. Curr Med Chem 2008;15:844-54. 
[42]  Devaraj S, Leonard S, Traber MG, Jialal I. Gamma-tocopherol supplementation 
alone and in combination with alpha-tocopherol alters biomarkers of oxidative 
stress and inflammation in subjects with metabolic syndrome. Free Radic Biol 
Med 2008;44:1203-8. 
[43]  Wang XD, Russell RM. Procarcinogenic and anticarcinogenic effects of beta-
carotene. Nutr Rev 1999;57:263-72. 
[44]  Alija AJ, Bresgen N, Sommerburg O, Langhans CD, Siems W, Eckl PM. Beta-
carotene breakdown products enhance genotoxic effects of oxidative stress in 
primary rat hepatocytes. Carcinogenesis 2006;27:1128-33. 
[45]  Clark SF. The biochemistry of antioxidants revisited. Nutr Clin Pract 2002;17:5-
17. 
[46]  Duarte TL, Lunec J. Review: When is an antioxidant not an antioxidant? A 
review of novel actions and reactions of vitamin C. Free Radic Res 
2005;39:671-86. 
[47]  Murata M, Kawanishi S. Oxidative DNA damage by vitamin A and its 
derivative via superoxide generation. J Biol Chem 2000;275:2003-8. 
[48]  Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 4th ed. 
Oxford: Oxford University Press; 2007. 
[49]  Bendich A, Langseth L. Safety of vitamin A. Am J Clin Nutr 1989;49:358-71. 
[50]  Dawson MI. The importance of vitamin A in nutrition. Curr Pharm Des 
 2000;6:311-25. 
  77
[51]  Fenech M. The role of folic acid and Vitamin B12 in genomic stability of 
human cells. Mutat Res 2001;475:57-67. 
[52]  Duthie SJ. Folate and cancer: how DNA damage, repair and methylation impact 
on colon carcinogenesis. J Inherit Metab Dis 2011;34:101-9. 
[53]  Jagerstad M. Folic acid fortification prevents neural tube defects and may also 
reduce cancer risks. Acta Paediatr 2012;101:1007-12. 
[54]  Laanpere M, Altmäe S, Stavreus-Evers A, Nilsson TK, Yngve A, Salumets A. 
Folate-mediated one-carbon metabolism and its effect on female fertility and 
pregnancy viability. Nutr Rev 2010;68:99-113. 
[55]  Ebbing M, Bonaa KH, Nygard O, Arnesen E, Ueland PM, Nordrehaug JE, et al. 
Cancer incidence and mortality after treatment with folic acid and vitamin B12. 
JAMA 2009;302:2119-26. 
[56]  Wien TN, Pike E, Wisloff T, Staff A, Smeland S, Klemp M. Cancer risk with 
folic acid supplements: a systematic review and meta-analysis. BMJ Open 2012; 
doi: 10.1136/bmjopen-2011-000653. 
[57]  Carr A, Frei B. Does vitamin C act as a pro-oxidant under physiological 
conditions? FASEB J 1999;13:1007-24. 
[58]  Verrax J, Calderon PB. The controversial place of vitamin C in cancer 
treatment. Biochem Pharmacol 2008;76:1644-52.  
[59]  Douglas RM, Hemila H, Chalker E, Treacy B. Vitamin C for preventing and 
treating the common cold. Cochrane Database Syst Rev 2007:CD000980. 
[60]  Giovannucci E. Vitamin D and cancer incidence in the Harvard cohorts. Annals 
of epidemiology 2009;19:84-8. 
[61]  Vermeer C. Vitamin K: the effect on health beyond coagulation - an overview. 
Food Nutr Res 2012;56. 
[62]  Greer FR. Vitamin K the basics--what's new? Early Hum Dev 2010;86 Suppl 
1:43-7. 
[63]  Miller PE, Snyder DC. Phytochemicals and cancer risk: a review of the 
epidemiological evidence. Nutr Clin Pract 2012;27:599-612. 
[64]  Sies H. Oxidative stress II. Oxidants and antioxidants. London: Academic Press 
1991. 
[65]  Halliwell B. Free radicals and antioxidants - quo vadis? Trends Pharmacol Sci 
2011;32:125-30. 
[66]  Milligan JR, Aguilera JA, Hoang O, Ly A, Tran NQ, Ward JF. Repair of guanyl 
radicals in plasmid DNA by electron transfer is coupled to proton transfer. J Am 
Chem Soc 2004;126:1682-7. 
[67]  Osiecki M, Ghanavi P, Atkinson K, Nielsen LK, Doran MR. The ascorbic acid 
paradox. Biochem Biophys Res Commun 2010;400:466-70. 
[68]  Palozza P, Calviello G, Serini S, Maggiano N, Lanza P, Ranelletti FO, et al. 
beta-carotene at high concentrations induces apoptosis by enhancing oxy-radical 
production in human adenocarcinoma cells. Free Radic Biol Med 2001;30:1000-
7. 
[69]  Lord CJ, Ashworth A. The DNA damage response and cancer therapy. Nature 
2012;481:287-94. 
[70]  Steenken S, Jovanovic SV. How easily oxidizable is DNA? One-electron 
reduction potentials of adenosine and guanosine radicals in aqueous solution. J 
Am Chem Soc 1997;119:617-8. 
[71]  ESCODD, Gedik CM, Collins A. Establishing the background level of base 
oxidation in human lymphocyte DNA: results of an interlaboratory validation 
study. FASEB J 2005;19:82-4. 
  78
[72]  Delaney S, Jarem DA, Volle CB, Yennie CJ. Chemical and biological 
consequences of oxidatively damaged guanine in DNA. Free Radic Res 
2012;46:420-41. 
[73]  Møller P, Cooke MS, Collins A, Olinski R, Rozalski R, Loft S. Harmonising 
measurements of 8-oxo-7,8-dihydro-2'-deoxyguanosine in cellular DNA and 
urine. Free Radic Res 2012;46:541-53. 
[74]  ECNIS. State of validation of biomarkers of carcinogen exposure and early 
effects and their applicability to molecular epidemiology. In: Farmer PB, Editors 
Kyrtopoulos SA and Emeny JM. Leicester, UK 2007. 
[75]  Jena NR. DNA damage by reactive species: Mechanisms, mutation and repair. J 
Biosci 2012;37:503-17. 
[76]  Crowe S, Cresswell K, Robertson A, Huby G, Avery A, Sheikh A. The case 
study approach. BMC Med Res Methodol 2011;11:100. 
[77]  Wang JJ, Attia J. Study designs in epidemiology and levels of evidence. Am J 
Ophthalmol 2010;149:367-70. 
[78]  Park JW, Cundy KC, Ames BN. Detection of DNA adducts by high-
performance liquid chromatography with electrochemical detection. 
Carcinogenesis 1989;10:827-32. 
[79]  ESCODD. Measurement of DNA oxidation in human cells by chromatographic 
and enzymic methods. Free Radic Biol Med 2003;34:1089-99. 
[80]  Collins AR. The comet assay for DNA damage and repair: principles, 
applications, and limitations. Mol Biotechnol 2004;26:249-61. 
[81]  Duthie SJ, McMillan P. Uracil misincorporation in human DNA detected using 
single cell gel electrophoresis. Carcinogenesis 1997;18:1709-14. 
[82]  Shaposhnikov SA, Salenko VB, Brunborg G, Nygren J, Collins AR. Single-cell 
gel electrophoresis (the comet assay): loops or fragments? Electrophoresis 
2008;29:3005-12. 
[83]  Collins AR, Oscoz AA, Brunborg G, Gaivao I, Giovannelli L, Kruszewski M, et 
al. The comet assay: topical issues. Mutagenesis 2008;23:143-51. 
[84]  Johansson C, Møller P, Forchhammer L, Loft S, Godschalk RW, Langie SA, et 
al. An ECVAG trial on assessment of oxidative damage to DNA measured by 
the comet assay. Mutagenesis 2010;25:125-32. 
[85]  Basten GP, Duthie SJ, Pirie L, Vaughan N, Hill MH, Powers HJ. Sensitivity of 
markers of DNA stability and DNA repair activity to folate supplementation in 
healthy volunteers. Br J Cancer 2006;94:1942-7. 
[86]  Kapiszewska M, Kalemba M, Wojciech U, Milewicz T. Uracil misincorporation 
into DNA of leukocytes of young women with positive folate balance depends 
on plasma vitamin B12 concentrations and methylenetetrahydrofolate reductase 
polymorphisms. A pilot study. J Nutr Biochem 2005;16:467-78. 
[87]  Stanczyk M, Sliwinski T, Trelinska J, Cuchra M, Markiewicz L, Dziki L, et al. 
Role of base-excision repair in the treatment of childhood acute lymphoblastic 
leukaemia with 6-mercaptopurine and high doses of methotrexate. Mutat Res 
2012;741:13-21. 
[88]  Gedik CM, Boyle SP, Wood SG, Vaughan NJ, Collins AR. Oxidative stress in 
humans: validation of biomarkers of DNA damage. Carcinogenesis 
2002;23:1441-6. 
[89]  Prior RL, Wu X, Schaich K. Standardized methods for the determination of 
antioxidant capacity and phenolics in foods and dietary supplements. J Agric 
Food Chem 2005;53:4290-302. 
[90]  Palozza P. Prooxidant actions of carotenoids in biologic systems. Nutr Rev 
1998;56:257-65. 
  79
[91]  Lorenzo Y, Azqueta A, Luna L, Bonilla F, Dominguez G, Collins AR. The 
carotenoid beta-cryptoxanthin stimulates the repair of DNA oxidation damage in 
addition to acting as an antioxidant in human cells. Carcinogenesis 
2009;30:308-14. 
[92]  Johansson C, Rytter E, Nygren J, Vessby B, Basu S, Möller L. Down-regulation 
of oxidative DNA lesions in human mononuclear cells after antioxidant 
supplementation correlates to increase of gamma-tocopherol. Int J Vitam Nutr 
Res 2008;78:183-94. 
[93]  Halliwell B. Oxidative stress in cell culture: an under-appreciated problem? 
FEBS Lett 2003;540:3-6. 
[94]  American Type Culture Collection Standards Development Organization 
Workgroup ASN-0002. Cell line misidentification: the beginning of the end. 
Nat Rev Cancer 2010;10:441-8. 
[95]  Chan ED, Riches DW, White CW. Redox paradox: effect of N-acetylcysteine 
and serum on oxidation reduction-sensitive mitogen-activated protein kinase 
signaling pathways. Am J Respir Cell Mol Biol 2001;24:627-32. 
[96]  Moore GE, Gerner RE, Franklin HA. Culture of normal human leukocytes. 
JAMA 1967;199:519-24. 
[97]  Kendall JM. Designing a research project: randomised controlled trials and their 
principles. Emerg Med J 2003;20:164-8. 
[98]  ECNIS. Dietary vitamins, polyphenols, selenium and probiotics: biomarkers of 
exposure and mechanisms of anticarcinogenic action. Sw. Teresy, Poland: Nofer 
Institute of Occupational Medicine; 2007. 
[99]  Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin 
A. Am J Clin Nutr 2006;83:191-201. 
[100]  van Helden YG, Keijer J, Heil SG, Pico C, Palou A, Oliver P, et al. Beta-
carotene affects oxidative stress-related DNA damage in lung epithelial cells 
and in ferret lung. Carcinogenesis 2009;30:2070-6. 
[101]  Kontek R, Drozda R, Sliwinski M, Grzegorczyk K. Genotoxicity of irinotecan 
and its modulation by vitamins A, C and E in human lymphocytes from healthy 
individuals and cancer patients. Toxicol In Vitro 2010;24:417-24. 
[102]  Zhou GD, Richardson M, Fazili IS, Wang J, Donnelly KC, Wang F, et al. Role 
of retinoic acid in the modulation of benzo(a)pyrene-DNA adducts in human 
hepatoma cells: implications for cancer prevention. Toxicol Appl Pharmacol 
2010;249:224-30. 
[103]  Dal-Pizzol F, Klamt F, Frota ML, Jr., Moraes LF, Moreira JC, Benfato MS. 
Retinol supplementation induces DNA damage and modulates iron turnover in 
rat Sertoli cells. Free Radic Res 2000;33:677-87. 
[104]  Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. Terminal differentiation of 
human promyelocytic leukemia cells induced by dimethyl sulfoxide and other 
polar compounds. Proc Natl Acad Sci USA 1978;75:2458-62. 
[105]  Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human 
promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci 
USA 1980;77:2936-40. 
[106]  Nordenfelt P, Bauer S, Lonnbro P, Tapper H. Phagocytosis of Streptococcus 
pyogenes by all-trans retinoic acid-differentiated HL-60 cells: roles of 
azurophilic granules and NADPH oxidase. PLoS One 2009;4:e7363. 
[107]  Caple F, Williams EA, Spiers A, Tyson J, Burtle B, Daly AK, et al. Inter-
individual variation in DNA damage and base excision repair in young, healthy 
non-smokers: effects of dietary supplementation and genotype. Br J Nutr 
2010;103:1585-93. 
  80
[108]  Lagadu S, Lechevrel M, Sichel F, Breton J, Pottier D, Couderc R, et al. 8-oxo-
7,8-dihydro-2'-deoxyguanosine as a biomarker of oxidative damage in 
oesophageal cancer patients: lack of association with antioxidant vitamins and 
polymorphism of hOGG1 and GST. J Exp Clin Cancer Res 2010;29:157. 
[109]  Caliskan-Can E, Firat H, Ardic S, Simsek B, Torun M, Yardim-Akaydin S. 
Increased levels of 8-hydroxydeoxyguanosine and its relationship with lipid 
peroxidation and antioxidant vitamins in lung cancer. Clin Chem Lab Med 
2008;46:107-12. 
[110]  Foksinski M, Gackowski D, Rozalski R, Siomek A, Guz J, Szpila A, et al. 
Effects of basal level of antioxidants on oxidative DNA damage in humans. Eur 
J Nutr 2007;46:174-80. 
[111]  Morin B, Narbonne JF, Ribera D, Badouard C, Ravanat JL. Effect of dietary fat-
soluble vitamins A and E and proanthocyanidin-rich extract from grape seeds on 
oxidative DNA damage in rats. Food Chem Toxicol 2008;46:787-96. 
[112]  Velanganni AA, Dharaneedharan S, Geraldine P, Balasundram C. Dietary 
supplementation of vitamin A, C and E prevents p-dimethylaminoazobenzene 
induced hepatic DNA damage in rats. Indian J Biochem Biophys 2007;44:157-
63. 
[113]  de Oliveira MR, Silvestrin RB, Mello e Souza T, Moreira JC. Therapeutic 
vitamin A doses increase the levels of markers of oxidative insult in substantia 
nigra and decrease locomotory and exploratory activity in rats after acute and 
chronic supplementation. Neurochem Res 2008;33:378-83. 
[114]  Dalmolin RJ, Zanotto-Filho A, De Oliveira RB, Duarte RF, Pasquali MA, 
Moreira JC. Retinol and retinoic acid increase MMP-2 activity by different 
pathways in cultured Sertoli cells. Free Radic Res 2007;41:1338-47. 
[115]  Myhre AM, Carlsen MH, Bohn SK, Wold HL, Laake P, Blomhoff R. Water-
miscible, emulsified, and solid forms of retinol supplements are more toxic than 
oil-based preparations. Am J Clin Nutr 2003;78:1152-9. 
[116]  Mamede AC, Tavares SD, Abrantes AM, Trindade J, Maia JM, Botelho MF. 
The role of vitamins in cancer: a review. Nutr Cancer 2011;63:479-94. 
[117]  van Zandwijk N, Dalesio O, Pastorino U, de Vries N, van Tinteren H. 
EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients 
with head and neck cancer or lung cancer. For the European Organization for 
Research and Treatment of Cancer Head and Neck and Lung Cancer 
Cooperative Groups. J Natl Cancer Inst 2000;92:977-86. 
[118]  Magiorkinis E, Beloukas A, Diamantis A. Scurvy: past, present and future. Eur J 
Intern Med 2011;22:147-52. 
[119]  Szent-Gyorgyi A. Observations on the function of peroxidase systems and the 
chemistry of the adrenal cortex: Description of a new carbohydrate derivative. 
Biochem J 1928;22:1387-409. 
[120]  Liang WJ, Johnson D, Jarvis SM. Vitamin C transport systems of mammalian 
cells. Mol Membr Biol 2001;18:87-95. 
[121]  Tsukaguchi H, Tokui T, Mackenzie B, Berger UV, Chen XZ, Wang Y, et al. A 
family of mammalian Na+-dependent L-ascorbic acid transporters. Nature 
1999;399:70-5. 
[122]  Stahl W, van den Berg H, Arthur J, Bast A, Dainty J, Faulks RM, et al. 
Bioavailability and metabolism. Mol Aspects Med 2002;23:39-100. 
[123]  Corti A, Casini AF, Pompella A. Cellular pathways for transport and efflux of 
ascorbate and dehydroascorbate. Arch Biochem Biophys 2010;500:107-15. 
[124]  Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, et al. Vitamin 
C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med 
2004;140:533-7. 
  81
[125]  Kurata T, Nishikawa Y. Chemical characteristics of dehydro-L-ascorbic acid. 
Biosci Biotechnol Biochem 2000;64:1651-5. 
[126]  Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal 
KR, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a 
recommended dietary allowance. Proc Natl Acad Sci USA 1996;93:3704-9. 
[127]  Anderson D, Yu TW, Phillips BJ, Schmezer P. The effect of various 
antioxidants and other modifying agents on oxygen-radical-generated DNA 
damage in human lymphocytes in the COMET assay. Mutat Res 1994;307:261-
71. 
[128]  Robichova S, Slamenova D, Chalupa I, Sebova L. DNA lesions and cytogenetic 
changes induced by N-nitrosomorpholine in HepG2, V79 and VH10 cells: the 
protective effects of Vitamins A, C and E. Mutat Res 2004;560:91-9. 
[129]  Turkez H. The role of ascorbic acid on titanium dioxide-induced genetic 
damage assessed by the comet assay and cytogenetic tests. Exp Toxicol Pathol 
2011;63:453-7. 
[130]  Anderson D, Phillips BJ. Comparative in vitro and in vivo effects of 
antioxidants. Food Chem Toxicol 1999;37:1015-25. 
[131]  Harreus U, Baumeister P, Zieger S, Matthias C. The influence of high doses of 
vitamin C and zinc on oxidative DNA damage. Anticancer Res 2005;25:3197-
201. 
[132]  Yurtcu E, Iseri OD, Sahin FI. Effects of ascorbic acid and beta-carotene on 
HepG2 human hepatocellular carcinoma cell line. Mol Biol Rep 2011;38:4265-
72. 
[133]  Szeto YT, Benzie IF. Effects of dietary antioxidants on human DNA ex vivo. 
Free Radic Res 2002;36:113-8. 
[134]  Ullah MF, Khan HY, Zubair H, Shamim U, Hadi SM. The antioxidant ascorbic 
acid mobilizes nuclear copper leading to a prooxidant breakage of cellular 
DNA: implications for chemotherapeutic action against cancer. Cancer 
Chemother Pharmacol 2011;67:103-10. 
[135]  Kang JS, Cho D, Kim YI, Hahm E, Kim YS, Jin SN, et al. Sodium ascorbate 
(vitamin C) induces apoptosis in melanoma cells via the down-regulation of 
transferrin receptor dependent iron uptake. J Cell Physiol 2005;204:192-7. 
[136]  Park S, Han SS, Park CH, Hahm ER, Lee SJ, Park HK, et al. L-Ascorbic acid 
induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-
mediated mechanisms. Int J Biochem Cell Biol 2004;36:2180-95. 
[137]  Sakagami H, Satoh K, Fukuchi K, Gomi K, Takeda M. Effect on an iron-
chelator on ascorbate-induced cytotoxicity. Free Radic Biol Med 1997;23:260-
70. 
[138]  Barroso MP, Gomez-Diaz C, Lopez-Lluch G, Malagon MM, Crane FL, Navas 
P. Ascorbate and alpha-tocopherol prevent apoptosis induced by serum removal 
independent of Bcl-2. Arch Biochem Biophys 1997;343:243-8. 
[139]  Witenberg B, Kalir HH, Raviv Z, Kletter Y, Kravtsov V, Fabian I. Inhibition by 
ascorbic acid of apoptosis induced by oxidative stress in HL-60 myeloid 
leukemia cells. Biochem Pharmacol 1999;57:823-32. 
[140]  Guaiquil VH, Farber CM, Golde DW, Vera JC. Efficient transport and 
accumulation of vitamin C in HL-60 cells depleted of glutathione. J Biol Chem 
1997;272:9915-21. 
[141]  Rodriguez-Aguilera JC, Navas P. Extracellular ascorbate stabilization: 
enzymatic or chemical process? J Bioenerg Biomembr 1994;26:379-84. 
[142]  Suhail N, Bilal N, Khan HY, Hasan S, Sharma S, Khan F, et al. Effect of 
vitamins C and E on antioxidant status of breast-cancer patients undergoing 
chemotherapy. J Clinical Pharm Ther 2012;37:22-6. 
  82
[143]  Panayiotidis M, Collins AR. Ex vivo assessment of lymphocyte antioxidant 
status using the comet assay. Free Radic Res 1997;27:533-7. 
[144]  Møller P, Viscovich M, Lykkesfeldt J, Loft S, Jensen A, Poulsen HE. Vitamin C 
supplementation decreases oxidative DNA damage in mononuclear blood cells 
of smokers. Eur J Nutr 2004;43:267-74. 
[145]  Austria R, Semenzato A, Bettero A. Stability of vitamin C derivatives in 
solution and topical formulations. J Pharm Biomed Anal 1997;15:795-801. 
[146]  Savini I, D'Angelo I, Ranalli M, Melino G, Avigliano L. Ascorbic acid 
maintenance in HaCaT cells prevents radical formation and apoptosis by UV-B. 
Free Radic Biol Med 1999;26:1172-80. 
[147]  Martin BD, Schoenhard JA, Hwang JM, Sugden KD. Ascorbate is a pro-oxidant 
in chromium-treated human lung cells. Mutat Res 2006;610:74-84. 
[148]  Udenfriend S, Clark CT, Axelrod J, Brodie BB. Ascorbic acid in aromatic 
hydroxylation. I. A model system for aromatic hydroxylation. J Biol Chem 
1954;208:731-9. 
[149]  Hadi SM, Ullah MF, Shamim U, Bhatt SH, Azmi AS. Catalytic therapy of 
cancer by ascorbic acid involves redox cycling of exogenous/endogenous 
copper ions and generation of reactive oxygen species. Chemotherapy 
2010;56:280-4. 
[150]  Duarte TL, Almeida GM, Jones GD. Investigation of the role of extracellular 
H2O2 and transition metal ions in the genotoxic action of ascorbic acid in cell 
culture models. Toxicol Lett 2007;170:57-65.  
[151]  Karasavvas N, Carcamo JM, Stratis G, Golde DW. Vitamin C protects HL60 
and U266 cells from arsenic toxicity. Blood 2005;105:4004-12. 
[152]  Chen K, Suh J, Carr AC, Morrow JD, Zeind J, Frei B. Vitamin C suppresses 
oxidative lipid damage in vivo, even in the presence of iron overload. Am J 
Physiol Endocrinol Metab 2000;279:E1406-12. 
[153]  Zhang W, Cui X, Wang D, Liu Y, Yong L, Li N, et al. Products of oxidized L-
ascorbic acid damage acellular DNA. J Nutr Health Aging 2012;16:442-4. 
[154]  Fisher AE, Naughton DP. Vitamin C contributes to inflammation via radical 
generating mechanisms: a cautionary note. Med Hypotheses 2003;61:657-60. 
[155]  Gorman JE, Clydesdale FM. The behavior and stability of iron-ascorbate 
complexes in solution. J Food Sci 1983:1217-25. 
[156]  Khan MM, Martell AE. Metal ion and metal chelate catalyzed oxidation of 
ascorbic acid by molecular oxygen. I. Cupric and ferric ion catalyzed oxidation. 
J Am Chem Soc 1967;89:4176-85. 
[157]  Bevan RJ, Mistry N, Patel PR, Halligan EP, Dove R, Lunec J. Can vitamin C 
induce nucleotide excision repair? Support from in vitro evidence. Br J Nutr 
2010;103:686-95. 
[158]  Gokhale P, Patel T, Morrison MJ, Vissers MC. The effect of intracellular 
ascorbate on the susceptibility of HL60 and Jurkat cells to chemotherapy agents. 
Apoptosis 2006;11:1737-46. 
[159]  Chen Q, Espey MG, Sun AY, Lee JH, Krishna MC, Shacter E, et al. Ascorbate 
in pharmacologic concentrations selectively generates ascorbate radical and 
hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA 
2007;104:8749-54. 
[160]  Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol 
Nutr Food Res 2007;51:267-92. 
[161]  Ramakrishnan U, Grant F, Goldenberg T, Zongrone A, Martorell R. Effect of 
women's nutrition before and during early pregnancy on maternal and infant 
outcomes: a systematic review. Paediatr Perinat Epidemiol 2012;26 Suppl 
1:285-301. 
  83
[162]  Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, et al. 
Folate deficiency causes uracil misincorporation into human DNA and 
chromosome breakage: implications for cancer and neuronal damage. Proc Natl 
Acad Sci USA 1997;94:3290-5. 
[163]  MacGregor JT, Wehr CM, Hiatt RA, Peters B, Tucker JD, Langlois RG, et al. 
'Spontaneous' genetic damage in man: evaluation of interindividual variability, 
relationship among markers of damage, and influence of nutritional status. 
Mutat Res 1997;377:125-35. 
[164]  Wickramasinghe SN, Fida S. Bone marrow cells from vitamin B12- and folate-
deficient patients misincorporate uracil into DNA. Blood 1994;83:1656-61. 
[165]  Ruan CJ, Rumpunen K, Nybom H. Advances in improvement of quality and 
resistance in a multipurpose crop: sea buckthorn. Crit Rev Biotechnol 2012. 
[166]  Larmo PS, Jarvinen RL, Setala NL, Yang B, Viitanen MH, Engblom JR, et al. 
Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in 
individuals with dry eye. J Nutr 2010;140:1462-8. 
[167]  Kallio H, Yang B, Peippo P. Effects of different origins and harvesting time on 
vitamin C, tocopherols, and tocotrienols in sea buckthorn (Hippophae 
rhamnoides) berries. J Agric Food Chem 2002;50:6136-42. 
[168]  Andersson SC, Rumpunen K, Johansson E, Olsson ME. Tocopherols and 
tocotrienols in sea buckthorn (Hippophae rhamnoides L.) berries during 
ripening. J Agric Food Chem 2008;56:6701-6. 
[169]  St George SD, Cenkowski S. Influence of harvest time on the quality of oil-
based compounds in sea buckthorn (Hippophae rhamnoides L. ssp. sinensis) 
seed and fruit. J Agric Food Chem 2007;55:8054-61. 
[170]  Yang B, Kallio HP. Fatty acid composition of lipids in sea buckthorn 
(Hippophae rhamnoides L.) berries of different origins. J Agric Food Chem 
2001;49:1939-47. 
[171]  Beveridge T, Li TS, Oomah BD, Smith A. Sea buckthorn products: manufacture 
and composition. J Agric Food Chem 1999;47:3480-8. 
[172]  Jover Cervero A, Bagan JV, Jimenez Soriano Y, Poveda Roda R. Dental 
management in renal failure: patients on dialysis. Med Oral Patol Oral Cir Bucal 
2008;13:E419-26. 
[173]  Guzeldemir E, Toygar HU, Tasdelen B, Torun D. Oral health-related quality of 
life and periodontal health status in patients undergoing hemodialysis. J Am 
Dent Assoc 2009;140:1283-93. 
[174]  Akar H, Akar GC, Carrero JJ, Stenvinkel P, Lindholm B. Systemic 
consequences of poor oral health in chronic kidney disease patients. Clin J Am 
Soc Nephrol 2011;6:218-26. 
[175]  Bossola M, Tazza L. Xerostomia in patients on chronic hemodialysis. Nat Rev 
Nephrol 2012;8:176-82. 
[176]  Kan E, Undeger U, Bali M, Basaran N. Assessment of DNA strand breakage by 
the alkaline COMET assay in dialysis patients and the role of Vitamin E 
supplementation. Mutat Res 2002;520:151-9. 
[177]  Handelman GJ, Levin NW. Guidelines for vitamin supplements in chronic 
kidney disease patients: what is the evidence? J Ren Nutr 2011;21:117-9. 
[178]  Montazerifar F, Hashemi M, Karajibani M, Dikshit M. Hemodialysis alters lipid 
profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in 
humans. J Med Food 2010;13:1490-3. 
[179]  Mydlik M, Derzsiova K. Vitamins and quality of life in hemodialysis patients. J 
Nephrol 2008;21 Suppl 13:S129-33. 
  84
[180]  Qin X, Huo Y, Langman CB, Hou F, Chen Y, Matossian D, et al. Folic acid 
therapy and cardiovascular disease in ESRD or advanced chronic kidney 
disease: a meta-analysis. Clin J Am Soc Nephrol 2011;6:482-8. 
[181]  Tayyebi-Khosroshahi H, Houshyar J, Tabrizi A, Vatankhah AM, Razzagi 
Zonouz N, Dehghan-Hesari R. Effect of omega-3 fatty acid on oxidative stress 
in patients on hemodialysis. Iran J Kidney Dis 2010;4:322-6. 
[182]  Bowden RG, Wilson RL, Deike E, Gentile M. Fish oil supplementation lowers 
C-reactive protein levels independent of triglyceride reduction in patients with 
end-stage renal disease. Nutr Clin Pract 2009;24:508-12. 
[183]  Ersson C, Thorman R, Rodhe Y, Möller L, Hylander B. DNA damage in 
salivary gland tissue in patients with chronic kidney disease, measured by the 
comet assay. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:209-
15. 
[184]  Larmo P, Alin J, Salminen E, Kallio H, Tahvonen R. Effects of sea buckthorn 
berries on infections and inflammation: a double-blind, randomized, placebo-
controlled trial. European journal of clinical nutrition 2008;62:1123-30. 
[185]  Larmo PS, Yang B, Hurme SA, Alin JA, Kallio HP, Salminen EK, et al. Effect 
of a low dose of sea buckthorn berries on circulating concentrations of 
cholesterol, triacylglycerols, and flavonols in healthy adults. Eur J Nutr 
2009;48:277-82. 
[186]  Ganju L, Padwad Y, Singh R, Karan D, Chanda S, Chopra MK, et al. Anti-
inflammatory activity of Seabuckthorn (Hippophae rhamnoides) leaves. Int 
Immunopharmacol 2005;5:1675-84. 
[187]  Basu M, Prasad R, Jayamurthy P, Pal K, Arumughan C, Sawhney RC. Anti-
atherogenic effects of seabuckthorn (Hippophaea rhamnoides) seed oil. 
Phytomedicine 2007;14:770-7. 
[188]  Johansson AK, Korte H, Yang B, Stanley JC, Kallio HP. Sea buckthorn berry 
oil inhibits platelet aggregation. J Nutr Biochem 2000;11:491-5. 
[189]  Lehtonen HM, Suomela JP, Tahvonen R, Yang B, Venojarvi M, Viikari J, et al. 
Different berries and berry fractions have various but slightly positive effects on 
the associated variables of metabolic diseases on overweight and obese women. 
Eur J Clin Nutr 2011;65:394-401. 
[190]  Jarvinen RL, Larmo PS, Setala NL, Yang B, Engblom JR, Viitanen MH, et al. 
Effects of oral sea buckthorn oil on tear film Fatty acids in individuals with dry 
eye. Cornea 2011;30:1013-9. 
[191]  Kruczek M, Swiderski A, Mech-Nowak A, Krol K. Antioxidant capacity of 
crude extracts containing carotenoids from the berries of various cultivars of Sea 
buckthorn (Hippophae rhamnoides L.). Acta Biochim Pol 2012;59:135-7. 
[192]  Geetha S, Sai Ram M, Singh V, Ilavazhagan G, Sawhney RC. Anti-oxidant and 
immunomodulatory properties of seabuckthorn (Hippophae rhamnoides)--an in 
vitro study. J Ethnopharmacol 2002;79:373-8. 
[193]  Varshneya C, Kant V, Mehta M. Total phenolic contents and free radical 
scavenging activities of different extracts of seabuckthorn (Hippophae 
rhamnoides) pomace without seeds. Int J Food Sci Nutr 2012;63:153-9. 
[194]  Shukla SK, Chaudhary P, Kumar IP, Samanta N, Afrin F, Gupta ML, et al. 
Protection from radiation-induced mitochondrial and genomic DNA damage by 
an extract of Hippophae rhamnoides. Environ Mol Mutagen 2006;47:647-56. 
[195]  Wu D, Meng Z. Effect of sulfur dioxide inhalation on the glutathione redox 
system in mice and protective role of sea buckthorn seed oil. Arch Environ 
Contam Toxicol 2003;45:423-8. 
[196]  Büyükokuroglu ME, Gülcin I. In vitro antioxidant and antiradical properties of 
Hippophae rhamnoides L. Pharmacogn Mag 2009;4:189-95. 
  85
[197]  Saini M, Tiwari S, Prasad J, Singh S, Kumar MS, Bala M. Hippophae leaf 
extract concentration regulates antioxidant and prooxidant effects on DNA. J 
Diet Suppl 2010;7:60-70. 
[198]  Goel HC, Kumar IP, Samanta N, Rana SV. Induction of DNA-protein cross-
links by Hippophae rhamnoides: implications in radioprotection and 
cytotoxicity. Mol Cell Biochem 2003;245:57-67. 
[199]  Geetha S, Ram MS, Sharma SK, Ilavazhagan G, Banerjee PK, Sawhney RC. 
Cytoprotective and antioxidant activity of seabuckthorn (Hippophae rhamnoides 
L.) flavones against tert-butyl hydroperoxide-induced cytotoxicity in 
lymphocytes. J Med Food 2009;12:151-8. 
[200]  Stopper H, Boullay F, Heidland A, Vienken J, Bahner U. Comet-assay analysis 
identifies genomic damage in lymphocytes of uremic patients. Am J Kidney Dis 
2001;38:296-301. 
[201]  Stoyanova E, Sandoval SB, Zuniga LA, El-Yamani N, Coll E, Pastor S, et al. 
Oxidative DNA damage in chronic renal failure patients. Nephrol Dial 
Transplant 2010;25:879-85. 
[202]  Yasukawa K, Kitanaka S, Kawata K, Goto K. Anti-tumor promoters phenolics 
and triterpenoid from Hippophae rhamnoides. Fitoterapia 2009;80:164-7. 
[203]  Padmavathi B, Upreti M, Singh V, Rao AR, Singh RP, Rath PC. 
Chemoprevention by Hippophae rhamnoides: effects on tumorigenesis, phase II 
and antioxidant enzymes, and IRF-1 transcription factor. Nutr  Cancer 
2005;51:59-67. 
[204]  Olsson ME, Gustavsson KE, Andersson S, Nilsson A, Duan RD. Inhibition of 
cancer cell proliferation in vitro by fruit and berry extracts and correlations with 
antioxidant levels. J Agr Food Chem 2004;52:7264-71. 
[205]  Gerhauser C. Cancer Chemoprevention and Nutri-Epigenetics: State of the Art 
and Future Challenges. Top Curr Chem 2012. 
 
 

